1
|
Cadman T, Strandberg-Larsen K, Calas L, Christiansen M, Culpin I, Dadvand P, de Castro M, Foraster M, Fossati S, Guxens M, Harris JR, Hillegers M, Jaddoe V, Lee Y, Lepeule J, El Marroun H, Maule M, McEachen R, Moccia C, Nader J, Nieuwenhuijsen M, Nybo Andersen AM, Pearson R, Swertz M, Vafeiadi M, Vrijheid M, Wright J, Lawlor DA, Pedersen M. Urban environment in pregnancy and postpartum depression: An individual participant data meta-analysis of 12 European birth cohorts. Environment International 2024; 185:108453. [PMID: 38368715 DOI: 10.1016/j.envint.2024.108453] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/17/2023] [Revised: 01/17/2024] [Accepted: 01/18/2024] [Indexed: 02/20/2024]
Abstract
BACKGROUND Urban environmental exposures associate with adult depression, but it is unclear whether they are associated to postpartum depression (PPD). OBJECTIVES We investigated associations between urban environment exposures during pregnancy and PPD. METHODS We included women with singleton deliveries to liveborn children from 12 European birth cohorts (N with minimum one exposure = 30,772, analysis N range 17,686-30,716 depending on exposure; representing 26-46 % of the 66,825 eligible women). We estimated maternal exposure during pregnancy to ambient air pollution with nitrogen dioxide (NO2) and particulate matter (PM2.5 and PM10), road traffic noise (Lden), natural spaces (Normalised Difference Vegetation Index; NDVI, proximity to major green or blue spaces) and built environment (population density, facility richness and walkability). Maternal PPD was assessed 3-18 months after birth using self-completed questionnaires. We used adjusted logistic regression models to estimate cohort-specific associations between each exposure and PPD and combined results via meta-analysis using DataSHIELD. RESULTS Of the 30,772 women included, 3,078 (10 %) reported having PPD. Exposure to PM10 was associated with slightly increased odds of PPD (adjusted odd ratios (OR) of 1.08 [95 % Confidence Intervals (CI): 0.99, 1.17] per inter quartile range increment of PM10) whilst associations for exposure to NO2 and PM2.5 were close to null. Exposure to high levels of road traffic noise (≥65 dB vs. < 65 dB) was associated with an OR of 1.12 [CI: 0.95, 1.32]. Associations between green spaces and PPD were close to null; whilst proximity to major blue spaces was associated with increased risk of PPD (OR 1.12, 95 %CI: 1.00, 1.26). All associations between built environment and PPD were close to null. Multiple exposure models showed similar results. DISCUSSION The study findings suggest that exposure to PM10, road traffic noise and blue spaces in pregnancy may increase PPD risk, however future studies should explore this causally.
Collapse
Affiliation(s)
- Tim Cadman
- Section for Epidemiology, Department of Public Health, University of Copenhagen, Copenhagen, Denmark; Department of Psychology, Education and Child Studies, Erasmus School of Social and Behavioural Sciences, Erasmus University Rotterdam, Rotterdam, the Netherlands; Department of Social Medicine, School of Medicine, University of Crete, Greece.
| | - Katrine Strandberg-Larsen
- Section for Epidemiology, Department of Public Health, University of Copenhagen, Copenhagen, Denmark
| | - Lucinda Calas
- Inserm, UMR1153 Center for Research in Epidemiology and Statistics (CRESS), Early Life Research on Later Health Team (EARoH), Paris, France
| | - Malina Christiansen
- Section for Epidemiology, Department of Public Health, University of Copenhagen, Copenhagen, Denmark
| | - Iryna Culpin
- MRC Integrative Epidemiology Unit at the University of Bristol, United Kingdom; Population Health Science, Bristol Medical School, University of Bristol, United Kingdom
| | - Payam Dadvand
- Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain; Pompeu Fabra University, Barcelona, Spain; Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Av. Monforte de Lemos, 3-5. Pabellón 11, 28029 Madrid, Spain
| | - Montserrat de Castro
- Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain; Pompeu Fabra University, Barcelona, Spain; Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Av. Monforte de Lemos, 3-5. Pabellón 11, 28029 Madrid, Spain
| | - Maria Foraster
- Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain; Pompeu Fabra University, Barcelona, Spain; Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Av. Monforte de Lemos, 3-5. Pabellón 11, 28029 Madrid, Spain
| | - Serena Fossati
- Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain; Pompeu Fabra University, Barcelona, Spain; Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Av. Monforte de Lemos, 3-5. Pabellón 11, 28029 Madrid, Spain
| | - Mònica Guxens
- Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain; Pompeu Fabra University, Barcelona, Spain; Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Av. Monforte de Lemos, 3-5. Pabellón 11, 28029 Madrid, Spain; Department of Child and Adolescent Psychiatry, University Medical Center, Erasmus MC, Rotterdam, the Netherlands
| | - Jennifer R Harris
- Center for Fertility and Health, Norwegian Institute of Public Health, Olso, Norway
| | - Manon Hillegers
- Department of Child and Adolescent Psychiatry, University Medical Center, Erasmus MC, Rotterdam, the Netherlands
| | - Vincent Jaddoe
- Department of Pediatrics, Erasmus MC, University Medical Center Rotterdam, the Netherlands
| | - Yunsung Lee
- Center for Fertility and Health, Norwegian Institute of Public Health, Olso, Norway
| | - Johanna Lepeule
- Université Grenoble Alpes INSERM CNRS Institute for Advanced Biosciences Team of Environmental Epidemiology Applied to Development and Respiratory Health, F-38700 La Tronche, France
| | - Hanan El Marroun
- Department of Child and Adolescent Psychiatry, University Medical Center, Erasmus MC, Rotterdam, the Netherlands; Department of Pediatrics, Erasmus MC, University Medical Center Rotterdam, the Netherlands
| | - Milena Maule
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO-Piemonte, Turin, Italy
| | - Rosie McEachen
- Bradford Institute for Health Research, Bradford BD9 6RJ, United Kingdom
| | - Chiara Moccia
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO-Piemonte, Turin, Italy
| | - Johanna Nader
- Department of Genetics and Bioinformatics, Division of Health Data and Digitalisation, Norwegian Institute of Public Health, Oslo, Norway
| | - Mark Nieuwenhuijsen
- Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain; Pompeu Fabra University, Barcelona, Spain; Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Av. Monforte de Lemos, 3-5. Pabellón 11, 28029 Madrid, Spain
| | - Anne-Marie Nybo Andersen
- Section for Epidemiology, Department of Public Health, University of Copenhagen, Copenhagen, Denmark
| | - Rebecca Pearson
- MRC Integrative Epidemiology Unit at the University of Bristol, United Kingdom; Population Health Science, Bristol Medical School, University of Bristol, United Kingdom; Manchester Metropolitan University, All Saints Building, All Saints, Manchester, United Kingdom
| | - Morris Swertz
- Genomics Coordination Center, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
| | - Marina Vafeiadi
- Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
| | - Martine Vrijheid
- Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain; Pompeu Fabra University, Barcelona, Spain; Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Av. Monforte de Lemos, 3-5. Pabellón 11, 28029 Madrid, Spain
| | - John Wright
- Bradford Institute for Health Research, Bradford BD9 6RJ, United Kingdom
| | - Deborah A Lawlor
- MRC Integrative Epidemiology Unit at the University of Bristol, United Kingdom; Population Health Science, Bristol Medical School, University of Bristol, United Kingdom
| | - Marie Pedersen
- Section for Epidemiology, Department of Public Health, University of Copenhagen, Copenhagen, Denmark
| |
Collapse
|
2
|
Maritano S, Moirano G, Isaevska E, Pizzi C, Ponzo V, Moccia C, Maule M, Lastrucci V, Alderotti G, Ronfani L, Brumatti LV, Rusconi F, Gagliardi L, Brescianini S, Nisticò L, De Sario M, Culasso M, Richiardi L. Examining the relationship between the environmental impact of diet and child growth from a co-benefit perspective. Environ Res 2024; 250:118496. [PMID: 38365051 DOI: 10.1016/j.envres.2024.118496] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/17/2023] [Revised: 01/29/2024] [Accepted: 02/13/2024] [Indexed: 02/18/2024]
Abstract
The adoption of diets that minimize both their environmental impacts and weight excess in children would be a major co-benefit for climate change mitigation. We evaluated the relationship between child diet-related environmental impact and anthropometric characteristics in an Italian birth cohort. The study involved 2127 children of the Piccolipiù birth cohort. At 4 years, their diet in the previous two months was assessed through a questionnaire, from which we derived individual: (i) diet-related daily greenhouse gas emissions (GHGE), (ii) land use (LU), (iii) adherence to the Mediterranean Diet (MD) and (iv) red meat consumption. We related these variables with overweight and obesity, waist circumference, and height at 4 years using regression models adjusted for a priori selected confounders. Diet-related GHGE and LU had a positive weak association with overweight and obesity, with an odds ratio (OR) for the fourth vs. second quartile of 1.30 for both GHGE (95% confidence intervals -CI-: 0.96; 1.77) and LU (95% CI: 0.96-1.76). Both OR estimates increased after adjustment for energy intake. GHGE and LU were not associated with height, with the exception of shorter children in the first quartile. A high vs. low MD adherence was associated with an increase in height Z-score of 0.11 (95% CI 0.01; 0.21). No association was found for red meat consumption. These results suggest that lowering the impact of high environmental impact diets may have, if anything, beneficial effects on child obesity, overweight, and height, with pro-MD patterns playing an important role.
Collapse
Affiliation(s)
- Silvia Maritano
- Cancer Epidemiology Unit, Medical Science Department, University of Turin and CPO Piemonte, Via Santena 7, 10126, Turin, Italy; University School for Advanced Studies IUSS Pavia, Palazzo del Broletto, Piazza della Vittoria, 27100, Pavia, PV, Italy.
| | - Giovenale Moirano
- Cancer Epidemiology Unit, Medical Science Department, University of Turin and CPO Piemonte, Via Santena 7, 10126, Turin, Italy
| | - Elena Isaevska
- Cancer Epidemiology Unit, Medical Science Department, University of Turin and CPO Piemonte, Via Santena 7, 10126, Turin, Italy
| | - Costanza Pizzi
- Cancer Epidemiology Unit, Medical Science Department, University of Turin and CPO Piemonte, Via Santena 7, 10126, Turin, Italy
| | - Valentina Ponzo
- Human Nutrition Unit, Medical Science Department, University of Turin, c.so Dogliotti 14, 10126, Turin, Italy
| | - Chiara Moccia
- Cancer Epidemiology Unit, Medical Science Department, University of Turin and CPO Piemonte, Via Santena 7, 10126, Turin, Italy
| | - Milena Maule
- Cancer Epidemiology Unit, Medical Science Department, University of Turin and CPO Piemonte, Via Santena 7, 10126, Turin, Italy
| | - Vieri Lastrucci
- Epidemiology Unit, Meyer Children's Hospital, Viale Pieraccini 24, 50139, Florence, Italy
| | - Giorgia Alderotti
- Epidemiology Unit, Meyer Children's Hospital, Viale Pieraccini 24, 50139, Florence, Italy
| | - Luca Ronfani
- Institute for Maternal and Child Health-IRCCS "Burlo Garofolo", via dell'Istria 65/1, 34137, Trieste, Italy
| | - Liza Vecchi Brumatti
- Institute for Maternal and Child Health-IRCCS "Burlo Garofolo", via dell'Istria 65/1, 34137, Trieste, Italy
| | - Franca Rusconi
- Department of Mother and Child Health, Azienda USL Toscana Nord Ovest, Via Cocchi 7/9, 56121, Pisa, Italy
| | - Luigi Gagliardi
- Division of Neonatology and Pediatrics, Ospedale Versilia, Viareggio, Azienda AUSL Toscana Nord Ovest, Pisa, Italy
| | - Sonia Brescianini
- Center for Behavioral Sciences and Mental Health, Italian National Health Institute, 00161, Rome, Italy
| | - Lorenza Nisticò
- Center for Behavioral Sciences and Mental Health, Italian National Health Institute, 00161, Rome, Italy
| | - Manuela De Sario
- Department of Epidemiology, Lazio Regional Health Service, Local Health Unit Roma 1, Rome, Italy
| | - Martina Culasso
- Department of Epidemiology, Lazio Regional Health Service, Local Health Unit Roma 1, Rome, Italy
| | - Lorenzo Richiardi
- Cancer Epidemiology Unit, Medical Science Department, University of Turin and CPO Piemonte, Via Santena 7, 10126, Turin, Italy
| |
Collapse
|
3
|
Moirano G, Pizzi C, Rusconi F, Maule M, Richiardi L, Popovic M. Family socioeconomic position and changes in planned health care for children with chronic diseases during the COVID-19 pandemic in Italy. Front Public Health 2023; 11:1174118. [PMID: 37521970 PMCID: PMC10372358 DOI: 10.3389/fpubh.2023.1174118] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2023] [Accepted: 06/23/2023] [Indexed: 08/01/2023] Open
Abstract
Introduction In this study, we aimed at evaluating whether, during the COVID-19 pandemic, children affected by chronic diseases were impacted by the deferral of planned healthcare caused by the restriction measures. Design This study was conducted using data from the Italian NINFEA birth cohort, which include children born between 2005 and 2016. Women who completed the 4-year NINFEA follow-up questionnaire before November 2020 (N = 5,307) were invited to complete a questionnaire targeted at evaluating the impacts of the pandemic on their children's health. The questionnaire asked mothers to report whether their children had a chronic disease or condition that required one or more regular health checks by a doctor in 2019 (used as a reference period) and whether the children had problems getting routine health checks after March 2020. Results We obtained information on 3,721 children. Out of 353 children with a chronic disease that required at least one medical visit in 2019, 130 (36.8%) experienced problems during the pandemic. Lower family income was associated with a higher risk of experiencing health access problems. We observed that children living in families at lower income tertiles had more chance of experiencing healthcare access problems than children living in families at the highest income tertiles (prevalence rate ratio for a tertile decrease in family income: 1.22; 95% CIs: 1.02-1.49). Conclusion Our study underlines that the COVID-19 pandemic may have caused healthcare access problems for children with prevalent chronic diseases, especially among those living in households with a low socioeconomic position.
Collapse
Affiliation(s)
- Giovenale Moirano
- Cancer Epidemiology Unit and CPO-Piemonte, Department of Medical Sciences, University of Torino, Torino, Italy
- Department of Public Health and Paediatrics, Post Graduate School of Medical Statistics, University of Torino, Torino, Italy
| | - Costanza Pizzi
- Cancer Epidemiology Unit and CPO-Piemonte, Department of Medical Sciences, University of Torino, Torino, Italy
| | - Franca Rusconi
- Department of Mother and Child Health, Azienda USL Toscana Nord Ovest, Pisa, Italy
| | - Milena Maule
- Cancer Epidemiology Unit and CPO-Piemonte, Department of Medical Sciences, University of Torino, Torino, Italy
| | - Lorenzo Richiardi
- Cancer Epidemiology Unit and CPO-Piemonte, Department of Medical Sciences, University of Torino, Torino, Italy
| | - Maja Popovic
- Cancer Epidemiology Unit and CPO-Piemonte, Department of Medical Sciences, University of Torino, Torino, Italy
| |
Collapse
|
4
|
Roccuzzo G, Moirano G, Fava P, Maule M, Ribero S, Quaglino P. Obesity and immune-checkpoint inhibitors in advanced melanoma: A meta-analysis of survival outcomes from clinical studies. Semin Cancer Biol 2023; 91:27-34. [PMID: 36871633 DOI: 10.1016/j.semcancer.2023.02.010] [Citation(s) in RCA: 8] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/31/2022] [Revised: 02/22/2023] [Accepted: 02/28/2023] [Indexed: 03/06/2023]
Abstract
Obesity is a chronic inflammatory condition that has been associated with different types of cancer. However, its role in melanoma incidence, progression, and response to immune-checkpoint-inhibitors (ICI) is still controversial. On the one hand, increased levels of lipids and adipokines can promote tumor proliferation and several genes associated with fatty acid metabolism have been found to be upregulated in melanomas. On the other hand, immunotherapy seems to be more effective in obese animal models, presumably due to an increase in CD8 + and subsequent decrease in PD-1 + T-cells in the tumor microenvironment. In humans, several studies have investigated the role of BMI (body mass index) and other adiposity-related parameters as potential prognostic markers of survival in advanced melanoma patients treated with ICI. The aim of this research has been to systematically review the scientific literature on studies evaluating the relationship between overweight/obesity and survival outcomes in patients with advanced melanoma treated with ICI and to perform a meta-analysis on those sharing common characteristics. After screening 1070 records identified through a literature search, 18 articles assessing the role of BMI-related exposure in relation to survival outcomes in ICI-treated patients with advanced melanoma were included in our review. In the meta-analysis of the association between overweight (defined as BMI>25 or BMI 25-30), overall survival (OS), and progression free survival (PFS), 7 studies were included, yielding a summary HR of 0.87 (95% CI: 0.74-1.03) and 0.96 (95% CI: 0.86-1.08), respectively. Our results show that, despite few suggestive findings, the use of BMI as a valuable predictor of melanoma patients' survival in terms of PFS and OS should not be currently recommended, due to the limited evidence available.
Collapse
Affiliation(s)
- Gabriele Roccuzzo
- Section of Dermatology, Department of Medical Sciences, University of Turin, Turin 10126, Torino, Italy.
| | - Giovenale Moirano
- Cancer Epidemiology Unit and CPO-Piemonte, Department of Medical Sciences, University of Torino, 10126 Torino, Italy; Postgraduate School in Biostatistics, Department of Public Health and Pediatrics, University of Turin, 10126 Torino, Italy
| | - Paolo Fava
- Section of Dermatology, Department of Medical Sciences, University of Turin, Turin 10126, Torino, Italy
| | - Milena Maule
- Cancer Epidemiology Unit and CPO-Piemonte, Department of Medical Sciences, University of Torino, 10126 Torino, Italy
| | - Simone Ribero
- Section of Dermatology, Department of Medical Sciences, University of Turin, Turin 10126, Torino, Italy
| | - Pietro Quaglino
- Section of Dermatology, Department of Medical Sciences, University of Turin, Turin 10126, Torino, Italy
| |
Collapse
|
5
|
Moccia C, Pizzi C, Moirano G, Popovic M, Zugna D, d'Errico A, Isaevska E, Fossati S, Nieuwenhuijsen MJ, Fariselli P, Sanavia T, Richiardi L, Maule M. Modelling socioeconomic position as a driver of the exposome in the first 18 months of life of the NINFEA birth cohort children. Environ Int 2023; 173:107864. [PMID: 36913779 DOI: 10.1016/j.envint.2023.107864] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/23/2022] [Revised: 03/02/2023] [Accepted: 03/02/2023] [Indexed: 06/18/2023]
Abstract
BACKGROUND The exposome drivers are less studied than its consequences but may be crucial in identifying population subgroups with unfavourable exposures. OBJECTIVES We used three approaches to study the socioeconomic position (SEP) as a driver of the early-life exposome in Turin children of the NINFEA cohort (Italy). METHODS Forty-two environmental exposures, collected at 18 months of age (N = 1989), were classified in 5 groups (lifestyle, diet, meteoclimatic, traffic-related, built environment). We performed cluster analysis to identify subjects sharing similar exposures, and intra-exposome-group Principal Component Analysis (PCA) to reduce the dimensionality. SEP at childbirth was measured through the Equivalised Household Income Indicator. SEP-exposome association was evaluated using: 1) an Exposome Wide Association Study (ExWAS), a one-exposure (SEP) one-outcome (exposome) approach; 2) multinomial regression of cluster membership on SEP; 3) regressions of each intra-exposome-group PC on SEP. RESULTS In the ExWAS, medium/low SEP children were more exposed to greenness, pet ownership, passive smoking, TV screen and sugar; less exposed to NO2, NOX, PM25abs, humidity, built environment, traffic load, unhealthy food facilities, fruit, vegetables, eggs, grain products, and childcare than high SEP children. Medium/low SEP children were more likely to belong to a cluster with poor diet, less air pollution, and to live in the suburbs than high SEP children. Medium/low SEP children were more exposed to lifestyle PC1 (unhealthy lifestyle) and diet PC2 (unhealthy diet), and less exposed to PC1s of the built environment (urbanization factors), diet (mixed diet), and traffic (air pollution) than high SEP children. CONCLUSIONS The three approaches provided consistent and complementary results, suggesting that children with lower SEP are less exposed to urbanization factors and more exposed to unhealthy lifestyles and diet. The simplest method, the ExWAS, conveys most of the information and is more replicable in other populations. Clustering and PCA may facilitate results interpretation and communication.
Collapse
Affiliation(s)
- Chiara Moccia
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy.
| | - Costanza Pizzi
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy
| | - Giovenale Moirano
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy
| | - Maja Popovic
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy
| | - Daniela Zugna
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy
| | - Antonio d'Errico
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy
| | - Elena Isaevska
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy
| | - Serena Fossati
- ISGlobal (Barcelona Institute for Global Health), Barcelona, Spain
| | | | - Piero Fariselli
- Department of Medical Sciences, University of Turin, Turin, Italy
| | - Tiziana Sanavia
- Department of Medical Sciences, University of Turin, Turin, Italy
| | - Lorenzo Richiardi
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy
| | - Milena Maule
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy
| |
Collapse
|
6
|
Botta L, Gatta G, Capocaccia R, Stiller C, Cañete A, Dal Maso L, Innos K, Mihor A, Erdmann F, Spix C, Lacour B, Marcos-Gragera R, Murray D, Rossi S, Hackl M, Van Eycken E, Van Damme N, Valerianova Z, Sekerija M, Scoutellas V, Demetriou A, Dušek L, Krejci D, Storm H, Mägi M, Innos K, Paapsi K, Malila N, Pitkäniemi J, Jooste V, Clavel J, Poulalhon C, Lacour B, Desandes E, Monnereau A, Erdmann F, Spix C, Katalinic A, Petridou E, Markozannes G, Garami M, Birgisson H, Murray D, Walsh PM, Mazzoleni G, Vittadello F, Cuccaro F, Galasso R, Sampietro G, Rosso S, Gasparotto C, Maifredi G, Ferrante M, Torrisi A, Sutera Sardo A, Gambino ML, Lanzoni M, Ballotari P, Giacomazzi E, Ferretti S, Caldarella A, Manneschi G, Gatta G, Sant M, Baili P, Berrino F, Botta L, Trama A, Lillini R, Bernasconi A, Bonfarnuzzo S, Vener C, Didonè F, Lasalvia P, Del Monego G, Buratti L, Serraino D, Taborelli M, Capocaccia R, De Angelis R, Demuru E, Di Benedetto C, Rossi S, Santaquilani M, Venanzi S, Tallon M, Boni L, Iacovacci S, Russo AG, Gervasi F, Spagnoli G, Cavalieri d'Oro L, Fusco M, Vitale MF, Usala M, Vitale F, Michiara M, Chiranda G, Sacerdote C, Maule M, Cascone G, Spata E, Mangone L, Falcini F, Cavallo R, Piras D, Dinaro Y, Castaing M, Fanetti AC, Minerba S, Candela G, Scuderi T, Rizzello RV, Stracci F, Tagliabue G, Rugge M, Brustolin A, Pildava S, Smailyte G, Azzopardi M, Johannesen TB, Didkowska J, Wojciechowska U, Bielska-Lasota M, Pais A, Ferreira AM, Bento MJ, Miranda A, Safaei Diba C, Zadnik V, Zagar T, Sánchez-Contador Escudero C, Franch Sureda P, Lopez de Munain A, De-La-Cruz M, Rojas MD, Aleman A, Vizcaino A, Almela F, Marcos-Gragera R, Sanvisens A, Sanchez MJ, Chirlaque MD, Sanchez-Gil A, Guevara M, Ardanaz E, Cañete-Nieto A, Peris-Bonet R, Galceran J, Carulla M, Kuehni C, Redmond S, Visser O, Karim-Kos H, Stevens S, Stiller C, Gavin A, Morrison D, Huws DW. Long-term survival and cure fraction estimates for childhood cancer in Europe (EUROCARE-6): results from a population-based study. Lancet Oncol 2022; 23:1525-1536. [DOI: 10.1016/s1470-2045(22)00637-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/04/2022] [Revised: 10/04/2022] [Accepted: 10/05/2022] [Indexed: 11/17/2022]
|
7
|
Maritano S, Moirano G, Popovic M, D'Errico A, Rusconi F, Maule M, Richiardi L. Maternal pesticides exposure in pregnancy and the risk of wheezing in infancy: A prospective cohort study. Environ Int 2022; 163:107229. [PMID: 35405505 DOI: 10.1016/j.envint.2022.107229] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/03/2021] [Revised: 03/08/2022] [Accepted: 04/03/2022] [Indexed: 06/14/2023]
Abstract
INTRODUCTION Pesticide exposure in pregnancy may have health effects in the offspring. We studied whether maternal pesticides exposure during pregnancy is associated with infant wheezing. METHODS The study involved 5997 children from the Italian NINFEA birth cohort, whose mothers were recruited during pregnancy between 2005 and 2016. We used questionnaires completed during pregnancy and 6 months after delivery to derive the following indirect measures of exposure: i) Self-reported pesticide use during the first and the third trimester of pregnancy; (ii) Agricultural activities during the same trimesters. We also evaluated the exposure to agricultural pesticides applied near home using the Corine Land Cover inventory to derive the proportion of a 200-metre buffer area around maternal home address covered by agricultural crops and specific crop types (arable land, fruit trees, heterogeneous cultivations). Questionnaires completed when the child turned 18 months reported information on wheezing between 6 and 18 months of age. We estimated the odds ratios of wheezing adjusting for the following maternal characteristics: age, education, parity, asthma, atopy, smoking in pregnancy, region and area of residence, pet ownership during pregnancy. Crops proximity analyses were restricted to residents in rural areas (N = 1674). RESULTS Agricultural activities during pregnancy were not associated with infant wheezing. Compared to no pesticide use, there was a weak positive association for self-reported use in the third trimester (POR: 1.30; 95 %CI 0.95-1.78) and a stronger association for use in both trimesters (POR: 1.72; 95 %CI 1.11-2.65). The relationship between the proportion of crops around the home address and the risk of infant wheezing, was J-shaped, in particular for fruit trees with the lowest risk for mid values and elevated risk for higher values. CONCLUSION We found some evidence of association for maternal pesticide use in pregnancy and residential proximity to fruit trees cultivations with infant wheezing.
Collapse
Affiliation(s)
- Silvia Maritano
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO-Piemonte, Via Santena 7, 10126 Turin, Italy.
| | - Giovenale Moirano
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO-Piemonte, Via Santena 7, 10126 Turin, Italy.
| | - Maja Popovic
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO-Piemonte, Via Santena 7, 10126 Turin, Italy.
| | - Antonio D'Errico
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO-Piemonte, Via Santena 7, 10126 Turin, Italy.
| | - Franca Rusconi
- Department of Mother and Child Health, Azienda USL Toscana Nord Ovest, Via Cocchi 7/9, 56121 Pisa, Italy.
| | - Milena Maule
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO-Piemonte, Via Santena 7, 10126 Turin, Italy.
| | - Lorenzo Richiardi
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO-Piemonte, Via Santena 7, 10126 Turin, Italy.
| |
Collapse
|
8
|
Castaño-Vinyals G, Sadetzki S, Vermeulen R, Momoli F, Kundi M, Merletti F, Maslanyj M, Calderon C, Wiart J, Lee AK, Taki M, Sim M, Armstrong B, Benke G, Schattner R, Hutter HP, Krewski D, Mohipp C, Ritvo P, Spinelli J, Lacour B, Remen T, Radon K, Weinmann T, Petridou ET, Moschovi M, Pourtsidis A, Oikonomou K, Kanavidis P, Bouka E, Dikshit R, Nagrani R, Chetrit A, Bruchim R, Maule M, Migliore E, Filippini G, Miligi L, Mattioli S, Kojimahara N, Yamaguchi N, Ha M, Choi K, Kromhout H, Goedhart G, 't Mannetje A, Eng A, Langer CE, Alguacil J, Aragonés N, Morales-Suárez-Varela M, Badia F, Albert A, Carretero G, Cardis E. Wireless phone use in childhood and adolescence and neuroepithelial brain tumours: Results from the international MOBI-Kids study. Environ Int 2022; 160:107069. [PMID: 34974237 DOI: 10.1016/j.envint.2021.107069] [Citation(s) in RCA: 14] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/02/2021] [Revised: 12/22/2021] [Accepted: 12/24/2021] [Indexed: 06/14/2023]
Abstract
In recent decades, the possibility that use of mobile communicating devices, particularly wireless (mobile and cordless) phones, may increase brain tumour risk, has been a concern, particularly given the considerable increase in their use by young people. MOBI-Kids, a 14-country (Australia, Austria, Canada, France, Germany, Greece, India, Israel, Italy, Japan, Korea, the Netherlands, New Zealand, Spain) case-control study, was conducted to evaluate whether wireless phone use (and particularly resulting exposure to radiofrequency (RF) and extremely low frequency (ELF) electromagnetic fields (EMF)) increases risk of brain tumours in young people. Between 2010 and 2015, the study recruited 899 people with brain tumours aged 10 to 24 years old and 1,910 controls (operated for appendicitis) matched to the cases on date of diagnosis, study region and age. Participation rates were 72% for cases and 54% for controls. The mean ages of cases and controls were 16.5 and 16.6 years, respectively; 57% were males. The vast majority of study participants were wireless phones users, even in the youngest age group, and the study included substantial numbers of long-term (over 10 years) users: 22% overall, 51% in the 20-24-year-olds. Most tumours were of the neuroepithelial type (NBT; n = 671), mainly glioma. The odds ratios (OR) of NBT appeared to decrease with increasing time since start of use of wireless phones, cumulative number of calls and cumulative call time, particularly in the 15-19 years old age group. A decreasing trend in ORs was also observed with increasing estimated cumulative RF specific energy and ELF induced current density at the location of the tumour. Further analyses suggest that the large number of ORs below 1 in this study is unlikely to represent an unknown causal preventive effect of mobile phone exposure: they can be at least partially explained by differential recall by proxies and prodromal symptoms affecting phone use before diagnosis of the cases. We cannot rule out, however, residual confounding from sources we did not measure. Overall, our study provides no evidence of a causal association between wireless phone use and brain tumours in young people. However, the sources of bias summarised above prevent us from ruling out a small increased risk.
Collapse
Affiliation(s)
- G Castaño-Vinyals
- Barcelona Institute of Global Health (ISGlobal), 88 Doctor Aiguader, E-08003 Barcelona, Spain; University Pompeu Fabra, Barcelona, Spain; CIBER Epidemiologia y Salud Pública, Madrid, Spain; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain
| | - S Sadetzki
- Cancer & Radiation Epidemiology Unit, Gertner Institute for Epidemiology & Health Policy Research, Sheba Medical Center, Tel-Hashomer, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Ministry of Health, Jerusalem, Israel
| | - R Vermeulen
- Institute for Risk Assessment Sciences (IRAS), Utrecht University, Utrecht, the Netherlands
| | - F Momoli
- School of Epidemiology and Public Health, University of Ottawa, Canada; Risk Science International, Ottawa, Canada
| | - M Kundi
- Department of Environmental Health, Center for Public Health, Medical University Vienna, Austria
| | - F Merletti
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO-Piemonte, Turin, Italy
| | | | | | - J Wiart
- Laboratoire de Traitement et Communication de l'Information (LTCI), Telecom Paris, Institut Polytechnique de Paris, 91120 Palaiseau, France
| | - A-K Lee
- Radio Technology Research Department, Electronics and Telecommunications Research Institute (ETRI), Yuseong-gu, Daejeon, Korea
| | - M Taki
- Department of Electrical & Electronic Engineering, Graduate Schools of Science and Engineering, Tokyo Metropolitan University, Tokyo, Japan
| | - M Sim
- School of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia
| | - B Armstrong
- School of Population and Global Health, The University of Western Australia, Perth 6009, Australia
| | - G Benke
- School of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia
| | - R Schattner
- School of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia
| | - H-P Hutter
- Department of Environmental Health, Center for Public Health, Medical University Vienna, Austria
| | - D Krewski
- Risk Science International, Ottawa, Canada; School of Epidemiology and Public Health, University of Ottawa Faculty of Medicine, Ottawa, Ontario, Canada; McLaughlin Centre for Population Health Risk Assessment, University of Ottawa Faculty of Medicine, Ottawa, Ontario, Canada
| | - C Mohipp
- University of Ottawa, Ottawa, Canada
| | - P Ritvo
- York University, Toronto, Ontario, Canada
| | - J Spinelli
- School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada
| | - B Lacour
- French National Registry of Childhood Solid Tumors, CHRU, Nancy, France; Inserm UMR 1153, Center of Research in Epidemiology and StatisticS (CRESS), Paris University, Epidemiology of Childhood and Adolescent Cancers Team (EPICEA), Paris, France
| | - T Remen
- Inserm UMR 1153, Center of Research in Epidemiology and StatisticS (CRESS), Paris University, Epidemiology of Childhood and Adolescent Cancers Team (EPICEA), Paris, France
| | - K Radon
- Institute and Clinic for Occupational, Social and Environmental Medicine, University Hospital, LMU Munich, Munich, Germany
| | - T Weinmann
- Institute and Clinic for Occupational, Social and Environmental Medicine, University Hospital, LMU Munich, Munich, Germany
| | - E Th Petridou
- Hellenic Society for Social Pediatrics & Health Promotion, Greece; Dept of Hygiene and Epidemiology, Medical School, National and Kapodistrian University of Athens, Greece
| | - M Moschovi
- Hellenic Society for Social Pediatrics & Health Promotion, Greece
| | - A Pourtsidis
- Hellenic Society for Social Pediatrics & Health Promotion, Greece
| | - K Oikonomou
- Hellenic Society for Social Pediatrics & Health Promotion, Greece
| | - P Kanavidis
- Hellenic Society for Social Pediatrics & Health Promotion, Greece
| | - E Bouka
- Hellenic Society for Social Pediatrics & Health Promotion, Greece
| | - R Dikshit
- Centre for Cancer Epidemiology, Tata Memorial Centre, Kharghar, Navi Mumbai 410210, India
| | - R Nagrani
- Centre for Cancer Epidemiology, Tata Memorial Centre, Kharghar, Navi Mumbai 410210, India; Leibniz Institute for Prevention Research and Epidemiology - BIPS, Achterstrasse 30, 28359 Bremen, Germany
| | - A Chetrit
- Cancer & Radiation Epidemiology Unit, Gertner Institute for Epidemiology & Health Policy Research, Sheba Medical Center, Tel-Hashomer, Israel
| | - R Bruchim
- Cancer & Radiation Epidemiology Unit, Gertner Institute for Epidemiology & Health Policy Research, Sheba Medical Center, Tel-Hashomer, Israel
| | - M Maule
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO-Piemonte, Turin, Italy
| | - E Migliore
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO-Piemonte, Turin, Italy
| | - G Filippini
- Scientific Director's Office, Carlo Besta Foundation and Neurological Institute, Milan, Italy
| | - L Miligi
- Environmental and Occupational Epidemiology Branch, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy
| | - S Mattioli
- Department of Medical and Surgical Sciences, Alma Mater Studiorum-University of Bologna, Italy
| | - N Kojimahara
- Department of Public Health, Tokyo Women's Medical University, Tokyo, Japan; Graduate School of Public Health, Shizuoka Graduate University of Public Health, Shizuoka, Japan
| | - N Yamaguchi
- Department of Public Health, Tokyo Women's Medical University, Tokyo, Japan; Saiseikai Research Institute of Care and Welfare, Tokyo, Japan
| | - M Ha
- Department of Preventive Medicine, Dankook University College of Medicine, 119 Dandae-ro, Cheonan, Chungnam, South Korea
| | - K Choi
- Department of Preventive Medicine, Dankook University College of Medicine, 119 Dandae-ro, Cheonan, Chungnam, South Korea
| | - H Kromhout
- Institute for Risk Assessment Sciences (IRAS), Utrecht University, Utrecht, the Netherlands
| | - G Goedhart
- Institute for Risk Assessment Sciences (IRAS), Utrecht University, Utrecht, the Netherlands
| | - A 't Mannetje
- Centre for Public Health Research, Massey University, Wellington, New Zealand
| | - A Eng
- Centre for Public Health Research, Massey University, Wellington, New Zealand
| | - C E Langer
- Barcelona Institute of Global Health (ISGlobal), 88 Doctor Aiguader, E-08003 Barcelona, Spain; University Pompeu Fabra, Barcelona, Spain; CIBER Epidemiologia y Salud Pública, Madrid, Spain
| | - J Alguacil
- CIBER Epidemiologia y Salud Pública, Madrid, Spain; Centro de Investigación en Recursos Naturales, Salud y Medio Ambiente (RENSMA), Universidad de Huelva, Huelva, Spain
| | - N Aragonés
- CIBER Epidemiologia y Salud Pública, Madrid, Spain; Epidemiology Section, Public Health Division, Department of Health of Madrid, 28035 Madrid, Spain
| | - M Morales-Suárez-Varela
- CIBER Epidemiologia y Salud Pública, Madrid, Spain; Unit of Public Health and Environmental Care, Department of Preventive Medicine and Public Health, Food Sciences, Toxicology and Forensic Medicine, University of Valencia, Valencia, Spain
| | - F Badia
- Barcelona Institute of Global Health (ISGlobal), 88 Doctor Aiguader, E-08003 Barcelona, Spain; University Pompeu Fabra, Barcelona, Spain; CIBER Epidemiologia y Salud Pública, Madrid, Spain; Institut Cartogràfic i Geològic de Catalunya, Barcelona, Spain
| | - A Albert
- Barcelona Institute of Global Health (ISGlobal), 88 Doctor Aiguader, E-08003 Barcelona, Spain; University Pompeu Fabra, Barcelona, Spain; CIBER Epidemiologia y Salud Pública, Madrid, Spain
| | - G Carretero
- Barcelona Institute of Global Health (ISGlobal), 88 Doctor Aiguader, E-08003 Barcelona, Spain; University Pompeu Fabra, Barcelona, Spain; CIBER Epidemiologia y Salud Pública, Madrid, Spain; Institut Català d'Oncologia, L'Hospitalet de Llobregat, Spain
| | - E Cardis
- Barcelona Institute of Global Health (ISGlobal), 88 Doctor Aiguader, E-08003 Barcelona, Spain; University Pompeu Fabra, Barcelona, Spain; CIBER Epidemiologia y Salud Pública, Madrid, Spain.
| |
Collapse
|
9
|
Byrne J, Schmidtmann I, Rashid H, Hagberg O, Bagnasco F, Bardi E, De Vathaire F, Essiaf S, Winther JF, Frey E, Gudmundsdottir T, Haupt R, Hawkins MM, Jakab Z, Jankovic M, Kaatsch P, Kremer LCM, Kuehni CE, Harila-Saari A, Levitt G, Reulen R, Ronckers CM, Maule M, Skinner R, Steliarova-Foucher E, Terenziani M, Zaletel LZ, Hjorth L, Garwicz S, Grabow D. Impact of era of diagnosis on cause-specific late mortality among 77 423 five-year European survivors of childhood and adolescent cancer: The PanCareSurFup consortium. Int J Cancer 2022; 150:406-419. [PMID: 34551126 DOI: 10.1002/ijc.33817] [Citation(s) in RCA: 11] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/10/2021] [Revised: 07/16/2021] [Accepted: 07/22/2021] [Indexed: 02/03/2023]
Abstract
Late mortality of European 5-year survivors of childhood or adolescent cancer has dropped over the last 60 years, but excess mortality persists. There is little information concerning secular trends in cause-specific mortality among older European survivors. PanCareSurFup pooled data from 12 cancer registries and clinics in 11 European countries from 77 423 five-year survivors of cancer diagnosed before age 21 between 1940 and 2008 followed for an average age of 21 years and a total of 1.27 million person-years to determine their risk of death using cumulative mortality, standardized mortality ratios (SMR), absolute excess risks (AER), and multivariable proportional hazards regression analyses. At the end of follow-up 9166 survivors (11.8%) had died compared to 927 expected (SMR 9.89, 95% confidence interval [95% CI] 9.69-10.09), AER 6.47 per 1000 person-years, (95% CI 6.32-6.62). At 60 to 68 years of attained age all-cause mortality was still higher than expected (SMR = 2.41, 95% CI 1.90-3.02). Overall cumulative mortality at 25 years from diagnosis dropped from 18.4% (95% CI 16.5-20.4) to 7.3% (95% CI 6.7-8.0) over the observation period. Compared to the diagnosis period 1960 to 1969, the mortality hazard ratio declined for first neoplasms (P for trend <.0001) and for infections (P < .0001); declines in relative mortality from second neoplasms and cardiovascular causes were less pronounced (P = .1105 and P = .0829, respectively). PanCareSurFup is the largest study with the longest follow-up of late mortality among European childhood and adolescent cancer 5-year survivors, and documents significant mortality declines among European survivors into modern eras. However, continuing excess mortality highlights survivors' long-term care needs.
Collapse
Affiliation(s)
| | - Irene Schmidtmann
- Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany
| | - Humayra Rashid
- Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany
| | | | - Francesca Bagnasco
- Epidemiology and Biostatistics Unit, and DOPO Clinic, IRCCS Istituto Giannina Gaslini, Genoa, Italy
| | - Edit Bardi
- St. Anna Children's Hospital, Vienna, Austria
- Department of Pediatrics and Adolescent Medicine, Johannes Kepler University Linz, Kepler University Hospital GmbH, Linz, Austria
| | - Florent De Vathaire
- INSERM, Centre for Research in Epidemiology and Population Health (CESP), Villejuif, France
- Université Paris-Sud Orsay, Villejuif, France
- Department of Research, Gustave Roussy, Villejuif, France
| | - Samira Essiaf
- SIOPE, c/o BLSI, Clos Chapelle-aux-Champs 30, Brussels, Belgium
| | - Jeanette Falck Winther
- Danish Cancer Society Research Center, Strandboulevarden, Copenhagen, Denmark
- Department of Clinical Medicine, Faculty of Health, Aarhus University, Aarhus, Denmark
| | - Eva Frey
- St. Anna Children's Hospital, Vienna, Austria
| | - Thorgerdur Gudmundsdottir
- Danish Cancer Society Research Center, Strandboulevarden, Copenhagen, Denmark
- Children's Hospital, Landspitali University Hospital, Reykjavik, Iceland
| | - Riccardo Haupt
- Epidemiology and Biostatistics Unit, and DOPO Clinic, IRCCS Istituto Giannina Gaslini, Genoa, Italy
| | - Michael M Hawkins
- Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham, Birmingham, UK
| | - Zsuzsanna Jakab
- Hungarian Childhood Cancer Registry, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary
| | - Momcilo Jankovic
- Pediatric Clinic, University of Milano-Bicocca, Foundation MBBM, Milan, Italy
- Italian Off-Therapy Register (OTR), Monza, Italy
| | - Peter Kaatsch
- German Childhood Cancer Registry (GCCR), Division of Childhood Cancer Epidemiology, Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), Johannes Gutenberg University Mainz, Mainz, Germany
| | - Leontien C M Kremer
- Department of Pediatric Oncology, Emma Children's Hospital/Amsterdam UMC, Amsterdam, The Netherlands
- Princess Maxima Centre for Paediatric Oncology, Utrecht, The Netherlands
| | - Claudia E Kuehni
- Swiss Childhood Cancer Registry, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland
- Paediatric Oncology, Department of Paediatrics, University Children's Hospital of Bern, University of Bern, Bern, Switzerland
| | - Arja Harila-Saari
- Department of Women and Children's Health, Uppsala University, Uppsala, Sweden
| | - Gill Levitt
- Great Ormond Street Hospital for Children NHS Foundation Trust, Great Ormond Street, London, UK
| | - Raoul Reulen
- Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham, Birmingham, UK
| | - Cécile M Ronckers
- Princess Maxima Centre for Paediatric Oncology, Utrecht, The Netherlands
- Brandenburg Medical School, Institute of Biostatistics and Registry Research, Neuruppin, Germany
| | - Milena Maule
- Childhood Cancer Registry of Piedmont, Department of Medical Science, University of Turin and Center for Cancer Prevention (CPO-Piemonte), Torino, Italy
| | - Roderick Skinner
- Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Newcastle upon Tyne, UK
- Department of Paediatric and Adolescent Haematology and Oncology, Great North Children's Hospital, Royal Victoria Infirmary, Newcastle Upon Tyne, UK
| | - Eva Steliarova-Foucher
- Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon Cedex, France
| | - Monica Terenziani
- Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
| | | | - Lars Hjorth
- Department of Clinical Sciences Lund, Lund University, Skåne University Hospital, Pediatrics, Lund, Sweden
| | - Stanislaw Garwicz
- Department of Clinical Sciences Lund, Lund University, Skåne University Hospital, Pediatrics, Lund, Sweden
| | - Desiree Grabow
- German Childhood Cancer Registry (GCCR), Division of Childhood Cancer Epidemiology, Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), Johannes Gutenberg University Mainz, Mainz, Germany
| |
Collapse
|
10
|
Zenone M, Zocchi L, Moccia C, Passerini SG, Sanavia T, Fariselli P, Broganelli P, Ribero S, Maule M, Quaglino P. Digital dermoscopy monitoring of melanocytic lesions: Two novel calculators combining static and dynamic features to identify melanoma. J Eur Acad Dermatol Venereol 2021; 36:391-402. [PMID: 34862986 DOI: 10.1111/jdv.17852] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2021] [Accepted: 10/27/2021] [Indexed: 11/28/2022]
Abstract
BACKGROUND Early diagnosis is the most effective intervention to improve the prognosis of cutaneous melanoma. Even though the introduction of dermoscopy has improved the diagnostic accuracy, it can still be difficult to distinguish some melanomas from benign melanocytic lesions. Digital dermoscopy monitoring can identify dynamic changes of melanocytic lesions: To date, some algorithms were proposed, but a universally accepted one is still lacking. OBJECTIVES To identify independent predictive variables associated with the diagnosis of cutaneous melanoma and develop a multivariable dermoscopic prediction model able to discriminate benign from malignant melanocytic lesions undergoing digital dermoscopy monitoring. METHODS We collected dermoscopic images of melanocytic lesions excised after dermoscopy monitoring and carried out static and dynamic evaluations of dermoscopic features. We built two multivariable predictive models based on logistic regression and random forest. RESULTS We evaluated 173 lesions (65 cutaneous melanomas and 108 nevi). Forty-two melanomas were in situ, and the median thickness of invasive melanomas was 0.35 mm. The median follow-up time was 9.8 months for melanomas and 9.1 for nevi. The logistic regression and random forest models performed with AUC values of 0.87 and 0.89, respectively, were substantially higher than those of the static evaluation models (ABCD TDS score, 0.57; 7-point checklist, 0.59). Finally, we built two risk calculators, which translate the proposed models into user-friendly applications, to assist clinicians in the decision-making process. CONCLUSIONS The present study demonstrates that the integration of dynamic and static evaluations of melanocytic lesions is a safe approach that can significantly boost the diagnostic accuracy for cutaneous melanoma. We propose two diagnostic tools that significantly increase the accuracy in discriminating melanoma from nevi during digital dermoscopy monitoring.
Collapse
Affiliation(s)
- M Zenone
- Dermatology Clinic, Department of Medical Sciences, University of Turin, Turin, Italy
| | - L Zocchi
- Dermatology Clinic, Department of Medical Sciences, University of Turin, Turin, Italy
| | - C Moccia
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy
| | - S G Passerini
- Dermatology Clinic, Department of Medical Sciences, University of Turin, Turin, Italy
| | - T Sanavia
- Department of Medical Sciences, University of Turin, Turin, Italy
| | - P Fariselli
- Department of Medical Sciences, University of Turin, Turin, Italy
| | - P Broganelli
- Dermatology Clinic, Department of Medical Sciences, University of Turin, Turin, Italy
| | - S Ribero
- Dermatology Clinic, Department of Medical Sciences, University of Turin, Turin, Italy
| | - M Maule
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO Piemonte, Turin, Italy
| | - P Quaglino
- Dermatology Clinic, Department of Medical Sciences, University of Turin, Turin, Italy
| |
Collapse
|
11
|
Farina E, Eboli I, Spadea T, Saugo C, Richiardi L, Maule M, Presti P, Bena A. 'Scuola sicura': a school screening testing programme to prevent the spread of COVID-19 in students in Piedmont. Epidemiol Prev 2021; 45:504-512. [PMID: 34766497 DOI: 10.19191/ep21.6.113] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
BACKGROUND 'Scuola sicura' (SS) programme aims to monitor the rate of COVID-19 and to contain its spread within the school population through early case isolation. OBJECTIVES to describe the initial process and outcome evaluation results. DESIGN descriptive study of an experimental screening testing programme in children in Piedmont Region (Northern Italy) in the period January-March 2021. The data used came from the COVID-19 platform and the Local Health Units, the archives of birth certificates (CedAP), and hospital discharge files (SDO). SETTING AND PARTICIPANTS the screening programme targeted second and third grade students in first level secondary schools. Participants were subdivided into four groups; one group each week underwent screening, yielding one test per student per month. MAIN OUTCOME MEASURES it was calculated: 1. number of positive cases detected vs total number of students tested in the SS programme; 2. number of positive cases detected outside the SS program vs. total number of students in the target population. The number of quarantines due to SS and no-SS case identification were detected. To investigate the spread of COVID-19 in households, the mother-child pairs were identified through record linkage between the CedAP and SDO archives, and positive mothers were identified. RESULTS sixty-nine percent of schools and 19.5% of the students participated in the programme. SS detected 114 positives cases for SARS-CoV-2. On 08.03.2021, the target classes started distance learning: 69 of the 114 positive students were identified before that date, leading to the activation of 67 quarantine measures. Only for 61 out of 69 of those students (88%) was possible to identify the mother; 46 mothers had performed a swab test after the positivity of their child with a positive result in 11 cases. Asymptomatic cases identified at screening during in-class learning period accounted for 26.5% of the total number of cases occurred in the participating classes. CONCLUSIONS this is one of the few studies (and the first in Italy) to describe the functioning and predictive capacity of school screening testing for SARS-CoV-2 in a real-world situation. The findings provide data-driven suggestions for government agencies when planning large-scale school screening testing programmes.
Collapse
Affiliation(s)
- Elena Farina
- SCaDU Servizio sovrazonale di epidemiologia, Azienda sanitaria locale TO3, Grugliasco (Italy)
| | - Ilenia Eboli
- SCaDU Servizio sovrazonale di epidemiologia, Azienda sanitaria locale TO3, Grugliasco (Italy)
| | - Teresa Spadea
- SCaDU Servizio sovrazonale di epidemiologia, Azienda sanitaria locale TO3, Grugliasco (Italy)
| | - Carlo Saugo
- Scuola di specializzazione in igiene e medicina preventiva, Università di Torino, Turin (Italy)
| | - Lorenzo Richiardi
- Dipartimento di Scienze Mediche, Università di Torino, Turin (Italy)
| | - Milena Maule
- Dipartimento di Scienze Mediche, Università di Torino, Turin (Italy)
| | | | - Antonella Bena
- SCaDU Servizio sovrazonale di epidemiologia, Azienda sanitaria locale TO3, Grugliasco (Italy); .,Centro regionale di documentazione per la promozione della salute, Turin (Italy)
| |
Collapse
|
12
|
Quarello P, Ferrari A, Mascarin M, Milano GM, Tornesello A, Bertolotti M, Spinelli M, Pierobon M, Perillo T, Maule M, Zecca M, Pession A, Fagioli F. Diagnostic Delay in Adolescents with Cancer During COVID-19 Pandemic: A New Price for Our Patients to Pay. J Adolesc Young Adult Oncol 2021; 11:316-319. [PMID: 34677087 DOI: 10.1089/jayao.2021.0057] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Worldwide, the coronavirus 19 disease pandemic caused a worse chance of a timely diagnosis for cancer patients. We conducted a retrospective analysis of new diagnoses registered in the national pediatric oncology database, comparing the first lockdown period (March-May 2020) with the same period of 2015-2019. The total number of cases (0-19 years) dropped by 20.8% (from 441 between 2015 and 2019 to 349 in 2020). A major reduction was observed for adolescents (15-19 years) (-32.9%) and for adolescents with solid tumors (-56.4%, p = 0.03). Our data suggest that the enforced lockdown reduced the possibility for these already vulnerable patients to access the referral centers.
Collapse
Affiliation(s)
- Paola Quarello
- Pediatric Onco-Hematology, Stem Cell Transplantation and Cellular Therapy Department, Azienda Ospedaliera-Universitaria Città della Salute e della Scienza, Regina Margherita Children's Hospital, Torino, Italy.,University of Torino, Torino, Italy
| | - Andrea Ferrari
- Pediatric Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milano, Italy
| | - Maurizio Mascarin
- AYA and Pediatric Radiotherapy Department, Centro di Riferimento Oncologico IRCCS, Aviano, Italy
| | - Giuseppe M Milano
- Department of Pediatric Hematology and Oncology and of Cell and Gene Therapy, Scientific Institute for Research and Healthcare (IRCCS), Bambino Gesù Childrens' Hospital, Rome, Italy
| | | | - Marina Bertolotti
- Pediatric Onco-Hematology, Stem Cell Transplantation and Cellular Therapy Department, Azienda Ospedaliera-Universitaria Città della Salute e della Scienza, Regina Margherita Children's Hospital, Torino, Italy
| | - Marco Spinelli
- Department of Pediatrics, University of Milano-Bicocca, Fondazione MBBM/Ospedale San Gerardo, Monza, Italy
| | - Marta Pierobon
- Hematology and Oncology Unit, Department of Women's and Children's Health, University of Padua, Padua, Italy
| | - Teresa Perillo
- Pediatric Hematology-Oncology Division, Department of Pediatrics, University of Bari, Bari, Italy
| | - Milena Maule
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin, Turin, Italy
| | - Marco Zecca
- Pediatric/Hematology/Oncology Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
| | - Andrea Pession
- Pediatric Department, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
| | - Franca Fagioli
- Pediatric Onco-Hematology, Stem Cell Transplantation and Cellular Therapy Department, Azienda Ospedaliera-Universitaria Città della Salute e della Scienza, Regina Margherita Children's Hospital, Torino, Italy.,University of Torino, Torino, Italy
| |
Collapse
|
13
|
Ubalde-Lopez M, Garani-Papadatos T, Scelo G, Casas M, Lissåker C, Peters S, Nohr EA, Albin M, Lucas R, Papantoniou K, Polańska K, Ramlau-Hansen CH, Šarac J, Selander J, Skröder H, Vasileiou E, Kogevinas M, Bültmann U, Mehlum IS, Maule M. Working life, health and well-being of parents: a joint effort to uncover hidden treasures in European birth cohorts. Scand J Work Environ Health 2021; 47:550-560. [PMID: 34432068 PMCID: PMC8504161 DOI: 10.5271/sjweh.3980] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
Abstract
Objective Birth cohorts collect valuable and under-utilized information on employment and health of parents before and during pregnancy, at birth, and sometimes after birth. In this discussion paper, we examine how these data could be exploited to study the complex relationships and interactions between parenthood, work, and health among parents themselves. Methods Using a web-based database of birth cohorts, we summarize information on maternal employment and health conditions and other potentially related variables in cohorts spread throughout Europe. This provided information on what data are available and could be used in future studies, and what was missing if specific questions are to be addressed, exploiting the opportunity to explore work–health associations across heterogenous geographical and social contexts. Results We highlight the many potentialities provided by birth cohorts and identify gaps that need to be addressed to adopt a life-course approach and investigate topics specific to the peri-pregnancy period, such as psychosocial aspects. We address the technical difficulties implied by data harmonization and the ethical challenges related to the repurposing of data, and provide scientific, ecological and economic arguments in favor of improving the value of data already available as a result of a serious investment in human and material resources. Conclusions There is a hidden treasure in birth cohorts that deserves to be brought out to study the relationships between employment and health among working parents in a time when the boundaries between work and life are being stretched more than ever before.
Collapse
Affiliation(s)
- Monica Ubalde-Lopez
- Cancer Epidemiology Unit, University of Turin, via Santena 7, 10126 Torino, Italy.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
14
|
Popovic M, Moccia C, Isaevska E, Moirano G, Pizzi C, Zugna D, Rusconi F, Merletti F, Maule M, Richiardi L. COVID-19-like symptoms and their relation to the SARS-CoV-2 epidemic in children and adults of an Italian birth cohort. Epidemiol Prev 2021; 45:486-495. [PMID: 34545726 DOI: 10.19191/ep21.6.093] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
OBJECTIVES to estimate the population prevalence of COVID-19-like symptoms in children and adults during the first SARS-CoV-2 epidemic wave hitting Italy in the spring 2020; to assess their geographical correlation with the cumulative number of COVID-19 cases by province; to analyse their clustering within families; to estimate their sensitivity, positive predictive value (PPV) and negative predictive value (NPV) for COVID-19 diagnosis in individuals tested for SARS-CoV-2. DESIGN cross-sectional study nested within a birth cohort. SETTING AND PARTICIPANTS mothers participating in an Italian birth cohort (NINFEA) were invited to complete an online questionnaire on COVID-19-like symptoms in their household. MAIN OUTCOME MEASURES population prevalence of COVID-19-like symptoms in children and adults, geographical correlation of COVID-19-like symptoms with the cumulative number of COVID-19 cases by province, clustering of COVID-19-like symptoms within families, and sensitivity, PPV and NPV of COVID-19-like symptoms for COVID-19 diagnosis in individuals tested for SARS-CoV-2. RESULTS information was collected on 3,184 households, 6,133 adults, and 5,751 children. In the period March-April 2020, 55.4% of the NINFEA families had at least one member with at least one COVID-19-like symptom. There was a strong geographical correlation between the population cumulative incidence of COVID-19 and the prevalence of muscle pain, fatigue, low-grade fever, and breathing difficulties in adults (Spearman's rho >=0.70). Having at least one family member with a COVID-19 diagnosis, compared with none tested for SARS-CoV-2, was associated with an increased prevalence ratio (PR) of almost all COVID-19-like symptoms in adults, and only of low-grade fever (37-37.5°C; PR 4.54; 95%CI 2.20-9.40) and anosmia/dysgeusia in children. Among adults with COVID-19 diagnosis, fatigue, muscle pain, and fever had a sensitivity >=70%. In individuals tested for SARS-CoV-2, with a 16.6% prevalence of COVID-19, breathing difficulties and nausea/vomiting had the highest PPVs, with point estimates close to 60%, and with NPVs close to 90%. CONCLUSIONS the geographical prevalence of COVID-19-like symptoms in adults may inform on local disease clusters, while certain symptoms in family members of confirmed COVID-19 cases could help identify the intra-familial spread of the virus and its further propagation in the community. Low-grade fever is frequent in children with at least one household member with COVID-19 and possibly indicates child infection.
Collapse
Affiliation(s)
- Maja Popovic
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and Reference Centre for Epidemiology and Cancer Prevention in Piedmont (CPO Piemonte), Turin (Italy);
| | - Chiara Moccia
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and Reference Centre for Epidemiology and Cancer Prevention in Piedmont (CPO Piemonte), Turin (Italy)
| | - Elena Isaevska
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and Reference Centre for Epidemiology and Cancer Prevention in Piedmont (CPO Piemonte), Turin (Italy)
| | - Giovenale Moirano
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and Reference Centre for Epidemiology and Cancer Prevention in Piedmont (CPO Piemonte), Turin (Italy)
| | - Costanza Pizzi
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and Reference Centre for Epidemiology and Cancer Prevention in Piedmont (CPO Piemonte), Turin (Italy)
| | - Daniela Zugna
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and Reference Centre for Epidemiology and Cancer Prevention in Piedmont (CPO Piemonte), Turin (Italy)
| | - Franca Rusconi
- Unit of Epidemiology, Meyer Children's University Hospital, Florence (Italy)
| | - Franco Merletti
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and Reference Centre for Epidemiology and Cancer Prevention in Piedmont (CPO Piemonte), Turin (Italy)
| | - Milena Maule
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and Reference Centre for Epidemiology and Cancer Prevention in Piedmont (CPO Piemonte), Turin (Italy)
| | - Lorenzo Richiardi
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and Reference Centre for Epidemiology and Cancer Prevention in Piedmont (CPO Piemonte), Turin (Italy)
| |
Collapse
|
15
|
Zumel-Marne A, Castaño-Vinyals G, Alguacil J, Villanueva CM, Maule M, Gracia-Lavedan E, Momoli F, Krewski D, Mohipp C, Petridou E, Bouka E, Merletti F, Migliore E, Piro S, Ha M, Mannetje A', Eng A, Aragones N, Cardis E. Exposure to drinking water trihalomethanes and nitrate and the risk of brain tumours in young people. Environ Res 2021; 200:111392. [PMID: 34087188 DOI: 10.1016/j.envres.2021.111392] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/17/2020] [Revised: 05/21/2021] [Accepted: 05/21/2021] [Indexed: 06/12/2023]
Abstract
Brain tumours (BTs) are one of the most frequent tumour types in young people. We explored the association between tap water, exposure to trihalomethanes (THM) and nitrate and neuroepithelial BT risk in young people. Analysis of tap water consumption were based on 321 cases and 919 appendicitis controls (10-24 years old) from 6 of the 14 participating countries in the international MOBI-Kids case-control study (2010-2016). Available historical residential tap water concentrations of THMs and nitrate, available from 3 countries for 86 cases and 352 controls and 85 cases and 343 for nitrate, respectively, were modelled and combined with the study subjects' personal consumption patterns to estimate ingestion and residential exposure levels in the study population (both pre- and postnatal). The mean age of participants was 16.6 years old and 56% were male. The highest levels and widest ranges for THMs were found in Spain (residential and ingested) and Italy and in Korea for nitrate. There was no association between BT and the amount of tap water consumed and the showering/bathing frequency. Odds Ratios (ORs) for BT in relation to both pre- and postnatal residential and ingestion levels of THMs were systematically below 1 (OR = 0.37 (0.08-1.73)) for postnatal average residential THMs higher than 66 μg/L. For nitrate, all ORs were above 1 (OR = 1.80 (0.91-3.55)) for postnatal average residential nitrate levels higher than 8.5 mg/L, with a suggestion of a trend of increased risk of neuroepithelial BTs with increasing residential nitrate levels in tap water, which appeared stronger in early in life. This, to our knowledge, is the first study on this topic in young people. Further research is required to clarify the observed associations.
Collapse
Affiliation(s)
- Angela Zumel-Marne
- ISGlobal, Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Madrid, Spain.
| | - Gemma Castaño-Vinyals
- ISGlobal, Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Madrid, Spain; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
| | - Juan Alguacil
- Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Madrid, Spain; Centro de Investigación en Recursos Naturales, Salud y Medio Ambiente (RENSMA), Universidad de Huelva, Huelva, Spain.
| | - Cristina M Villanueva
- ISGlobal, Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Madrid, Spain; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
| | - Milena Maule
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO-Piemonte, Turin, Italy.
| | - Esther Gracia-Lavedan
- ISGlobal, Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Madrid, Spain.
| | - Franco Momoli
- School of Epidemiology and Public Health, University of Ottawa Faculty of Medicine, Ontario, Ottawa Hospital Research Institute, Ottawa, Canada.
| | - Daniel Krewski
- School of Epidemiology and Public Health, University of Ottawa Faculty of Medicine, Ontario, Ottawa Hospital Research Institute, Ottawa, Canada; McLaughlin Centre for Population Health Risk Assessment, University of Ottawa Faculty of Medicine, Ottawa, Ontario, Canada; Risk Science International, Ottawa, Ontario, Canada.
| | | | - Eleni Petridou
- Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, Athens, Greece; Hellenic Society for Social Pediatrics & Health Promotion, Athens, Greece.
| | - Evdoxia Bouka
- Hellenic Society for Social Pediatrics & Health Promotion, Athens, Greece.
| | - Franco Merletti
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO-Piemonte, Turin, Italy.
| | - Enrica Migliore
- CPO-Piemonte, AOU Città della Salute e della Scienza, Turin, Italy.
| | - Sara Piro
- Environmental and Occupational Epidemiology Branch, Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research Prevention and Clinical Network-ISPRO, Florence, Italy.
| | - Mina Ha
- Department of Preventive Medicine, Dankook University College of Medicine, 119 Dandae-ro, Cheonan, Chungnam, Korea.
| | - Andrea 't Mannetje
- Centre for Public Health Research, Massey University, Wallace St, Mount Cook, Wellington, New Zealand.
| | - Amanda Eng
- Centre for Public Health Research, Massey University, Wallace St, Mount Cook, Wellington, New Zealand.
| | - Nuria Aragones
- Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP), Madrid, Spain; Epidemiology Section, Public Health Division, Department of Health of Madrid, Spain.
| | - Elisabeth Cardis
- ISGlobal, Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
| |
Collapse
|
16
|
Pizzi C, Moccia C, Moirano G, d'Errico A, Maule M, Fossati S, Lioret S, Calas L, Richiardi L. 1459Socioeconomic position influence on the early-life individual exposome in the Italian NINFEA birth cohort. Int J Epidemiol 2021. [DOI: 10.1093/ije/dyab168.536] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Early exposure to unhealthy lifestyles and environmental risk factors is known to affect health throughout the life-course. There is also evidence that the exposure patterns are influenced by the socioeconomic position (SEP).
Methods
We use the data of the Turin participants of the Italian NINFEA birth cohort (n∼2500) to study how family SEP drives the early life exposome. SEP at birth is measured through the EHII (Equivalized Household Income Indicator), while the exposome includes urban environment, diet and lifestyle exposures measured during infancy. We use standard regression models to evaluate the effect of EHII on each exposome variable accounting for multiple comparison and potential confounders (Drivers-Exposome Wide Association Study – DExWAS) and the hierarchical clustering on the principal components approach to identify groups with similar exposure pattern.
Results
The DExWAS show that low EHII is associated with lower consumption of fruit and vegetables, lower levels of NO2, building and facilities densities, traffic, walkability and connectivity index, higher land-use diversity index, and higher exposure to pets. The hierarchical cluster analysis identifies three groups, with subjects belonging to the cluster characterized by higher level of urban environment risk factors and a healthier diet having a higher mean EHII.
Conclusions
These SEP-early life exposome analyses will be replicated in several European birth cohorts participating in the H2020 ATHLETE and LifeCycle projects.
Key messages
In the Italian city of Turin children from low SEP family are exposed to higher levels of environmental risk factors and unhealthy lifestyles during infancy.
Collapse
Affiliation(s)
- Costanza Pizzi
- Department of Medical Sciences, University Of Turin, Turin, Italy
| | - Chiara Moccia
- Department of Medical Sciences, University Of Turin, Turin, Italy
| | | | - Antonio d'Errico
- Department of Medical Sciences, University Of Turin, Turin, Italy
| | - Milena Maule
- Department of Medical Sciences, University Of Turin, Turin, Italy
| | - Serena Fossati
- ISGlobal, Universitat Pompeu Fabra (UPF), CIBER Epidemiología y Salud Pública (CIBERESP), Spain
| | | | - Lucinda Calas
- Université de Paris, CRESS, INSERM, INRAE, Paris, France
| | | |
Collapse
|
17
|
Quaglino P, Prince H, Cowan R, Vermeer M, Papadavid L, Bagot M, Servitjie O, Berti E, Guenova E, Stadler R, Querfeld C, Busschots A, Hodak E, Patsatsi A, Sanches J, Maule M, Yoo J, Kevin M, Fava P, Ribero S, Zocchi L, Rubatto M, Fierro M, Wehkamp U, Marshalko M, Mitteldorf C, Akilov O, Ortiz-Romero P, Estrach T, Vakeva L, Enz P, Wobser M, Bayne M, Jonak C, Rubeta M, Forbes A, Bates A, Battistella M, Amel-Kashipaz R, Vydianath B, Combalia A, Georgiou E, Hauben E, Hong E, Jost M, Knobler R, Amitay-Laish I, Miyashiro D, Cury-Martins J, Martinez X, Muniesa C, Prag-Naveh H, Nikolaou V, Quint K, Ram-Wolff C, Rieger K, Stranzenbach R, Szepesi Á, Alberti-Violetti S, Felicity E, Cerroni L, Kempf W, Whittaker S, Willemze R, Kim Y, Scarisbrick J. Treatment of early-stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study. Br J Dermatol 2021; 184:722-730. [PMID: 32479678 PMCID: PMC7704558 DOI: 10.1111/bjd.19252] [Citation(s) in RCA: 36] [Impact Index Per Article: 12.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/22/2020] [Indexed: 02/06/2023]
Abstract
BACKGROUND The PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study is a prospective analysis of an international database. Here we examine front-line treatments and quality of life (QoL) in patients with newly diagnosed mycosis fungoides (MF). OBJECTIVES To identify (i) differences in first-line approaches according to tumour-nodes-metastasis-blood (TNMB) staging; (ii) parameters related to a first-line systemic approach and (iii) response rates and QoL measures. METHODS In total, 395 newly diagnosed patients with early-stage MF (stage IA-IIA) were recruited from 41 centres in 17 countries between 1 January 2015 and 31 December 2018 following central clinicopathological review. RESULTS The most common first-line therapy was skin-directed therapy (SDT) (322 cases, 81·5%), while a smaller percentage (44 cases, 11·1%) received systemic therapy. Expectant observation was used in 7·3%. In univariate analysis, the use of systemic therapy was significantly associated with higher clinical stage (IA, 6%; IB, 14%; IIA, 20%; IA-IB vs. IIA, P < 0·001), presence of plaques (T1a/T2a, 5%; T1b/T2b, 17%; P < 0·001), higher modified Severity Weighted Assessment Tool (> 10, 15%; ≤ 10, 7%; P = 0·01) and folliculotropic MF (FMF) (24% vs. 12%, P = 0·001). Multivariate analysis demonstrated significant associations with the presence of plaques (T1b/T2b vs. T1a/T2a, odds ratio 3·07) and FMF (odds ratio 2·83). The overall response rate (ORR) to first-line SDT was 73%, while the ORR to first-line systemic treatments was lower (57%) (P = 0·027). Health-related QoL improved significantly both in patients with responsive disease and in those with stable disease. CONCLUSIONS Disease characteristics such as presence of plaques and FMF influence physician treatment choices, and SDT was superior to systemic therapy even in patients with such disease characteristics. Consequently, future treatment guidelines for early-stage MF need to address these issues.
Collapse
Affiliation(s)
- P. Quaglino
- Dermatologic Clinic, University of Turin Medical School, Torino, Italy
| | - H.M. Prince
- Sir Peter MacCallum Department of Oncology, University of Melbourne, Australia
| | - R. Cowan
- Christie Hospital, Manchester UK
| | - M. Vermeer
- Leiden University Medical Centre, The Netherlands
| | | | - M. Bagot
- Hospital St Louis, Paris, France
| | - O. Servitjie
- Hospital Universitari de Bellvitge, Barcelona, Spain
| | | | | | - R. Stadler
- University Medical Centre, Johannes Wesling, Minden, Germany
| | - C. Querfeld
- City of Hope National Medical Center and Beckman Research Institute, Duarte, California, US
| | | | - E. Hodak
- Rabin Medical Center, Tel Aviv University, Israel
| | - A. Patsatsi
- Aristotle University of Thessaloniki, in Papageorgiou General Hospital, Greece
| | - J. Sanches
- University of Sao Paulo Medical School, Brazil, South America
| | - M. Maule
- Cancer Epidemiology Unit, Department Medical Sciences, University of Turin, Italy
| | - J. Yoo
- University Hospitals Birmingham, UK
| | - M. Kevin
- University Hospitals Birmingham, UK
| | - P. Fava
- Dermatologic Clinic, University of Turin Medical School, Torino, Italy
| | - S. Ribero
- Dermatologic Clinic, University of Turin Medical School, Torino, Italy
| | - L. Zocchi
- Dermatologic Clinic, University of Turin Medical School, Torino, Italy
| | - M. Rubatto
- Dermatologic Clinic, University of Turin Medical School, Torino, Italy
| | - M.T. Fierro
- Dermatologic Clinic, University of Turin Medical School, Torino, Italy
| | - U. Wehkamp
- University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
| | | | - C. Mitteldorf
- HELIOS Klinikum Hildesheim GmbH, University Medical Center Göttingen, Germany
| | - O. Akilov
- University of Pittsburgh School of Medicine, Pennsylvania, USA
| | | | - T. Estrach
- Hospital Clinico, University of Barcelona, Spain
| | - L. Vakeva
- Helsinki University Central Hospital, Finland
| | - P.A. Enz
- Hospital Italiano De Buenos Aires, Argentina, South America
| | - M. Wobser
- University Hospital Wuerzburg, Germany
| | | | - C. Jonak
- Dept of Dermatology, Medical University of Vienna, Austria
| | - M. Rubeta
- Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford UK
| | | | - A. Bates
- University Hospital Southampton, Southampton, UK
| | | | | | | | - A. Combalia
- Hospital Clinico, University of Barcelona, Spain
| | - E. Georgiou
- Aristotle University of Thessaloniki, in Papageorgiou General Hospital, Greece
| | - E. Hauben
- Belgium University Hospitals Leuven, Leuven, Belgium
| | | | - M. Jost
- University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
| | - R. Knobler
- Dept of Dermatology, Medical University of Vienna, Austria
| | | | - D. Miyashiro
- University of Sao Paulo Medical School, Brazil, South America
| | - J. Cury-Martins
- University of Sao Paulo Medical School, Brazil, South America
| | - X. Martinez
- City of Hope National Medical Center and Beckman Research Institute, Duarte, California, US
| | - C. Muniesa
- Hospital Universitari de Bellvitge, Barcelona, Spain
| | | | | | - K. Quint
- Leiden University Medical Centre, The Netherlands
| | | | | | - R. Stranzenbach
- University Medical Centre, Johannes Wesling, Minden, Germany
| | - Á. Szepesi
- Semmelweis University, Budapest, Hungary
| | | | | | - L. Cerroni
- Department of Dermatology, Research Unit Dermatopathology, Medical University of Graz, Graz, Austria
| | - W. Kempf
- Kempf und Pfaltz, Histologische Diagnostik, Zurich, Switzerland
| | - S. Whittaker
- Kings College London, Guys and St Thomas NHS Foundation Trust, London
| | - R. Willemze
- Leiden University Medical Centre, The Netherlands
| | | | | |
Collapse
|
18
|
Guida M, Strippoli S, Maule M, Quaglino P, Ramondetta A, Chiaron Sileni V, Antonini Cappellini G, Queirolo P, Ridolfi L, Del Vecchio M, Cocorocchio E, Di Giacomo AM, Festino L, Merelli B, Occelli M, Brugnara S, Minisini A, Sava S, Tommasi S, De Summa S. Immune checkpoint inhibitor associated vitiligo and its impact on survival in patients with metastatic melanoma: an Italian Melanoma Intergroup study. ESMO Open 2021; 6:100064. [PMID: 33711672 PMCID: PMC7970061 DOI: 10.1016/j.esmoop.2021.100064] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2020] [Revised: 01/19/2021] [Accepted: 01/25/2021] [Indexed: 12/17/2022] Open
Abstract
Background Checkpoint inhibitors in melanoma can lead to self-immune side-effects such as vitiligo-like depigmentation (VLD). Beyond the reported association with favorable prognosis, there are limited data regarding VLD patient features and their echo on the therapeutic outcomes. Methods To assess the association between VLD and a series of clinical and biological features as well as therapeutic outcomes, we built an observational cohort study by recruiting patients who developed VLD during checkpoint inhibitors. Results A total of 148 patients from 15 centers (101 men, median age 66 years, BRAF mutated 23%, M1c 42%, Eastern Cooperative Oncology Group (ECOG) status 0/1 99%, normal lactate dehydrogenase 74%) were enrolled. VLD was induced by ipilimumab, programmed cell death-1 (PD-1) inhibitors, and their combination in 32%, 56%, and 12%, respectively. The median onset was 26 weeks and it was associated with other skin and nonskin toxicities in 27% and 28%, respectively. After 3 years of VLD onset, 52% (95% confidence interval 39% to 63%) were progression free and 82% (95% confidence interval 70% to 89%) were still alive. The overall response rate was 73% with 26% complete response. Univariable analysis indicated that BRAF V600 mutation was associated with a better overall survival (P = 0.028), while in multivariable analysis a longer progression-free survival was associated with BRAF V600 (P = 0.093), female sex (P = 0.008), and M stage other than 1a (P = 0.024). When VLD occurred, there was a significant decrease of white blood cell (WBC) count (P = 0.05) and derived WBC-to-lymphocytes ratio (dWLR; P = 0.003). A lower monocyte count (P = 0.02) and dWLR (P = 0.01) were also reported in responder patients. Conclusions Among VLD population, some features might help to identify patients with an effective response to immunotherapy, allowing clinicians to make more appropriate choices in terms of therapeutic options and duration. This multicentric retrospective study outlined the melanoma profile of 148 patients with vitiligo-like depigmentation (VLD) induced by checkpoint inhibitors. Median VLD onset was 26 weeks and it was associated with other immune toxicities in one-third of cases. After 3 years of VLD onset, 52% and 82% of patients, respectively, were progression free and still alive with a response rate of 73%. Some features such as BRAF V600, female sex, and M stage were associated with better outcomes as well as a specific blood profile.
Collapse
Affiliation(s)
- M Guida
- Rare Tumors and Melanoma Unit, IRCCS Istituto Tumori 'Giovanni Paolo II', Bari, Italy.
| | - S Strippoli
- Rare Tumors and Melanoma Unit, IRCCS Istituto Tumori 'Giovanni Paolo II', Bari, Italy
| | - M Maule
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin, Turin, Italy
| | - P Quaglino
- Dermatologic Clinic, Department of Medical Sciences, University of Turin Medical School, Turin, Italy
| | - A Ramondetta
- Dermatologic Clinic, Department of Medical Sciences, University of Turin Medical School, Turin, Italy
| | | | | | - P Queirolo
- Skin Cancer Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy
| | - L Ridolfi
- Medical Oncology Department, IRCCS National Cancer Research Centre, Meldola (FO), Italy
| | - M Del Vecchio
- Medical Oncology Unit, Department of Medical Oncology and Hematology, Fondazione IRCCS, Milan, Italy
| | - E Cocorocchio
- Division of Medical Oncology for Melanoma, Sarcoma, and Rare Tumors, IEO, European Institute of Oncology IRCCS, Milan, Italy
| | - A M Di Giacomo
- Center for Immuno-Oncology University Hospital of Siena, Siena, Italy
| | - L Festino
- Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale, Naples, Italy
| | - B Merelli
- Department of Medical Oncology, ASST Papa Giovanni XXIII, Bergamo, Italy
| | - M Occelli
- Department of Medicine, Clinical Oncology and Translational Research, Azienda Ospedaliera Santa Croce and Carle University Teaching Hospital, Cuneo, Italy
| | - S Brugnara
- Oncology Unit, S. Chiara Hospital, Trento, Italy
| | - A Minisini
- Department of Oncology, ASUIUD University Hospital of Udine, Udine, Italy
| | - S Sava
- Medical Oncology Unit, A.O. Papardo & Department of Human Pathology, University of Messina, Messina, Italy
| | - S Tommasi
- Molecular Diagnostic and Pharmacogenetics Laboratory, IRCCS Istituto Tumori 'Giovanni Paolo II', Bari, Italy
| | - S De Summa
- Molecular Diagnostic and Pharmacogenetics Laboratory, IRCCS Istituto Tumori 'Giovanni Paolo II', Bari, Italy
| | | |
Collapse
|
19
|
Moirano G, Zanet S, Giorgi E, Battisti E, Falzoi S, Acquaotta F, Fratianni S, Richiardi L, Ferroglio E, Maule M. Integrating environmental, entomological, animal, and human data to model the Leishmania infantum transmission risk in a newly endemic area in Northern Italy. One Health 2020; 10:100159. [PMID: 33117874 PMCID: PMC7582207 DOI: 10.1016/j.onehlt.2020.100159] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2020] [Revised: 08/06/2020] [Accepted: 08/06/2020] [Indexed: 12/16/2022] Open
Abstract
INTRODUCTION Historically, leishmaniasis in Italy was constrained to areas with Mediterranean climate. In the last 20 years, sand fly vectors (Phlebotomus perniciosus), cases of canine leishmaniasis (CanL) and cases of human visceral leishmaniasis (VL) have been observed in Northern Italian regions, traditionally classified as cold areas unsuitable for sand fly survival. AIM We aim to evaluate through a One-Health approach the risk of endemic transmission of Leishmania infantum in the Piedmont Region, Northern Italy. METHODS We collected environmental, entomological, animal, and human data. We applied a geostatistical binomial model to map the probability of P. perniciosus presence in the study area, using selected environmental parameters as predictors. We evaluated the spatial relationship between the probability of P. perniciosus presence and the geographical distribution of CanL and VL cases observed between 1999 and 2013. RESULTS Between 1999 and 2003, 142 sampling sets (17%) out of 839 resulted positive for P. perniciosus. Elevation, degree of slope, normalized difference vegetation index (NDVI) and summer temperatures were associated with positive sampling sets. During the study period, 164 (13.6%) of Piedmont municipalities reported at least one autochthonous case of CanL, while 89 VL cases were observed in 54 municipalities (4.5%). We observed an association between municipalities affected by autochthonous CanL cases and the estimated probability of P. perniciosus presence (Odds Ratio for 10% increase of probability: 2.66; 95% confidence intervals (CI): 2.16-3.37). We found that human VL incident cases were positively associated with the probability of the municipality of residence of being endemic for CanL (Incidence Rate Ratio for 10% increase of probability: 1.49; 95% CI 1.02-2.16). CONCLUSIONS Using a One-Health approach, we quantified the spatial association between the distribution of P. perniciosus, municipalities endemic for CanL and incident cases of human VL, suggesting that the disease has become endemic in the Piedmont region.
Collapse
Affiliation(s)
- G. Moirano
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin, Torino, Italy
| | - S. Zanet
- Dept. of Veterinary Sciences, University of Turin, Torino, Italy
| | - E. Giorgi
- CHICAS, Lancaster University Medical School, Lancaster, UK
| | - E. Battisti
- Dept. of Veterinary Sciences, University of Turin, Torino, Italy
| | - S. Falzoi
- Department of Earth Sciences, University of Turin, Torino, Italy
| | - F. Acquaotta
- Department of Earth Sciences, University of Turin, Torino, Italy
- Centro di Ricerca sui Rischi Naturali, Ambiente Montano e Collinare (NatRisk), Grugliasco, Italy
| | - S. Fratianni
- Department of Earth Sciences, University of Turin, Torino, Italy
- Centro di Ricerca sui Rischi Naturali, Ambiente Montano e Collinare (NatRisk), Grugliasco, Italy
| | - L. Richiardi
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin, Torino, Italy
| | - E. Ferroglio
- Dept. of Veterinary Sciences, University of Turin, Torino, Italy
| | - M. Maule
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin, Torino, Italy
| |
Collapse
|
20
|
Isaevska E, Popovic M, Pizzi C, Fiano V, Rusconi F, Merletti F, Richiardi L, Maule M. Maternal antibiotic use and vaginal infections in the third trimester of pregnancy and the risk of obesity in preschool children. Pediatr Obes 2020; 15:e12632. [PMID: 32174046 PMCID: PMC7507215 DOI: 10.1111/ijpo.12632] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/25/2019] [Accepted: 01/27/2020] [Indexed: 12/20/2022]
Abstract
BACKGROUND/OBJECTIVES Several exposures during pregnancy are associated with offspring body mass index (BMI). The objective of this study was to evaluate whether third trimester antibiotic use and vaginal infections are associated with BMI in preschool children. SUBJECTS/METHODS The study population included singletons from the NINFEA birth cohort with available anthropometric measurements at the age of 4 (3151 born with vaginal and 1111 born with caesarean delivery). Self-reported use of antibiotics and the presence of vaginal infection in the third trimester were analysed in association with the child's BMI, classified into three categories: thinness, normal and overweight/obesity, using both the International Obesity Task Force (IOTF) and the World Health Organization (WHO) recommended cut-offs. RESULTS Maternal vaginal infections in the third trimester of pregnancy were associated with higher relative risk ratios (RRR) for overweight/obesity at age of four in children delivered vaginally: 1.92 (95% confidence interval [CI]: 1.37 to 2.70). This association appeared stronger for children born to women with pre-pregnancy BMI >25 kg/m2 (RRR: 4.78; 95% CI 2.45 to 9.35), and was robust when different obesity cut-offs were used. The results regarding third trimester antibiotic use in vaginal deliveries were less conclusive (RRRs for overweight/obesity: 1.43 (0.92 to 2.21) and 1.11 (0.57 to 2.20), for the IOTF and WHO cut-offs, respectively). Third trimester vaginal infections were not associated with BMI in children delivered by caesarean section. CONCLUSIONS Maternal third trimester vaginal infections are associated with an increased overweight/obesity risk in children born by vaginal delivery, and especially in children of mothers with pre-pregnancy overweight/obesity.
Collapse
Affiliation(s)
- Elena Isaevska
- Department of Medical SciencesUniversity of Turin, CPO PiemonteTurinItaly
| | - Maja Popovic
- Department of Medical SciencesUniversity of Turin, CPO PiemonteTurinItaly
| | - Costanza Pizzi
- Department of Medical SciencesUniversity of Turin, CPO PiemonteTurinItaly
| | - Valentina Fiano
- Department of Medical SciencesUniversity of Turin, CPO PiemonteTurinItaly
| | - Franca Rusconi
- Unit of Epidemiology“Anna Meyer” Children's University HospitalFlorenceItaly
| | - Franco Merletti
- Department of Medical SciencesUniversity of Turin, CPO PiemonteTurinItaly
| | - Lorenzo Richiardi
- Department of Medical SciencesUniversity of Turin, CPO PiemonteTurinItaly
| | - Milena Maule
- Department of Medical SciencesUniversity of Turin, CPO PiemonteTurinItaly
| |
Collapse
|
21
|
Sacerdote C, Mosso ML, Alessi D, Merletti F, Tagliabue G, D'Agostino A, Fabiano S, Savoia F, Piga P, Sessa M, Vetrano F, Gatta G, Maule M. An application of the Toronto Childhood Cancer Stage Guidelines in three population-based cancer registries: The case of central nervous tumors. Pediatr Blood Cancer 2020; 67:e28303. [PMID: 32301558 DOI: 10.1002/pbc.28303] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/31/2019] [Revised: 03/11/2020] [Accepted: 03/16/2020] [Indexed: 11/07/2022]
Abstract
BACKGROUND Cancer stage is a determinant of survival of childhood central nervous system (CNS) cancers and could help the interpretation of survival variability among countries. Consensus guidelines to stage childhood malignancies in population cancer registries ("Toronto Childhood Cancer Stage Guidelines") have been recently proposed with the goal of data comparability. Indeed, stage is not systematically recorded in all registries and, when it is, different classification systems are used. We applied the Toronto Childhood Cancer Stage Guidelines to CNS cancer cases of three population-based cancer registries with the aim of evaluating the feasibility of staging this type of cancer and the critical points in the classification of CNS tumors. PROCEDURES The Toronto Childhood Cancer Stage Guidelines were applied to 175 CNS patients, diagnosed from January 1, 2002 to December 31, 2014 in three cancer registries in Italy, and the percentage of cases that could be staged was assessed. RESULTS One hundred eight of 126 (86%) medulloblastomas and other embryonal CNS cancers and 22 of 49 (45%) ependymomas were staged. Using these guidelines, survival of children with localized tumors could be discriminated from that of children with metastatic disease. CONCLUSIONS The use of the Toronto Childhood Cancer Stage Guidelines is feasible for staging medulloblastoma in Italian population-based cancer registries, whereas it is more difficult for ependymomas. In Italy, cerebrospinal fluid examination, one of the decisive tests to stage CNS tumors, is not routinely performed as a first-line diagnosis procedure in ependymoma pediatric patients. A similar exercise by a larger number of cancer registries in different countries could suggest improvements in the childhood cancer staging system.
Collapse
Affiliation(s)
- Carlotta Sacerdote
- Unit of Cancer Epidemiology, Citta' della Salute e della Scienza Hospital and Centre for Cancer Prevention, Turin, Italy.,Department of Medical Sciences, University of Turin, Turin, Italy
| | | | - Daniela Alessi
- Unit of Cancer Epidemiology, Citta' della Salute e della Scienza Hospital and Centre for Cancer Prevention, Turin, Italy
| | - Franco Merletti
- Unit of Cancer Epidemiology, Citta' della Salute e della Scienza Hospital and Centre for Cancer Prevention, Turin, Italy.,Department of Medical Sciences, University of Turin, Turin, Italy
| | - Giovanna Tagliabue
- Lombardy Cancer Registry, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
| | - Anna D'Agostino
- Lombardy Cancer Registry, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
| | - Sabrina Fabiano
- Lombardy Cancer Registry, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
| | - Fabio Savoia
- Childhood Cancer Registry of Campania, AORN Santobono-Pausilipon, Naples, Italy
| | - Patrizia Piga
- Childhood Cancer Registry of Campania, AORN Santobono-Pausilipon, Naples, Italy
| | - Marcella Sessa
- Childhood Cancer Registry of Campania, AORN Santobono-Pausilipon, Naples, Italy
| | - Francesco Vetrano
- Childhood Cancer Registry of Campania, AORN Santobono-Pausilipon, Naples, Italy
| | - Gemma Gatta
- Evaluative Epidemiology Unit, Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy
| | - Milena Maule
- Unit of Cancer Epidemiology, Citta' della Salute e della Scienza Hospital and Centre for Cancer Prevention, Turin, Italy.,Department of Medical Sciences, University of Turin, Turin, Italy
| |
Collapse
|
22
|
Moirano G, Richiardi L, Novara C, Maule M. Approaches to Daily Monitoring of the SARS-CoV-2 Outbreak in Northern Italy. Front Public Health 2020; 8:222. [PMID: 32574301 PMCID: PMC7256452 DOI: 10.3389/fpubh.2020.00222] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2020] [Accepted: 05/13/2020] [Indexed: 11/23/2022] Open
Abstract
Italy was the first European country affected by the Sars-Cov-2 pandemic, with the first autochthonous case identified on Feb 21st. Specific control measures restricting social contacts were introduced by the Italian government starting from the beginning of March. In the current study we analyzed public data from the four most affected Italian regions. We (i) estimated the time-varying reproduction number (Rt), the average number of secondary cases that each infected individual would infect at time t, to monitor the positive impact of restriction measures; (ii) applied the generalized logistic and the modified Richards models to describe the epidemic pattern and obtain short-term forecasts. We observed a monotonic decrease of Rt over time in all regions, and the peak of incident cases ~2 weeks after the implementation of the first strict containment measures. Our results show that phenomenological approaches may be useful to monitor the epidemic growth in its initial phases and suggest that costly and disruptive public health controls might have had a positive impact in limiting the Sars-Cov-2 spread in Northern Italy.
Collapse
Affiliation(s)
- Giovenale Moirano
- Department of Medical Sciences, University of Turin, and CPO Piemonte, AOU Città della Salute e della Scienza, Turin, Italy
| | - Lorenzo Richiardi
- Department of Medical Sciences, University of Turin, and CPO Piemonte, AOU Città della Salute e della Scienza, Turin, Italy
| | - Carlo Novara
- Department of Electronics and Telecommunications, Politecnico di Torino, Turin, Italy
| | - Milena Maule
- Department of Medical Sciences, University of Turin, and CPO Piemonte, AOU Città della Salute e della Scienza, Turin, Italy
| |
Collapse
|
23
|
Pasqual E, Castaño-Vinyals G, Thierry-Chef I, Kojimahara N, Sim MR, Kundi M, Krewski D, Momoli F, Lacour B, Remen T, Radon K, Weinmann T, Petridou E, Moschovi M, Dikshit R, Sadetski S, Maule M, Farinotti M, Ha M, 't Mannetje A, Alguacil J, Aragonés N, Vermeulen R, Kromhout H, Cardis E. Exposure to Medical Radiation during Fetal Life, Childhood and Adolescence and Risk of Brain Tumor in Young Age: Results from The MOBI-Kids Case-Control Study. Neuroepidemiology 2020; 54:343-355. [PMID: 32200380 DOI: 10.1159/000506131] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2019] [Accepted: 01/20/2020] [Indexed: 11/19/2022] Open
Abstract
BACKGROUND We explored the association between ionizing radiation (IR) from pre-natal and post-natal radio-diagnostic procedures and brain cancer risk within the MOBI-kids study. METHODS MOBI-kids is an international (Australia, Austria, Canada, France, Germany, Greece, India, Israel, Italy, Japan, Korea, New Zealand, Spain, The Netherlands) case-control study including 899 brain tumor (645 neuroepithelial) cases aged 10-24 years and 1,910 sex-, age-, country-matched controls. Medical radiological history was collected through personal interview. We estimated brain IR dose for each procedure, building a look-up table by age and time period. Lifetime cumulative doses were calculated using 2 and 5 years lags from the diagnostic date. Risk was estimated using conditional logistic regression. Neurological, psychological and genetic conditions were evaluated as potential confounders. The main analyses focused on neuroepithelial tumors. RESULTS Overall, doses were very low, with a skewed distribution (median 0.02 mGy, maximum 217 mGy). ORs for post-natal exposure were generally below 1. ORs were increased in the highest dose categories both for post and pre-natal exposures: 1.63 (95% CI 0.44-6.00) and 1.55 (0.57-4.23), respectively, based on very small numbers of cases. The change in risk estimates after adjustment for medical conditions was modest. CONCLUSIONS There was little evidence for an association between IR from radio-diagnostic procedures and brain tumor risk in children and adolescents. Though doses were very low, our results suggest a higher risk for pre-natal and early life exposure, in line with current evidence.
Collapse
Affiliation(s)
- Elisa Pasqual
- Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.,Universitat Pompeu Fabra (UPF), Barcelona, Spain.,CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain
| | - Gemma Castaño-Vinyals
- Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.,Universitat Pompeu Fabra (UPF), Barcelona, Spain.,CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.,IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain
| | - Isabelle Thierry-Chef
- Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.,Universitat Pompeu Fabra (UPF), Barcelona, Spain.,CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain
| | - Noriko Kojimahara
- Department of Public Health, School of Medicine, Tokyo Women's Medical University, Tokyo, Japan
| | - Malcolm R Sim
- Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
| | - Michael Kundi
- Department of Environmental Health, Center for Public Health, Medical University Vienna, Vienna, Austria
| | - Daniel Krewski
- McLaughlin Centre for Population Health Risk Assessment, Institute of Population Health, Ottawa, Ontario, Canada.,Department of Epidemiology and Community Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada
| | - Franco Momoli
- Ottawa Hospital Research Institute, Children's Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, Canada
| | - Brigitte Lacour
- French National Registry of Childhood Solid Tumors, CHRU, Nancy, France.,Inserm U1153, Center of Research in Epidemiology and StatisticS (CRESS), Paris, France.,Paris University, Epidemiology of Childhood and Adolescent Cancers Team (EPICEA), Paris, France
| | - Thomas Remen
- French National Registry of Childhood Solid Tumors, CHRU, Nancy, France.,Inserm U1153, Center of Research in Epidemiology and StatisticS (CRESS), Paris, France.,Paris University, Epidemiology of Childhood and Adolescent Cancers Team (EPICEA), Paris, France
| | - Katja Radon
- Institute and Clinic for Occupational, Social and Environmental Medicine, University Hospital, LMU Munich, Munich, Germany
| | - Tobias Weinmann
- Institute and Clinic for Occupational, Social and Environmental Medicine, University Hospital, LMU Munich, Munich, Germany
| | - Eleni Petridou
- Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, Athens, Greece.,Unit of Clinical Epidemiology, Karolinska Institute, Stockholm, Sweden
| | - Maria Moschovi
- Haematology-Oncology Unit, First Department of Pediatrics, National and Kapodistrian University of Athens, Medical School, "Aghia Sophia" Children's Hospital, Athens, Greece
| | - Rajesh Dikshit
- Centre for Cancer Epidemiology, Tata Memorial Centre, Mumbai, India
| | - Siegal Sadetski
- Cancer and Radiation Epidemiology Unit, Gertner Institute, Chaim Sheba Medical Center, Ramat Gan, Israel
| | - Milena Maule
- Unit of Cancer Epidemiology, Department of Medical Sciences, University of Turin, Turin, Italy
| | - Mariangela Farinotti
- Unit of Neuroepidemiology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy
| | - Mina Ha
- Department of Preventive Medicine, Dankook University College of Medicine, Cheonan, Republic of Korea
| | - Andrea 't Mannetje
- Centre for Public Health Research, Massey University, Wellington, New Zealand
| | - Juan Alguacil
- CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.,Centro de Investigación en Recursos Naturales, Salud y Medio Ambiente (RENSMA), Universidad de Huelva, Huelva, Spain
| | - Nuria Aragonés
- CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.,Cancer Epidemiology Section, Public Health Division, Department of Health of Madrid, Madrid, Spain
| | - Roel Vermeulen
- Division Environmental Epidemiology, Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands
| | - Hans Kromhout
- Division Environmental Epidemiology, Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands
| | - Elisabeth Cardis
- Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain, .,Universitat Pompeu Fabra (UPF), Barcelona, Spain, .,CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain,
| |
Collapse
|
24
|
Albin M, Bültmann U, Casas M, Lawlor DA, Lendzhova V, Leombruni R, Lissaker C, Lucas R, Maule M, Peters S, Polańska K, Sarac J, Selander J, Skroder H, Mehlum IS, Ubalde-Lopez M. Employment and health of working parents: a joint effort to uncover hidden treasures in birth cohorts. Eur J Public Health 2019. [DOI: 10.1093/eurpub/ckz186.154] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Birth and child cohorts include a wealth of valuable and under-utilized data on employment and health of parents during pregnancy, at birth and often at one or more follow-up assessments.
OMEGA-NET is a EU COST Action aimed at creating a network to optimize the use of European occupational, industrial and population cohorts and to promote health research on occupation and employment. Within this network, Task Group 3.3 is exploring the possibility of exploiting birth cohort data to investigate the interplay between health, socio-economic conditions, working life and work participation of parents around and after the birth of their children, identify gaps in knowledge, and devise strategies to fill them.
Using a web-based database, www.birthcohorts.net, we have identified cohorts with occupational and health information in up to 200,000 parents. Out of 47 cohorts with information on mothers, maternal employment status and occupational exposures during pregnancy were recorded in 18 and 35 cohorts, respectively. For paternal exposures, the corresponding numbers were 6 and 15. To exploit these data, many challenges have to be overcome, primarily harmonization of exposures and outcomes. Cohorts cover different time periods and geographical regions, which can be at the same time a challenge and a blessing, providing hints on causal effects and mechanisms. Other strengths of pooling birth cohorts include the life-course nature of data and the possibility to investigate neglected occupationally-related exposures like work-family conflicts and their effects on health.
We argue that parental data collected in birth cohorts are a valuable under-exploited source of information that would allow cross-national comparisons of the relationships between work, career trajectories and health of young parents.
Key messages
Birth cohorts hide a treasure of occupational and health information of young working parents. OMEGA-NET has plans to dig them out to investigate their interplay.
Collapse
Affiliation(s)
- M Albin
- OMEGA-NET, Network on the Coordination and Harmonisation of European Occupational Cohorts (OMEGA-NET) project; Task Group 3.3 Employment patterns in the young
| | - U Bültmann
- OMEGA-NET, Network on the Coordination and Harmonisation of European Occupational Cohorts (OMEGA-NET) project; Task Group 3.3 Employment patterns in the young
| | - M Casas
- OMEGA-NET, Network on the Coordination and Harmonisation of European Occupational Cohorts (OMEGA-NET) project; Task Group 3.3 Employment patterns in the young
| | - D A Lawlor
- OMEGA-NET, Network on the Coordination and Harmonisation of European Occupational Cohorts (OMEGA-NET) project; Task Group 3.3 Employment patterns in the young
| | - V Lendzhova
- OMEGA-NET, Network on the Coordination and Harmonisation of European Occupational Cohorts (OMEGA-NET) project; Task Group 3.3 Employment patterns in the young
| | - R Leombruni
- OMEGA-NET, Network on the Coordination and Harmonisation of European Occupational Cohorts (OMEGA-NET) project; Task Group 3.3 Employment patterns in the young
| | - C Lissaker
- OMEGA-NET, Network on the Coordination and Harmonisation of European Occupational Cohorts (OMEGA-NET) project; Task Group 3.3 Employment patterns in the young
| | - R Lucas
- OMEGA-NET, Network on the Coordination and Harmonisation of European Occupational Cohorts (OMEGA-NET) project; Task Group 3.3 Employment patterns in the young
| | - M Maule
- OMEGA-NET, Network on the Coordination and Harmonisation of European Occupational Cohorts (OMEGA-NET) project; Task Group 3.3 Employment patterns in the young
| | - S Peters
- OMEGA-NET, Network on the Coordination and Harmonisation of European Occupational Cohorts (OMEGA-NET) project; Task Group 3.3 Employment patterns in the young
| | - K Polańska
- OMEGA-NET, Network on the Coordination and Harmonisation of European Occupational Cohorts (OMEGA-NET) project; Task Group 3.3 Employment patterns in the young
| | - J Sarac
- OMEGA-NET, Network on the Coordination and Harmonisation of European Occupational Cohorts (OMEGA-NET) project; Task Group 3.3 Employment patterns in the young
| | - J Selander
- OMEGA-NET, Network on the Coordination and Harmonisation of European Occupational Cohorts (OMEGA-NET) project; Task Group 3.3 Employment patterns in the young
| | - H Skroder
- OMEGA-NET, Network on the Coordination and Harmonisation of European Occupational Cohorts (OMEGA-NET) project; Task Group 3.3 Employment patterns in the young
| | - I S Mehlum
- OMEGA-NET, Network on the Coordination and Harmonisation of European Occupational Cohorts (OMEGA-NET) project; Task Group 3.3 Employment patterns in the young
| | - M Ubalde-Lopez
- OMEGA-NET, Network on the Coordination and Harmonisation of European Occupational Cohorts (OMEGA-NET) project; Task Group 3.3 Employment patterns in the young
| |
Collapse
|
25
|
Moirano G, Richiardi L, Calzolari M, Merletti F, Maule M. Recent rapid changes in the spatio-temporal distribution of West Nile Neuro-invasive Disease in Italy. Zoonoses Public Health 2019; 67:54-61. [PMID: 31612606 DOI: 10.1111/zph.12654] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2019] [Revised: 07/12/2019] [Accepted: 09/13/2019] [Indexed: 12/01/2022]
Abstract
In Italy, the first human case of West Nile Virus (WNV) infection was reported in 2008 and, since then, the number of cases has been steadily increasing. In this study, we describe the temporal and spatial pattern of WNV infection risk among humans in Italy, focusing on the human cases of West Nile Neuro-invasive Disease (WNND) observed between 2008 and 2017. Incidence rates are estimated for each year and province under study. The incidence temporal trend is estimated using Poisson regression, and a spatio-temporal cluster detection analysis is performed to detect high-risk areas. In total, 231 WNND cases were notified in Italy between 2008 and 2017. The annual incidence rates increased during the study period (annual percentage change: 11.7%; 95%CI: -0.9%; 26.1%). A geographical spread of the disease was observed during the study period throughout Northern Italy, with an increasing number of affected provinces. Provinces close to the Po River (the main river in the north of Italy) and the Oristano province (in the Sardinia Island) experienced the highest incidence rates during the study period. Our study shows a gradual, but rapid spread of WNND across Northern Italy from east to west and suggests the hypothesis that provinces close to Po River might present ecological and climatic conditions favourable to the virus circulation.
Collapse
Affiliation(s)
- Giovenale Moirano
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO-Piemonte, Torino, Italy
| | - Lorenzo Richiardi
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO-Piemonte, Torino, Italy
| | - Mattia Calzolari
- Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia-Romagna 'B. Ubertini' (IZSLER), Brescia, Italy
| | - Franco Merletti
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO-Piemonte, Torino, Italy
| | - Milena Maule
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO-Piemonte, Torino, Italy
| |
Collapse
|
26
|
Isaevska E, Popovic M, Alessi D, Mosso ML, Sacerdote C, Magnani C, Pastore G, Rosso T, Zengarini N, Dockerty J, Merletti F, Maule M. Association between maternal education and survival after childhood cancer. Pediatr Blood Cancer 2019; 66:e27616. [PMID: 30677232 DOI: 10.1002/pbc.27616] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/01/2018] [Revised: 12/28/2018] [Accepted: 01/02/2019] [Indexed: 11/10/2022]
Abstract
BACKGROUND Several nonbiological factors, including socioeconomic status indicators and other family characteristics, influence survival from childhood cancers. Our study explores the association between parental education and childhood cancer survival. METHODS The specialized Childhood Cancer Registry of the Piedmont region in Italy provided data on all the cases (aged 0-14) diagnosed with cancer in the period 1976-2011 who resided in the city of Turin (capital of the Piedmont region) at least once since 1971. Information on parental education was extracted from the Turin Longitudinal Study by record linkage. The association between parental educational level and survival was estimated using Cox regression. RESULTS The study included 949 children. We observed a disadvantage in the overall survival for children of less educated mothers. No such effect was observed for paternal education. The effect of maternal education was particularly strong for central nervous system tumors (hazard ratios, 2.9; 95% confidence interval, 1.1-8.0). A similar effect, though smaller in magnitude, was observed for leukemia and embryonal tumors, whereas the estimates for lymphoma were imprecise. CONCLUSIONS Our study shows an association between maternal educational level and survival in children with central nervous system tumors, a diagnosis that often requires long-lasting treatment and special care. Giving support to the families of affected children to provide them the optimal care has the potential to improve children's cancer treatment outcomes.
Collapse
Affiliation(s)
- Elena Isaevska
- Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin, Turin, Italy
| | - Maja Popovic
- Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin, Turin, Italy
| | - Daniela Alessi
- Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin, Turin, Italy.,Piedmont Cancer Registry, Biella and Vercelli Provinces, Epidemiology Unit, ASL VC, Vercelli, Italy
| | - Maria Luisa Mosso
- Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin, Turin, Italy
| | - Carlotta Sacerdote
- Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin, Turin, Italy
| | - Corrado Magnani
- Department of Translational Medicine, Unit of Medical Statistics and Cancer Epidemiology, CPO Piemonte and University of Piemonte Orientale, Novara, Italy
| | - Guido Pastore
- Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin, Turin, Italy
| | - Tiziana Rosso
- Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin, Turin, Italy
| | | | - John Dockerty
- Department of Preventive and Social Medicine, University of Otago, P O Box 56, Dunedin, New Zealand
| | - Franco Merletti
- Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin, Turin, Italy
| | - Milena Maule
- Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin, Turin, Italy
| |
Collapse
|
27
|
Girardo M, Zenga F, Bruno LL, Rava A, Massè A, Maule M, Fusini F. Treatment of Aggressive Vertebral Hemangiomas with Poly Vinyl Alcohol (PVA) Microparticles Embolization, PMMA, and Short Segment Stabilization: Preliminary Results with at Least 5 Years of Follow-up. World Neurosurg 2019; 128:e283-e288. [PMID: 31028979 DOI: 10.1016/j.wneu.2019.04.138] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2019] [Revised: 04/14/2019] [Accepted: 04/15/2019] [Indexed: 12/29/2022]
Abstract
OBJECTIVE Vertebral hemangiomas (VHs) are the most common incidental lesions of vertebral body, but they are very challenging to treat if they become symptomatic. Several treatments have been proposed but none was superior to others. The aim of this study is to analyze blood loss and long-term clinical and neurological results of aggressive VHs treated with arterial embolization the day before operation, followed by vertebroplasty, posterior decompression, and short segment stabilization. METHODS Ten patients (4 males and 6 females) were treated for aggressive VHs with polyvinyl alcohol microparticles embolization, posterior short segment stabilization, and poly methyl methacrylate. Clinical and neurological outcomes were assessed with visual analog, Nurick, and American Spinal Injury Association (ASIA) scales. RESULTS At last follow-up mean, visual analog scale was 1.8 ± 1.3, with a significant difference with preoperative values (P = 0.00018). Neurological deficits persisted in 4 patients (ASIA scale: C in 1 patient [10%], D in 3 patients [30%]), but they improved from baseline in all cases. Also, Nurick scale rating improved in all patients (0 in 3 patients [30%], 1 in 4 patients [40%], 2 in 2 patients [20%], and 3 in the last one [10%]). A statistically significant difference between pre- and postoperative values was observed for both scores (ASIA, P = 0.0102; Nurick, P = 0.026). Relapse of pathology was recorded in 2 patients. CONCLUSIONS Polyvinyl alcohol microparticles embolization, short segment fixation, and vertebroplasty is an effective treatment option for aggressive VHs, with a fast surgical time, poor blood loss, and improvement of preoperative clinical and neurological outcomes.
Collapse
Affiliation(s)
- Massimo Girardo
- Spine Surgery Unit, Orthopaedic and Trauma Centre, Città della Salute e della Scienza di Torino, University of Turin, Turin, Italy
| | - Francesco Zenga
- Department of Neurosurgery, Molinette Hospital, Città della Salute e della Scienza di Torino, Turin, Italy
| | - Laura Lorien Bruno
- Spine Surgery Unit, Orthopaedic and Trauma Centre, Città della Salute e della Scienza di Torino, University of Turin, Turin, Italy
| | - Alessandro Rava
- Department of Orthopaedic and Traumatology, Orthopaedic and Trauma Centre, Città della Salute e della Scienza di Torino, University of Turin, Turin, Italy.
| | - Alessandro Massè
- Department of Orthopaedic and Traumatology, Orthopaedic and Trauma Centre, Città della Salute e della Scienza di Torino, University of Turin, Turin, Italy
| | - Milena Maule
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin, Turin, Italy
| | - Federico Fusini
- Department of Orthopaedic and Traumatology, Orthopaedic and Trauma Centre, Città della Salute e della Scienza di Torino, University of Turin, Turin, Italy
| |
Collapse
|
28
|
Bergandi L, Giuggia B, Alovisi M, Comba A, Silvagno F, Maule M, Aldieri E, Scotti N, Scacciatella P, Conrotto F, Berutti E, Pasqualini D. Endothelial Dysfunction Marker Variation in Young Adults with Chronic Apical Periodontitis before and after Endodontic Treatment. J Endod 2019; 45:500-506. [PMID: 30910354 DOI: 10.1016/j.joen.2019.01.018] [Citation(s) in RCA: 21] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2018] [Revised: 01/23/2019] [Accepted: 01/29/2019] [Indexed: 01/26/2023]
Abstract
INTRODUCTION Cardiovascular diseases are the leading cause of mortality worldwide. Apical periodontitis (AP) has been associated with an increased risk of cardiovascular diseases. A correlation has been shown between chronic AP and endothelial dysfunction (ED), but there is no evidence to indicate ED improves after endodontic treatment in patients with periapical lesions. The aim of this study was to investigate vascular and molecular markers of early ED before and after root canal treatment in young adults with chronic AP. METHODS Twenty control subjects and 21 patients with AP were assessed at baseline. The AP patients were also evaluated 2 and 12 months post-treatment. Endothelial flow reserve was assessed via an endothelial function test, and enzyme-linked immunosorbent assays were used to evaluate plasma levels of proinflammatory cytokines interleukin (IL)-1, IL-6, and tumor necrosis factor alpha; vasoconstrictor ED marker endothelin (ET)-1; circulating endothelial adhesion markers intercellular adhesion molecule 1 (ICAM-1)/CD54 and soluble vascular cellular adhesion molecule (sVCAM)-1/CD106; soluble CD14; and the endothelial leukocyte adhesion molecule (E-selectin). RESULTS AP was associated with increased serum levels of ET-1, ICAM-1, E-selectin, IL-1, and sCD14, suggesting early vascular ED, with no macroscopic evidence of a reduction in endothelial flow reserve. Root canal treatment ameliorated inflammation and early ED, lowering plasma levels of IL-1, sCD14, ET-1, ICAM-1/CD54, and E-selectin to those of control subjects. CONCLUSIONS Our findings suggest that AP may drive early vascular ED and that the endodontic therapy of AP ameliorates early ED.
Collapse
Affiliation(s)
| | - Beatrice Giuggia
- Department of Surgical Sciences, Dental School, University of Turin, Turin, Italy
| | - Mario Alovisi
- Department of Surgical Sciences, Dental School, University of Turin, Turin, Italy
| | - Allegra Comba
- Department of Surgical Sciences, Dental School, University of Turin, Turin, Italy
| | | | - Milena Maule
- Department of Medical Sciences, Division of Cardiology, Città della Salute e della Scienza di Torino, Turin, Italy
| | | | - Nicola Scotti
- Department of Surgical Sciences, Dental School, University of Turin, Turin, Italy
| | - Paolo Scacciatella
- Department of Medical Sciences, Cancer Epidemiology Unit, University of Turin, Turin, Italy
| | - Federico Conrotto
- Department of Medical Sciences, Cancer Epidemiology Unit, University of Turin, Turin, Italy
| | - Elio Berutti
- Department of Surgical Sciences, Dental School, University of Turin, Turin, Italy
| | - Damiano Pasqualini
- Department of Surgical Sciences, Dental School, University of Turin, Turin, Italy.
| |
Collapse
|
29
|
Quaglino P, Maule M, Prince HM, Porcu P, Horwitz S, Duvic M, Talpur R, Vermeer M, Bagot M, Guitart J, Papadavid E, Sanches JA, Hodak E, Sugaya M, Berti E, Ortiz-Romero P, Pimpinelli N, Servitje O, Pileri A, Zinzani PL, Estrach T, Knobler R, Stadler R, Fierro MT, Alberti Violetti S, Amitay-Laish I, Antoniou C, Astrua C, Chaganti S, Child F, Combalia A, Fabbro S, Fava P, Grandi V, Jonak C, Martinez-Escala E, Kheterpal M, Kim EJ, McCormack C, Miyagaki T, Miyashiro D, Morris S, Muniesa C, Nikolaou V, Ognibene G, Onida F, Osella-Abate S, Porkert S, Postigo-Llorente C, Ram-Wolff C, Ribero S, Rogers K, Sanlorenzo M, Stranzenbach R, Spaccarelli N, Stevens A, Zugna D, Rook AH, Geskin LJ, Willemze R, Whittaker S, Hoppe R, Scarisbrick J, Kim Y. Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium. Ann Oncol 2019; 30:494. [PMID: 29947731 DOI: 10.1093/annonc/mdy207] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- P Quaglino
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - M Maule
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - H M Prince
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - P Porcu
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - S Horwitz
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - M Duvic
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - R Talpur
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - M Vermeer
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - M Bagot
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - J Guitart
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - E Papadavid
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - J A Sanches
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - E Hodak
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - M Sugaya
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - E Berti
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - P Ortiz-Romero
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - N Pimpinelli
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - O Servitje
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - A Pileri
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - P L Zinzani
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - T Estrach
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - R Knobler
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - R Stadler
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - M T Fierro
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - S Alberti Violetti
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - I Amitay-Laish
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - C Antoniou
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - C Astrua
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - S Chaganti
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - F Child
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - A Combalia
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - S Fabbro
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - P Fava
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - V Grandi
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - C Jonak
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - E Martinez-Escala
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - M Kheterpal
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - E J Kim
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - C McCormack
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - T Miyagaki
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - D Miyashiro
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - S Morris
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - C Muniesa
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - V Nikolaou
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - G Ognibene
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - F Onida
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - S Osella-Abate
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - S Porkert
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - C Postigo-Llorente
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - C Ram-Wolff
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - S Ribero
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - K Rogers
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - M Sanlorenzo
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - R Stranzenbach
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - N Spaccarelli
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - A Stevens
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - D Zugna
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - A H Rook
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - L J Geskin
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - R Willemze
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - S Whittaker
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - R Hoppe
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - J Scarisbrick
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| | - Y Kim
- Dermatologic Clinic, Department of Medical Sciences; Cancer Epidemiology Uni, Department of Medical Sciences, University of Torino, Torino, Italy; Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne; University of Melbourne, Melbourne, Australia; Division of Hematologic Malignancies, Ohio State University; Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York; Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA; Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands; Dermatology Department, Hospital St Louis, Paris, France; Department of Dermatology and Pathology, Northwestern University, Chicago, USA; 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece; Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil; Beilinson Hospital, Petach Tikva; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Dermatolog, Faculty of Medicine, University of Tokyo, Tokyo, Japan; Department of Dermatology, Fondazione Ca' Granda, IRCCS, OMP, Milano, Italy; Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain; Dermatologic Clinic, University of Florence, Florence, Italy; Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain; Dermatologic Clinic, University of Bologna, Bologna; Seragnoli Institute of Haematology, Bologna, Italy; Department of Dermatolog, Hospital Clinico, University of Barcelona, Barcelona, Spain; Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria; University Clinic for Dermatolog, Venereology, Allergology and Phlebology, Minden, Germany; Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham; Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK; Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia; Comprehensive Skin Cancer Center, Columbia University Medical Center; Department of Dermatology, Stanford University Medical Centre, USA
| |
Collapse
|
30
|
Lavia C, Bonnin S, Maule M, Erginay A, Tadayoni R, Gaudric A. VESSEL DENSITY OF SUPERFICIAL, INTERMEDIATE, AND DEEP CAPILLARY PLEXUSES USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY. Retina 2019; 39:247-258. [PMID: 30550527 PMCID: PMC6358199 DOI: 10.1097/iae.0000000000002413] [Citation(s) in RCA: 68] [Impact Index Per Article: 13.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
PURPOSE To provide values of retinal vessel density (VD) in the three retinal capillary plexuses, foveal avascular zone (FAZ) area, and retinal layer thickness in a cohort of healthy subjects. METHODS The optical coherence tomography angiography maps of 148 eyes of 84 healthy subjects, aged 22 to 76 years, were analyzed for measuring VD of the retinal capillary plexuses, using the Optovue device comprising a projection artifact removal algorithm. Foveal avascular zone metrics were measured, and the relationship between optical coherence tomography angiography findings and age, sex, and image quality was studied. RESULTS The deep capillary plexus showed the lowest VD (31.6% ± 4.4%) in all macular areas and age groups compared with the superficial vascular plexus (47.8% ± 2.8%) and intermediate capillary plexus (45.4% ± 4.2%). The mean VD decreased by 0.06%, 0.06%, and 0.08% per year, respectively, in the superficial vascular plexus, intermediate capillary plexus, and deep capillary plexus. Mean FAZ area, FAZ acircularity index, and capillary density in a 300-µm area around the FAZ were 0.25 ± 0.1 mm, 1.1 ± 0.05, and 50.8 ± 3.4%, respectively. The yearly increase in FAZ area was 0.003 mm (P < 0.001). CONCLUSION The deep capillary plexus, a single monoplanar capillary plexus located in the outer plexiform layer, has the lowest VD, a significant finding that might be used to evaluate retinal vascular diseases. Vascular density decreased with age in the three capillary plexuses.
Collapse
Affiliation(s)
- Carlo Lavia
- Service d'Ophtalmologie, Hôpital Lariboisière, AP-HP, Assistance Publique-Hôpitaux de Paris, Université Paris Diderot, Sorbonne Paris Cité, France
- Department of Surgical Sciences, Eye Clinic, University of Turin, Turin, Italy; and
| | - Sophie Bonnin
- Service d'Ophtalmologie, Hôpital Lariboisière, AP-HP, Assistance Publique-Hôpitaux de Paris, Université Paris Diderot, Sorbonne Paris Cité, France
| | - Milena Maule
- Department of Medical Sciences, CPO-Piemonte, AOU Città della Salute e della Scienza di Torino, University of Turin, Turin, Italy
| | - Ali Erginay
- Service d'Ophtalmologie, Hôpital Lariboisière, AP-HP, Assistance Publique-Hôpitaux de Paris, Université Paris Diderot, Sorbonne Paris Cité, France
| | - Ramin Tadayoni
- Service d'Ophtalmologie, Hôpital Lariboisière, AP-HP, Assistance Publique-Hôpitaux de Paris, Université Paris Diderot, Sorbonne Paris Cité, France
| | - Alain Gaudric
- Service d'Ophtalmologie, Hôpital Lariboisière, AP-HP, Assistance Publique-Hôpitaux de Paris, Université Paris Diderot, Sorbonne Paris Cité, France
| |
Collapse
|
31
|
Moirano G, Gasparrini A, Acquaotta F, Fratianni S, Merletti F, Maule M, Richiardi L. West Nile Virus infection in Northern Italy: Case-crossover study on the short-term effect of climatic parameters. Environ Res 2018; 167:544-549. [PMID: 30145430 DOI: 10.1016/j.envres.2018.08.016] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/24/2018] [Revised: 07/03/2018] [Accepted: 08/10/2018] [Indexed: 06/08/2023]
Abstract
BACKGROUND Changes in climatic conditions are hypothesized to play a role in the increasing number of West Nile Virus (WNV) outbreaks observed in Europe in recent years. OBJECTIVES We aimed to investigate the association between WNV infection and climatic parameters recorded in the 8 weeks before the diagnosis in Northern Italy. METHODS We collected epidemiological data about new infected cases for the period 2010-2015 from the European Center for Disease Control and Prevention (ECDC) and meteorological data from 25 stations throughout the study area. Analyses were performed using a conditional Poisson regression with a time-stratified case-crossover design, specifically modified to account for seasonal variations. Exposures included weekly average of maximum temperatures, weekly average of mean temperatures, weekly average of minimum temperatures and weekly total precipitation. RESULTS We found an association between incidence of WNV infection and temperatures recorded 5-6 weeks before diagnosis (Incidence Rate Ratio (IRR) for 1 °C increase in maximum temperatures at lag 6: 1.11; 95% CI 1.01-1.20). Increased weekly total precipitation, recorded 1-4 weeks before diagnosis, were associated with higher incidence of WNV infection, particularly for precipitation recorded 2 weeks before diagnosis (IRR for 5 mm increase of cumulative precipitation at lag 2: 1.16; 95% CI 1.08-1.25). CONCLUSIONS Increased precipitation and temperatures might have a lagged direct effect on the incidence of WNV infection. Climatic parameters may be useful for detecting areas and periods of the year potentially characterized by a higher incidence of WNV infection.
Collapse
Affiliation(s)
- Giovenale Moirano
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO-Piemonte, Torino Via Santena 7, 10126, Italy.
| | - Antonio Gasparrini
- Department of Public Health, Environments and Society, London School of Hygiene & Tropical Medicine, London, UK
| | - Fiorella Acquaotta
- Department of Earth Sciences, University of Turin, via Valperga Caluso 35, 10125 Torino, Italy; Centro interdipartimentale sui rischi naturali in ambiente montano e collinare NatRisk, via Leonardo da Vinci 44, 10095 Grugliasco, TO, Italy
| | - Simona Fratianni
- Department of Earth Sciences, University of Turin, via Valperga Caluso 35, 10125 Torino, Italy; Centro interdipartimentale sui rischi naturali in ambiente montano e collinare NatRisk, via Leonardo da Vinci 44, 10095 Grugliasco, TO, Italy
| | - Franco Merletti
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO-Piemonte, Torino Via Santena 7, 10126, Italy
| | - Milena Maule
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO-Piemonte, Torino Via Santena 7, 10126, Italy
| | - Lorenzo Richiardi
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO-Piemonte, Torino Via Santena 7, 10126, Italy
| |
Collapse
|
32
|
Goedhart G, van Wel L, Langer CE, de Llobet Viladoms P, Wiart J, Hours M, Kromhout H, Benke G, Bouka E, Bruchim R, Choi KH, Eng A, Ha M, Huss A, Kiyohara K, Kojimahara N, Krewski D, Lacour B, 't Mannetje A, Maule M, Migliore E, Mohipp C, Momoli F, Petridou ET, Radon K, Remen T, Sadetzki S, Sim M, Weinmann T, Cardis E, Vrijheid M, Vermeulen R. Recall of mobile phone usage and laterality in young people: The multinational Mobi-Expo study. Environ Res 2018; 165:150-157. [PMID: 29704776 DOI: 10.1016/j.envres.2018.04.018] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/29/2017] [Revised: 04/16/2018] [Accepted: 04/18/2018] [Indexed: 06/08/2023]
Abstract
OBJECTIVE To study recall of mobile phone usage, including laterality and hands-free use, in young people. METHODS Actual mobile phone use was recorded among volunteers aged between 10 and 24 years from 12 countries by the software application XMobiSense and was compared with self-reported mobile phone use at 6 and 18 months after using the application. The application recorded number and duration of voice calls, number of text messages, amount of data transfer, laterality (% of call time the phone was near the right or left side of the head, or neither), and hands-free usage. After data cleaning, 466 participants were available for the main analyses (recorded vs. self-reported phone use after 6 months). RESULTS Participants were on average 18.6 years old (IQR 15.2-21.8 years). The Spearman correlation coefficients between recorded and self-reported (after 6 months) number and duration of voice calls were 0.68 and 0.65, respectively. Number of calls was on average underestimated by the participants (adjusted geometric mean ratio (GMR) self-report/recorded = 0.52, 95% CI = 0.47-0.58), while duration of calls was overestimated (GMR=1.32, 95%, CI = 1.15-1.52). The ratios significantly differed by country, age, maternal educational level, and level of reported phone use, but not by time of the interview (6 vs. 18 months). Individuals who reported low mobile phone use underestimated their use, while individuals who reported the highest level of phone use were more likely to overestimate their use. Individuals who reported using the phone mainly on the right side of the head used it more on the right (71.1%) than the left (28.9%) side. Self-reported left side users, however, used the phone only slightly more on the left (53.3%) than the right (46.7%) side. Recorded percentage hands-free use (headset, speaker mode, Bluetooth) increased with increasing self-reported frequency of hands-free device usage. Frequent (≥50% of call time) reported headset or speaker mode use corresponded with 17.1% and 17.2% of total call time, respectively, that was recorded as hands-free use. DISCUSSION These results indicate that young people can recall phone use moderately well, with recall depending on the amount of phone use and participants' characteristics. The obtained information can be used to calibrate self-reported mobile use to improve estimation of radiofrequency exposure from mobile phones.
Collapse
Affiliation(s)
- Geertje Goedhart
- Institute for Risk Assessment Sciences (IRAS), Utrecht University, PO Box 80178, 3508 TD Utrecht, the Netherlands
| | - Luuk van Wel
- Institute for Risk Assessment Sciences (IRAS), Utrecht University, PO Box 80178, 3508 TD Utrecht, the Netherlands.
| | - Chelsea E Langer
- ISGlobal, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain; Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain
| | - Patricia de Llobet Viladoms
- ISGlobal, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain; Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain
| | - Joe Wiart
- Chaire C2M, LTCI, Telecom ParisTech, Université Paris-Saclay, France
| | - Martine Hours
- Epidemiological Research and Surveillance Unit in Transport, Occupation and Environment (UMRESTTE), Université de Lyon/The French Institute of science and technology for transport, development and networks (IFSTTAR), Lyon, France
| | - Hans Kromhout
- Institute for Risk Assessment Sciences (IRAS), Utrecht University, PO Box 80178, 3508 TD Utrecht, the Netherlands
| | - Geza Benke
- Department of Epidemiology & Preventive Medicine, School of Public Health & Preventive Medicine, Monash University, Melbourne, Australia
| | - Evdoxia Bouka
- Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, Athens, Greece
| | - Revital Bruchim
- Cancer and Radiation Epidemiology Unit, Gertner Institute for Epidemiology and Health Policy Research, Chaim Sheba Medical Center, Tel Hashomer, Israel
| | - Kyung-Hwa Choi
- Department of Preventive Medicine, Dankook University College of Medicine, Cheonan, Republic of Korea
| | - Amanda Eng
- Centre for Public Health Research, Massey University, Wellington, New Zealand
| | - Mina Ha
- Department of Preventive Medicine, Dankook University College of Medicine, Cheonan, Republic of Korea
| | - Anke Huss
- Institute for Risk Assessment Sciences (IRAS), Utrecht University, PO Box 80178, 3508 TD Utrecht, the Netherlands
| | - Kosuke Kiyohara
- Department of Public Health, Tokyo Women's Medical University, Tokyo, Japan
| | - Noriko Kojimahara
- Department of Public Health, Tokyo Women's Medical University, Tokyo, Japan
| | - Daniel Krewski
- School of Epidemiology and Public Health, University of Ottawa, Canada
| | - Brigitte Lacour
- French National Registry of Childhood Solid Tumours, CHU, Nancy, Inserm UMRS-1153, CRESS-EPICEA, University of Paris-Sorbonne, Paris, France
| | - Andrea 't Mannetje
- Centre for Public Health Research, Massey University, Wellington, New Zealand
| | - Milena Maule
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and AOU Città della Salute e della Scienza di Torino, Italy
| | - Enrica Migliore
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and AOU Città della Salute e della Scienza di Torino, Italy
| | - Charmaine Mohipp
- French National Registry of Childhood Solid Tumours, CHU, Nancy, Inserm UMRS-1153, CRESS-EPICEA, University of Paris-Sorbonne, Paris, France
| | - Franco Momoli
- School of Epidemiology and Public Health, University of Ottawa, Canada; Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Canada; Ottawa Hospital Research Institute, Canada
| | - Eleni Th Petridou
- Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, Athens, Greece
| | - Katja Radon
- Occupational and Environmental Epidemiology & NetTeaching Unit, Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine, University Hospital of Munich (LMU), Munich, Germany
| | - Thomas Remen
- French National Registry of Childhood Solid Tumours, CHU, Nancy, France
| | - Siegal Sadetzki
- Cancer and Radiation Epidemiology Unit, Gertner Institute for Epidemiology and Health Policy Research, Chaim Sheba Medical Center, Tel Hashomer, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - Malcolm Sim
- Department of Epidemiology & Preventive Medicine, School of Public Health & Preventive Medicine, Monash University, Melbourne, Australia
| | - Tobias Weinmann
- Occupational and Environmental Epidemiology & NetTeaching Unit, Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine, University Hospital of Munich (LMU), Munich, Germany
| | - Elisabeth Cardis
- ISGlobal, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain; Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain
| | - Martine Vrijheid
- ISGlobal, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain; Biomedical Research Centre Network for Epidemiology and Public Health (CIBERESP), Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain
| | - Roel Vermeulen
- Institute for Risk Assessment Sciences (IRAS), Utrecht University, PO Box 80178, 3508 TD Utrecht, the Netherlands
| |
Collapse
|
33
|
Manzoni P, García Sánchez R, Meyer M, Stolfi I, Pugni L, Messner H, Cattani S, Betta PM, Memo L, Decembrino L, Bollani L, Rinaldi M, Fioretti M, Quercia M, Maule M, Tavella E, Mussa A, Tzialla C, Laforgia N, Mosca F, Magaldi R, Mostert M, Farina D. Exposure to Gastric Acid Inhibitors Increases the Risk of Infection in Preterm Very Low Birth Weight Infants but Concomitant Administration of Lactoferrin Counteracts This Effect. J Pediatr 2018; 193:62-67.e1. [PMID: 29198543 DOI: 10.1016/j.jpeds.2017.09.080] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/28/2017] [Revised: 09/26/2017] [Accepted: 09/28/2017] [Indexed: 01/08/2023]
Abstract
OBJECTIVE To investigate whether exposure to inhibitors of gastric acidity, such as H2 blockers or proton pump inhibitors, can independently increase the risk of infections in very low birth weight (VLBW) preterm infants in the neonatal intensive care unit. STUDY DESIGN This is a secondary analysis of prospectively collected data from a multicenter, randomized controlled trial of bovine lactoferrin (BLF) supplementation (with or without the probiotic Lactobacillus rhamnosus GG) vs placebo in prevention of late-onset sepsis (LOS) and necrotizing enterocolitis (NEC) in preterm infants. Inhibitors of gastric acidity were used at the recommended dosages/schedules based on the clinical judgment of attending physicians. The distribution of days of inhibitors of gastric acidity exposure between infants with and without LOS/NEC was assessed. The mutually adjusted effects of birth weight, gestational age, duration of inhibitors of gastric acidity treatment, and exposure to BLF were controlled through multivariable logistic regression. Interaction between inhibitors of gastric acidity and BLF was tested; the effects of any day of inhibitors of gastric acidity exposure were then computed for BLF-treated vs -untreated infants. RESULTS Two hundred thirty-five of 743 infants underwent treatment with inhibitors of gastric acidity, and 86 LOS episodes occurred. After multivariate analysis, exposure to inhibitors of gastric acidity remained significantly and independently associated with LOS (OR, 1.03; 95% CI, 1.008-1.067; P = .01); each day of inhibitors of gastric acidity exposure conferred an additional 3.7% odds of developing LOS. Risk was significant for Gram-negative (P < .001) and fungal (P = .001) pathogens, but not for Gram-positive pathogens (P = .97). On the test for interaction, 1 additional day of exposure to inhibitors of gastric acidity conferred an additional 7.7% risk for LOS (P = .003) in BLF-untreated infants, compared with 1.2% (P = .58) in BLF-treated infants. CONCLUSION Exposure to inhibitors of gastric acidity is significantly associated with the occurrence of LOS in preterm VLBW infants. Concomitant administration of BLF counteracts this selective disadvantage. TRIAL REGISTRATION isrctn.org: ISRCTN53107700.
Collapse
Affiliation(s)
- Paolo Manzoni
- Neonatology and NICU, S Anna Hospital, AOU Città della Salute e della Scienza, Torino, Italy.
| | - Ruben García Sánchez
- Neonatology and NICU, Complejo Asistencial Universitario de Salamanca, Salamanca, Spain
| | - Michael Meyer
- Neonatology and NICU, Middlemore Hospital, Auckland, New Zealand
| | - Ilaria Stolfi
- Neonatology, Azienda Ospedaliera Universitaria Policlinico Umberto I, Rome, Italy
| | - Lorenza Pugni
- NICU, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milan, Italy
| | - Hubert Messner
- Neonatology and NICU, Ospedale Regionale, Bolzano/Bozen, Italy
| | - Silvia Cattani
- NICU, University of Modena and Reggio Emilia, Modena, Italy
| | | | - Luigi Memo
- UOC di Pediatria e Patologia Neonatale, Ospedale San Martino, Belluno, Italy
| | - Lidia Decembrino
- Patologia Neonatale, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
| | - Lina Bollani
- Patologia Neonatale, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
| | | | - Maria Fioretti
- Neonatology and NICU, S Anna Hospital, AOU Città della Salute e della Scienza, Torino, Italy
| | - Michele Quercia
- Cancer Epidemiology Unit, University of Turin, Department of Medical Sciences, Torino, Italy
| | - Milena Maule
- Cancer Epidemiology Unit, University of Turin, Torino, Italy
| | - Elena Tavella
- Neonatology and NICU, S Anna Hospital, AOU Città della Salute e della Scienza, Torino, Italy
| | - Alessandro Mussa
- Neonatology and NICU, S Anna Hospital, AOU Città della Salute e della Scienza, Torino, Italy
| | - Chryssoula Tzialla
- Patologia Neonatale, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
| | - Nicola Laforgia
- Cancer Epidemiology Unit, University of Turin, Department of Medical Sciences, Torino, Italy
| | - Fabio Mosca
- NICU, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milan, Italy
| | | | - Michael Mostert
- Department of Pediatrics, University of Turin, Torino, Italy
| | - Daniele Farina
- Neonatology and NICU, S Anna Hospital, AOU Città della Salute e della Scienza, Torino, Italy
| | | |
Collapse
|
34
|
Fidler MM, Reulen RC, Winter DL, Allodji RS, Bagnasco F, Bárdi E, Bautz A, Bright CJ, Byrne J, Feijen EAM, Garwicz S, Grabow D, Gudmundsdottir T, Guha J, Haddy N, Jankovic M, Kaatsch P, Kaiser M, Kuonen R, Linge H, Maule M, Merletti F, Øfstaas H, Ronckers CM, Skinner R, Teepen J, Terenziani M, Vu-Bezin G, Wesenberg F, Wiebe T, Jakab Z, Haupt R, Lähteenmäki P, Zaletel LZ, Kuehni CE, Winther JF, de Vathaire F, Kremer LC, Hjorth L, Hawkins MM. Risk of Subsequent Bone Cancers Among 69 460 Five-Year Survivors of Childhood and Adolescent Cancer in Europe. J Natl Cancer Inst 2017; 110:4237499. [PMID: 28954302 DOI: 10.1093/jnci/djx165] [Citation(s) in RCA: 30] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2017] [Accepted: 07/19/2017] [Indexed: 01/28/2023] Open
Abstract
Introduction We investigate the risks of subsequent primary bone cancers after childhood and adolescent cancer in 12 European countries. For the first time, we satisfactorily address the risks beyond 40 years from diagnosis and beyond 40 years of age among all survivors. Methods This largest-ever assembled cohort comprises 69 460 five-year survivors of cancer diagnosed before age 20 years. Standardized incidence ratios, absolute excess risks, and multivariable-adjusted relative risks and relative excess risks were calculated. All statistical tests were two-sided. Results Overall, survivors were 21.65 times (95% confidence interval = 18.97 to 24.60 times) more likely to be diagnosed with a subsequent primary bone cancer than expected from the general population. The greatest excess numbers of bone cancers were observed after retinoblastoma, bone sarcoma, and soft tissue sarcoma. The excess number of bone cancers declined linearly with both years since diagnosis and attained age (all P < .05). Beyond 40 years from diagnosis and age 40 years, there were at most 0.45 excess bone cancers among all survivors per 10 000 person-years at risk; beyond 30 years from diagnosis and age 30 years, there were at most 5.02 excess bone cancers after each of retinoblastoma, bone sarcoma, and soft tissue sarcoma, per 10 000 person-years at risk. Conclusions For all survivors combined and the cancer groups with the greatest excess number of bone cancers, the excess numbers observed declined with both age and years from diagnosis. These results provide novel, reliable, and unbiased information about risks and risk factors among long-term survivors of childhood and adolescent cancer.
Collapse
Affiliation(s)
- Miranda M Fidler
- Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham, Birmingham, UK; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France; Cancer and Radiation Team, U1018 INSERM, Villejuif, France; Epidemiology and Biostatistics Section, Gaslini Children Hospital, Genova, Italy; 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Kepler Universitätsklinikum, Linz, Austria; Survivorship Unit, Danish Cancer Society Research Center, Copenhagen, Denmark; Boyne Research Institute, Drogheda, Ireland; Department of Pediatric Oncology, Emma Children's Hospital/Academic Medical Center, Amsterdam, the Netherlands; Department of Pediatrics, Skane University Hospital, Lund University, Lund, Sweden; German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Mainz, Germany; Children's Hospital, Landspitali University Hospital, Reykjavik, Iceland; Pediatric Hematology Unit, San Gerardo Hospital, Monza, Italy; Swiss Childhood Cancer Registry, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and AOU Città della Salute e della Scienza di Torino, Torino, Italy; Norwegian National Advisory Unit on Solid Tumors in Children; Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, and Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy; Norwegian Cancer Registry and Department of Pediatric Medicine, Oslo University Hospital, Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Norway; Hungarian Childhood Cancer Registry, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Department of Pediatrics and Adolescent Medicine, Turku University and Turku University Hospital, Turku, Finland; Institute of Oncology, Ljubljana, Slovenia; Department of Pediatrics, University Children's Hospital of Bern, University of Bern, Bern, Switzerland
| | - Raoul C Reulen
- Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham, Birmingham, UK; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France; Cancer and Radiation Team, U1018 INSERM, Villejuif, France; Epidemiology and Biostatistics Section, Gaslini Children Hospital, Genova, Italy; 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Kepler Universitätsklinikum, Linz, Austria; Survivorship Unit, Danish Cancer Society Research Center, Copenhagen, Denmark; Boyne Research Institute, Drogheda, Ireland; Department of Pediatric Oncology, Emma Children's Hospital/Academic Medical Center, Amsterdam, the Netherlands; Department of Pediatrics, Skane University Hospital, Lund University, Lund, Sweden; German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Mainz, Germany; Children's Hospital, Landspitali University Hospital, Reykjavik, Iceland; Pediatric Hematology Unit, San Gerardo Hospital, Monza, Italy; Swiss Childhood Cancer Registry, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and AOU Città della Salute e della Scienza di Torino, Torino, Italy; Norwegian National Advisory Unit on Solid Tumors in Children; Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, and Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy; Norwegian Cancer Registry and Department of Pediatric Medicine, Oslo University Hospital, Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Norway; Hungarian Childhood Cancer Registry, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Department of Pediatrics and Adolescent Medicine, Turku University and Turku University Hospital, Turku, Finland; Institute of Oncology, Ljubljana, Slovenia; Department of Pediatrics, University Children's Hospital of Bern, University of Bern, Bern, Switzerland
| | - David L Winter
- Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham, Birmingham, UK; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France; Cancer and Radiation Team, U1018 INSERM, Villejuif, France; Epidemiology and Biostatistics Section, Gaslini Children Hospital, Genova, Italy; 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Kepler Universitätsklinikum, Linz, Austria; Survivorship Unit, Danish Cancer Society Research Center, Copenhagen, Denmark; Boyne Research Institute, Drogheda, Ireland; Department of Pediatric Oncology, Emma Children's Hospital/Academic Medical Center, Amsterdam, the Netherlands; Department of Pediatrics, Skane University Hospital, Lund University, Lund, Sweden; German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Mainz, Germany; Children's Hospital, Landspitali University Hospital, Reykjavik, Iceland; Pediatric Hematology Unit, San Gerardo Hospital, Monza, Italy; Swiss Childhood Cancer Registry, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and AOU Città della Salute e della Scienza di Torino, Torino, Italy; Norwegian National Advisory Unit on Solid Tumors in Children; Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, and Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy; Norwegian Cancer Registry and Department of Pediatric Medicine, Oslo University Hospital, Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Norway; Hungarian Childhood Cancer Registry, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Department of Pediatrics and Adolescent Medicine, Turku University and Turku University Hospital, Turku, Finland; Institute of Oncology, Ljubljana, Slovenia; Department of Pediatrics, University Children's Hospital of Bern, University of Bern, Bern, Switzerland
| | - Rodrigue S Allodji
- Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham, Birmingham, UK; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France; Cancer and Radiation Team, U1018 INSERM, Villejuif, France; Epidemiology and Biostatistics Section, Gaslini Children Hospital, Genova, Italy; 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Kepler Universitätsklinikum, Linz, Austria; Survivorship Unit, Danish Cancer Society Research Center, Copenhagen, Denmark; Boyne Research Institute, Drogheda, Ireland; Department of Pediatric Oncology, Emma Children's Hospital/Academic Medical Center, Amsterdam, the Netherlands; Department of Pediatrics, Skane University Hospital, Lund University, Lund, Sweden; German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Mainz, Germany; Children's Hospital, Landspitali University Hospital, Reykjavik, Iceland; Pediatric Hematology Unit, San Gerardo Hospital, Monza, Italy; Swiss Childhood Cancer Registry, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and AOU Città della Salute e della Scienza di Torino, Torino, Italy; Norwegian National Advisory Unit on Solid Tumors in Children; Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, and Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy; Norwegian Cancer Registry and Department of Pediatric Medicine, Oslo University Hospital, Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Norway; Hungarian Childhood Cancer Registry, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Department of Pediatrics and Adolescent Medicine, Turku University and Turku University Hospital, Turku, Finland; Institute of Oncology, Ljubljana, Slovenia; Department of Pediatrics, University Children's Hospital of Bern, University of Bern, Bern, Switzerland
| | - Francesca Bagnasco
- Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham, Birmingham, UK; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France; Cancer and Radiation Team, U1018 INSERM, Villejuif, France; Epidemiology and Biostatistics Section, Gaslini Children Hospital, Genova, Italy; 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Kepler Universitätsklinikum, Linz, Austria; Survivorship Unit, Danish Cancer Society Research Center, Copenhagen, Denmark; Boyne Research Institute, Drogheda, Ireland; Department of Pediatric Oncology, Emma Children's Hospital/Academic Medical Center, Amsterdam, the Netherlands; Department of Pediatrics, Skane University Hospital, Lund University, Lund, Sweden; German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Mainz, Germany; Children's Hospital, Landspitali University Hospital, Reykjavik, Iceland; Pediatric Hematology Unit, San Gerardo Hospital, Monza, Italy; Swiss Childhood Cancer Registry, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and AOU Città della Salute e della Scienza di Torino, Torino, Italy; Norwegian National Advisory Unit on Solid Tumors in Children; Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, and Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy; Norwegian Cancer Registry and Department of Pediatric Medicine, Oslo University Hospital, Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Norway; Hungarian Childhood Cancer Registry, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Department of Pediatrics and Adolescent Medicine, Turku University and Turku University Hospital, Turku, Finland; Institute of Oncology, Ljubljana, Slovenia; Department of Pediatrics, University Children's Hospital of Bern, University of Bern, Bern, Switzerland
| | - Edit Bárdi
- Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham, Birmingham, UK; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France; Cancer and Radiation Team, U1018 INSERM, Villejuif, France; Epidemiology and Biostatistics Section, Gaslini Children Hospital, Genova, Italy; 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Kepler Universitätsklinikum, Linz, Austria; Survivorship Unit, Danish Cancer Society Research Center, Copenhagen, Denmark; Boyne Research Institute, Drogheda, Ireland; Department of Pediatric Oncology, Emma Children's Hospital/Academic Medical Center, Amsterdam, the Netherlands; Department of Pediatrics, Skane University Hospital, Lund University, Lund, Sweden; German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Mainz, Germany; Children's Hospital, Landspitali University Hospital, Reykjavik, Iceland; Pediatric Hematology Unit, San Gerardo Hospital, Monza, Italy; Swiss Childhood Cancer Registry, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and AOU Città della Salute e della Scienza di Torino, Torino, Italy; Norwegian National Advisory Unit on Solid Tumors in Children; Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, and Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy; Norwegian Cancer Registry and Department of Pediatric Medicine, Oslo University Hospital, Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Norway; Hungarian Childhood Cancer Registry, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Department of Pediatrics and Adolescent Medicine, Turku University and Turku University Hospital, Turku, Finland; Institute of Oncology, Ljubljana, Slovenia; Department of Pediatrics, University Children's Hospital of Bern, University of Bern, Bern, Switzerland
| | - Andrea Bautz
- Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham, Birmingham, UK; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France; Cancer and Radiation Team, U1018 INSERM, Villejuif, France; Epidemiology and Biostatistics Section, Gaslini Children Hospital, Genova, Italy; 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Kepler Universitätsklinikum, Linz, Austria; Survivorship Unit, Danish Cancer Society Research Center, Copenhagen, Denmark; Boyne Research Institute, Drogheda, Ireland; Department of Pediatric Oncology, Emma Children's Hospital/Academic Medical Center, Amsterdam, the Netherlands; Department of Pediatrics, Skane University Hospital, Lund University, Lund, Sweden; German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Mainz, Germany; Children's Hospital, Landspitali University Hospital, Reykjavik, Iceland; Pediatric Hematology Unit, San Gerardo Hospital, Monza, Italy; Swiss Childhood Cancer Registry, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and AOU Città della Salute e della Scienza di Torino, Torino, Italy; Norwegian National Advisory Unit on Solid Tumors in Children; Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, and Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy; Norwegian Cancer Registry and Department of Pediatric Medicine, Oslo University Hospital, Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Norway; Hungarian Childhood Cancer Registry, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Department of Pediatrics and Adolescent Medicine, Turku University and Turku University Hospital, Turku, Finland; Institute of Oncology, Ljubljana, Slovenia; Department of Pediatrics, University Children's Hospital of Bern, University of Bern, Bern, Switzerland
| | - Chloe J Bright
- Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham, Birmingham, UK; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France; Cancer and Radiation Team, U1018 INSERM, Villejuif, France; Epidemiology and Biostatistics Section, Gaslini Children Hospital, Genova, Italy; 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Kepler Universitätsklinikum, Linz, Austria; Survivorship Unit, Danish Cancer Society Research Center, Copenhagen, Denmark; Boyne Research Institute, Drogheda, Ireland; Department of Pediatric Oncology, Emma Children's Hospital/Academic Medical Center, Amsterdam, the Netherlands; Department of Pediatrics, Skane University Hospital, Lund University, Lund, Sweden; German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Mainz, Germany; Children's Hospital, Landspitali University Hospital, Reykjavik, Iceland; Pediatric Hematology Unit, San Gerardo Hospital, Monza, Italy; Swiss Childhood Cancer Registry, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and AOU Città della Salute e della Scienza di Torino, Torino, Italy; Norwegian National Advisory Unit on Solid Tumors in Children; Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, and Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy; Norwegian Cancer Registry and Department of Pediatric Medicine, Oslo University Hospital, Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Norway; Hungarian Childhood Cancer Registry, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Department of Pediatrics and Adolescent Medicine, Turku University and Turku University Hospital, Turku, Finland; Institute of Oncology, Ljubljana, Slovenia; Department of Pediatrics, University Children's Hospital of Bern, University of Bern, Bern, Switzerland
| | - Julianne Byrne
- Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham, Birmingham, UK; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France; Cancer and Radiation Team, U1018 INSERM, Villejuif, France; Epidemiology and Biostatistics Section, Gaslini Children Hospital, Genova, Italy; 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Kepler Universitätsklinikum, Linz, Austria; Survivorship Unit, Danish Cancer Society Research Center, Copenhagen, Denmark; Boyne Research Institute, Drogheda, Ireland; Department of Pediatric Oncology, Emma Children's Hospital/Academic Medical Center, Amsterdam, the Netherlands; Department of Pediatrics, Skane University Hospital, Lund University, Lund, Sweden; German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Mainz, Germany; Children's Hospital, Landspitali University Hospital, Reykjavik, Iceland; Pediatric Hematology Unit, San Gerardo Hospital, Monza, Italy; Swiss Childhood Cancer Registry, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and AOU Città della Salute e della Scienza di Torino, Torino, Italy; Norwegian National Advisory Unit on Solid Tumors in Children; Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, and Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy; Norwegian Cancer Registry and Department of Pediatric Medicine, Oslo University Hospital, Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Norway; Hungarian Childhood Cancer Registry, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Department of Pediatrics and Adolescent Medicine, Turku University and Turku University Hospital, Turku, Finland; Institute of Oncology, Ljubljana, Slovenia; Department of Pediatrics, University Children's Hospital of Bern, University of Bern, Bern, Switzerland
| | - Elizabeth A M Feijen
- Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham, Birmingham, UK; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France; Cancer and Radiation Team, U1018 INSERM, Villejuif, France; Epidemiology and Biostatistics Section, Gaslini Children Hospital, Genova, Italy; 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Kepler Universitätsklinikum, Linz, Austria; Survivorship Unit, Danish Cancer Society Research Center, Copenhagen, Denmark; Boyne Research Institute, Drogheda, Ireland; Department of Pediatric Oncology, Emma Children's Hospital/Academic Medical Center, Amsterdam, the Netherlands; Department of Pediatrics, Skane University Hospital, Lund University, Lund, Sweden; German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Mainz, Germany; Children's Hospital, Landspitali University Hospital, Reykjavik, Iceland; Pediatric Hematology Unit, San Gerardo Hospital, Monza, Italy; Swiss Childhood Cancer Registry, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and AOU Città della Salute e della Scienza di Torino, Torino, Italy; Norwegian National Advisory Unit on Solid Tumors in Children; Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, and Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy; Norwegian Cancer Registry and Department of Pediatric Medicine, Oslo University Hospital, Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Norway; Hungarian Childhood Cancer Registry, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Department of Pediatrics and Adolescent Medicine, Turku University and Turku University Hospital, Turku, Finland; Institute of Oncology, Ljubljana, Slovenia; Department of Pediatrics, University Children's Hospital of Bern, University of Bern, Bern, Switzerland
| | - Stanislaw Garwicz
- Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham, Birmingham, UK; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France; Cancer and Radiation Team, U1018 INSERM, Villejuif, France; Epidemiology and Biostatistics Section, Gaslini Children Hospital, Genova, Italy; 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Kepler Universitätsklinikum, Linz, Austria; Survivorship Unit, Danish Cancer Society Research Center, Copenhagen, Denmark; Boyne Research Institute, Drogheda, Ireland; Department of Pediatric Oncology, Emma Children's Hospital/Academic Medical Center, Amsterdam, the Netherlands; Department of Pediatrics, Skane University Hospital, Lund University, Lund, Sweden; German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Mainz, Germany; Children's Hospital, Landspitali University Hospital, Reykjavik, Iceland; Pediatric Hematology Unit, San Gerardo Hospital, Monza, Italy; Swiss Childhood Cancer Registry, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and AOU Città della Salute e della Scienza di Torino, Torino, Italy; Norwegian National Advisory Unit on Solid Tumors in Children; Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, and Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy; Norwegian Cancer Registry and Department of Pediatric Medicine, Oslo University Hospital, Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Norway; Hungarian Childhood Cancer Registry, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Department of Pediatrics and Adolescent Medicine, Turku University and Turku University Hospital, Turku, Finland; Institute of Oncology, Ljubljana, Slovenia; Department of Pediatrics, University Children's Hospital of Bern, University of Bern, Bern, Switzerland
| | - Desiree Grabow
- Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham, Birmingham, UK; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France; Cancer and Radiation Team, U1018 INSERM, Villejuif, France; Epidemiology and Biostatistics Section, Gaslini Children Hospital, Genova, Italy; 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Kepler Universitätsklinikum, Linz, Austria; Survivorship Unit, Danish Cancer Society Research Center, Copenhagen, Denmark; Boyne Research Institute, Drogheda, Ireland; Department of Pediatric Oncology, Emma Children's Hospital/Academic Medical Center, Amsterdam, the Netherlands; Department of Pediatrics, Skane University Hospital, Lund University, Lund, Sweden; German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Mainz, Germany; Children's Hospital, Landspitali University Hospital, Reykjavik, Iceland; Pediatric Hematology Unit, San Gerardo Hospital, Monza, Italy; Swiss Childhood Cancer Registry, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and AOU Città della Salute e della Scienza di Torino, Torino, Italy; Norwegian National Advisory Unit on Solid Tumors in Children; Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, and Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy; Norwegian Cancer Registry and Department of Pediatric Medicine, Oslo University Hospital, Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Norway; Hungarian Childhood Cancer Registry, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Department of Pediatrics and Adolescent Medicine, Turku University and Turku University Hospital, Turku, Finland; Institute of Oncology, Ljubljana, Slovenia; Department of Pediatrics, University Children's Hospital of Bern, University of Bern, Bern, Switzerland
| | - Thorgerdur Gudmundsdottir
- Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham, Birmingham, UK; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France; Cancer and Radiation Team, U1018 INSERM, Villejuif, France; Epidemiology and Biostatistics Section, Gaslini Children Hospital, Genova, Italy; 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Kepler Universitätsklinikum, Linz, Austria; Survivorship Unit, Danish Cancer Society Research Center, Copenhagen, Denmark; Boyne Research Institute, Drogheda, Ireland; Department of Pediatric Oncology, Emma Children's Hospital/Academic Medical Center, Amsterdam, the Netherlands; Department of Pediatrics, Skane University Hospital, Lund University, Lund, Sweden; German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Mainz, Germany; Children's Hospital, Landspitali University Hospital, Reykjavik, Iceland; Pediatric Hematology Unit, San Gerardo Hospital, Monza, Italy; Swiss Childhood Cancer Registry, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and AOU Città della Salute e della Scienza di Torino, Torino, Italy; Norwegian National Advisory Unit on Solid Tumors in Children; Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, and Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy; Norwegian Cancer Registry and Department of Pediatric Medicine, Oslo University Hospital, Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Norway; Hungarian Childhood Cancer Registry, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Department of Pediatrics and Adolescent Medicine, Turku University and Turku University Hospital, Turku, Finland; Institute of Oncology, Ljubljana, Slovenia; Department of Pediatrics, University Children's Hospital of Bern, University of Bern, Bern, Switzerland
| | - Joyeeta Guha
- Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham, Birmingham, UK; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France; Cancer and Radiation Team, U1018 INSERM, Villejuif, France; Epidemiology and Biostatistics Section, Gaslini Children Hospital, Genova, Italy; 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Kepler Universitätsklinikum, Linz, Austria; Survivorship Unit, Danish Cancer Society Research Center, Copenhagen, Denmark; Boyne Research Institute, Drogheda, Ireland; Department of Pediatric Oncology, Emma Children's Hospital/Academic Medical Center, Amsterdam, the Netherlands; Department of Pediatrics, Skane University Hospital, Lund University, Lund, Sweden; German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Mainz, Germany; Children's Hospital, Landspitali University Hospital, Reykjavik, Iceland; Pediatric Hematology Unit, San Gerardo Hospital, Monza, Italy; Swiss Childhood Cancer Registry, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and AOU Città della Salute e della Scienza di Torino, Torino, Italy; Norwegian National Advisory Unit on Solid Tumors in Children; Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, and Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy; Norwegian Cancer Registry and Department of Pediatric Medicine, Oslo University Hospital, Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Norway; Hungarian Childhood Cancer Registry, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Department of Pediatrics and Adolescent Medicine, Turku University and Turku University Hospital, Turku, Finland; Institute of Oncology, Ljubljana, Slovenia; Department of Pediatrics, University Children's Hospital of Bern, University of Bern, Bern, Switzerland
| | - Nadia Haddy
- Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham, Birmingham, UK; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France; Cancer and Radiation Team, U1018 INSERM, Villejuif, France; Epidemiology and Biostatistics Section, Gaslini Children Hospital, Genova, Italy; 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Kepler Universitätsklinikum, Linz, Austria; Survivorship Unit, Danish Cancer Society Research Center, Copenhagen, Denmark; Boyne Research Institute, Drogheda, Ireland; Department of Pediatric Oncology, Emma Children's Hospital/Academic Medical Center, Amsterdam, the Netherlands; Department of Pediatrics, Skane University Hospital, Lund University, Lund, Sweden; German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Mainz, Germany; Children's Hospital, Landspitali University Hospital, Reykjavik, Iceland; Pediatric Hematology Unit, San Gerardo Hospital, Monza, Italy; Swiss Childhood Cancer Registry, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and AOU Città della Salute e della Scienza di Torino, Torino, Italy; Norwegian National Advisory Unit on Solid Tumors in Children; Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, and Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy; Norwegian Cancer Registry and Department of Pediatric Medicine, Oslo University Hospital, Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Norway; Hungarian Childhood Cancer Registry, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Department of Pediatrics and Adolescent Medicine, Turku University and Turku University Hospital, Turku, Finland; Institute of Oncology, Ljubljana, Slovenia; Department of Pediatrics, University Children's Hospital of Bern, University of Bern, Bern, Switzerland
| | - Momcilo Jankovic
- Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham, Birmingham, UK; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France; Cancer and Radiation Team, U1018 INSERM, Villejuif, France; Epidemiology and Biostatistics Section, Gaslini Children Hospital, Genova, Italy; 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Kepler Universitätsklinikum, Linz, Austria; Survivorship Unit, Danish Cancer Society Research Center, Copenhagen, Denmark; Boyne Research Institute, Drogheda, Ireland; Department of Pediatric Oncology, Emma Children's Hospital/Academic Medical Center, Amsterdam, the Netherlands; Department of Pediatrics, Skane University Hospital, Lund University, Lund, Sweden; German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Mainz, Germany; Children's Hospital, Landspitali University Hospital, Reykjavik, Iceland; Pediatric Hematology Unit, San Gerardo Hospital, Monza, Italy; Swiss Childhood Cancer Registry, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and AOU Città della Salute e della Scienza di Torino, Torino, Italy; Norwegian National Advisory Unit on Solid Tumors in Children; Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, and Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy; Norwegian Cancer Registry and Department of Pediatric Medicine, Oslo University Hospital, Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Norway; Hungarian Childhood Cancer Registry, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Department of Pediatrics and Adolescent Medicine, Turku University and Turku University Hospital, Turku, Finland; Institute of Oncology, Ljubljana, Slovenia; Department of Pediatrics, University Children's Hospital of Bern, University of Bern, Bern, Switzerland
| | - Peter Kaatsch
- Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham, Birmingham, UK; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France; Cancer and Radiation Team, U1018 INSERM, Villejuif, France; Epidemiology and Biostatistics Section, Gaslini Children Hospital, Genova, Italy; 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Kepler Universitätsklinikum, Linz, Austria; Survivorship Unit, Danish Cancer Society Research Center, Copenhagen, Denmark; Boyne Research Institute, Drogheda, Ireland; Department of Pediatric Oncology, Emma Children's Hospital/Academic Medical Center, Amsterdam, the Netherlands; Department of Pediatrics, Skane University Hospital, Lund University, Lund, Sweden; German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Mainz, Germany; Children's Hospital, Landspitali University Hospital, Reykjavik, Iceland; Pediatric Hematology Unit, San Gerardo Hospital, Monza, Italy; Swiss Childhood Cancer Registry, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and AOU Città della Salute e della Scienza di Torino, Torino, Italy; Norwegian National Advisory Unit on Solid Tumors in Children; Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, and Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy; Norwegian Cancer Registry and Department of Pediatric Medicine, Oslo University Hospital, Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Norway; Hungarian Childhood Cancer Registry, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Department of Pediatrics and Adolescent Medicine, Turku University and Turku University Hospital, Turku, Finland; Institute of Oncology, Ljubljana, Slovenia; Department of Pediatrics, University Children's Hospital of Bern, University of Bern, Bern, Switzerland
| | - Melanie Kaiser
- Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham, Birmingham, UK; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France; Cancer and Radiation Team, U1018 INSERM, Villejuif, France; Epidemiology and Biostatistics Section, Gaslini Children Hospital, Genova, Italy; 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Kepler Universitätsklinikum, Linz, Austria; Survivorship Unit, Danish Cancer Society Research Center, Copenhagen, Denmark; Boyne Research Institute, Drogheda, Ireland; Department of Pediatric Oncology, Emma Children's Hospital/Academic Medical Center, Amsterdam, the Netherlands; Department of Pediatrics, Skane University Hospital, Lund University, Lund, Sweden; German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Mainz, Germany; Children's Hospital, Landspitali University Hospital, Reykjavik, Iceland; Pediatric Hematology Unit, San Gerardo Hospital, Monza, Italy; Swiss Childhood Cancer Registry, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and AOU Città della Salute e della Scienza di Torino, Torino, Italy; Norwegian National Advisory Unit on Solid Tumors in Children; Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, and Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy; Norwegian Cancer Registry and Department of Pediatric Medicine, Oslo University Hospital, Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Norway; Hungarian Childhood Cancer Registry, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Department of Pediatrics and Adolescent Medicine, Turku University and Turku University Hospital, Turku, Finland; Institute of Oncology, Ljubljana, Slovenia; Department of Pediatrics, University Children's Hospital of Bern, University of Bern, Bern, Switzerland
| | - Rahel Kuonen
- Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham, Birmingham, UK; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France; Cancer and Radiation Team, U1018 INSERM, Villejuif, France; Epidemiology and Biostatistics Section, Gaslini Children Hospital, Genova, Italy; 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Kepler Universitätsklinikum, Linz, Austria; Survivorship Unit, Danish Cancer Society Research Center, Copenhagen, Denmark; Boyne Research Institute, Drogheda, Ireland; Department of Pediatric Oncology, Emma Children's Hospital/Academic Medical Center, Amsterdam, the Netherlands; Department of Pediatrics, Skane University Hospital, Lund University, Lund, Sweden; German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Mainz, Germany; Children's Hospital, Landspitali University Hospital, Reykjavik, Iceland; Pediatric Hematology Unit, San Gerardo Hospital, Monza, Italy; Swiss Childhood Cancer Registry, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and AOU Città della Salute e della Scienza di Torino, Torino, Italy; Norwegian National Advisory Unit on Solid Tumors in Children; Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, and Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy; Norwegian Cancer Registry and Department of Pediatric Medicine, Oslo University Hospital, Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Norway; Hungarian Childhood Cancer Registry, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Department of Pediatrics and Adolescent Medicine, Turku University and Turku University Hospital, Turku, Finland; Institute of Oncology, Ljubljana, Slovenia; Department of Pediatrics, University Children's Hospital of Bern, University of Bern, Bern, Switzerland
| | - Helena Linge
- Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham, Birmingham, UK; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France; Cancer and Radiation Team, U1018 INSERM, Villejuif, France; Epidemiology and Biostatistics Section, Gaslini Children Hospital, Genova, Italy; 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Kepler Universitätsklinikum, Linz, Austria; Survivorship Unit, Danish Cancer Society Research Center, Copenhagen, Denmark; Boyne Research Institute, Drogheda, Ireland; Department of Pediatric Oncology, Emma Children's Hospital/Academic Medical Center, Amsterdam, the Netherlands; Department of Pediatrics, Skane University Hospital, Lund University, Lund, Sweden; German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Mainz, Germany; Children's Hospital, Landspitali University Hospital, Reykjavik, Iceland; Pediatric Hematology Unit, San Gerardo Hospital, Monza, Italy; Swiss Childhood Cancer Registry, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and AOU Città della Salute e della Scienza di Torino, Torino, Italy; Norwegian National Advisory Unit on Solid Tumors in Children; Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, and Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy; Norwegian Cancer Registry and Department of Pediatric Medicine, Oslo University Hospital, Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Norway; Hungarian Childhood Cancer Registry, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Department of Pediatrics and Adolescent Medicine, Turku University and Turku University Hospital, Turku, Finland; Institute of Oncology, Ljubljana, Slovenia; Department of Pediatrics, University Children's Hospital of Bern, University of Bern, Bern, Switzerland
| | - Milena Maule
- Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham, Birmingham, UK; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France; Cancer and Radiation Team, U1018 INSERM, Villejuif, France; Epidemiology and Biostatistics Section, Gaslini Children Hospital, Genova, Italy; 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Kepler Universitätsklinikum, Linz, Austria; Survivorship Unit, Danish Cancer Society Research Center, Copenhagen, Denmark; Boyne Research Institute, Drogheda, Ireland; Department of Pediatric Oncology, Emma Children's Hospital/Academic Medical Center, Amsterdam, the Netherlands; Department of Pediatrics, Skane University Hospital, Lund University, Lund, Sweden; German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Mainz, Germany; Children's Hospital, Landspitali University Hospital, Reykjavik, Iceland; Pediatric Hematology Unit, San Gerardo Hospital, Monza, Italy; Swiss Childhood Cancer Registry, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and AOU Città della Salute e della Scienza di Torino, Torino, Italy; Norwegian National Advisory Unit on Solid Tumors in Children; Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, and Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy; Norwegian Cancer Registry and Department of Pediatric Medicine, Oslo University Hospital, Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Norway; Hungarian Childhood Cancer Registry, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Department of Pediatrics and Adolescent Medicine, Turku University and Turku University Hospital, Turku, Finland; Institute of Oncology, Ljubljana, Slovenia; Department of Pediatrics, University Children's Hospital of Bern, University of Bern, Bern, Switzerland
| | - Franco Merletti
- Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham, Birmingham, UK; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France; Cancer and Radiation Team, U1018 INSERM, Villejuif, France; Epidemiology and Biostatistics Section, Gaslini Children Hospital, Genova, Italy; 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Kepler Universitätsklinikum, Linz, Austria; Survivorship Unit, Danish Cancer Society Research Center, Copenhagen, Denmark; Boyne Research Institute, Drogheda, Ireland; Department of Pediatric Oncology, Emma Children's Hospital/Academic Medical Center, Amsterdam, the Netherlands; Department of Pediatrics, Skane University Hospital, Lund University, Lund, Sweden; German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Mainz, Germany; Children's Hospital, Landspitali University Hospital, Reykjavik, Iceland; Pediatric Hematology Unit, San Gerardo Hospital, Monza, Italy; Swiss Childhood Cancer Registry, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and AOU Città della Salute e della Scienza di Torino, Torino, Italy; Norwegian National Advisory Unit on Solid Tumors in Children; Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, and Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy; Norwegian Cancer Registry and Department of Pediatric Medicine, Oslo University Hospital, Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Norway; Hungarian Childhood Cancer Registry, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Department of Pediatrics and Adolescent Medicine, Turku University and Turku University Hospital, Turku, Finland; Institute of Oncology, Ljubljana, Slovenia; Department of Pediatrics, University Children's Hospital of Bern, University of Bern, Bern, Switzerland
| | - Hilde Øfstaas
- Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham, Birmingham, UK; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France; Cancer and Radiation Team, U1018 INSERM, Villejuif, France; Epidemiology and Biostatistics Section, Gaslini Children Hospital, Genova, Italy; 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Kepler Universitätsklinikum, Linz, Austria; Survivorship Unit, Danish Cancer Society Research Center, Copenhagen, Denmark; Boyne Research Institute, Drogheda, Ireland; Department of Pediatric Oncology, Emma Children's Hospital/Academic Medical Center, Amsterdam, the Netherlands; Department of Pediatrics, Skane University Hospital, Lund University, Lund, Sweden; German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Mainz, Germany; Children's Hospital, Landspitali University Hospital, Reykjavik, Iceland; Pediatric Hematology Unit, San Gerardo Hospital, Monza, Italy; Swiss Childhood Cancer Registry, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and AOU Città della Salute e della Scienza di Torino, Torino, Italy; Norwegian National Advisory Unit on Solid Tumors in Children; Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, and Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy; Norwegian Cancer Registry and Department of Pediatric Medicine, Oslo University Hospital, Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Norway; Hungarian Childhood Cancer Registry, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Department of Pediatrics and Adolescent Medicine, Turku University and Turku University Hospital, Turku, Finland; Institute of Oncology, Ljubljana, Slovenia; Department of Pediatrics, University Children's Hospital of Bern, University of Bern, Bern, Switzerland
| | - Cecile M Ronckers
- Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham, Birmingham, UK; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France; Cancer and Radiation Team, U1018 INSERM, Villejuif, France; Epidemiology and Biostatistics Section, Gaslini Children Hospital, Genova, Italy; 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Kepler Universitätsklinikum, Linz, Austria; Survivorship Unit, Danish Cancer Society Research Center, Copenhagen, Denmark; Boyne Research Institute, Drogheda, Ireland; Department of Pediatric Oncology, Emma Children's Hospital/Academic Medical Center, Amsterdam, the Netherlands; Department of Pediatrics, Skane University Hospital, Lund University, Lund, Sweden; German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Mainz, Germany; Children's Hospital, Landspitali University Hospital, Reykjavik, Iceland; Pediatric Hematology Unit, San Gerardo Hospital, Monza, Italy; Swiss Childhood Cancer Registry, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and AOU Città della Salute e della Scienza di Torino, Torino, Italy; Norwegian National Advisory Unit on Solid Tumors in Children; Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, and Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy; Norwegian Cancer Registry and Department of Pediatric Medicine, Oslo University Hospital, Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Norway; Hungarian Childhood Cancer Registry, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Department of Pediatrics and Adolescent Medicine, Turku University and Turku University Hospital, Turku, Finland; Institute of Oncology, Ljubljana, Slovenia; Department of Pediatrics, University Children's Hospital of Bern, University of Bern, Bern, Switzerland
| | - Roderick Skinner
- Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham, Birmingham, UK; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France; Cancer and Radiation Team, U1018 INSERM, Villejuif, France; Epidemiology and Biostatistics Section, Gaslini Children Hospital, Genova, Italy; 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Kepler Universitätsklinikum, Linz, Austria; Survivorship Unit, Danish Cancer Society Research Center, Copenhagen, Denmark; Boyne Research Institute, Drogheda, Ireland; Department of Pediatric Oncology, Emma Children's Hospital/Academic Medical Center, Amsterdam, the Netherlands; Department of Pediatrics, Skane University Hospital, Lund University, Lund, Sweden; German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Mainz, Germany; Children's Hospital, Landspitali University Hospital, Reykjavik, Iceland; Pediatric Hematology Unit, San Gerardo Hospital, Monza, Italy; Swiss Childhood Cancer Registry, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and AOU Città della Salute e della Scienza di Torino, Torino, Italy; Norwegian National Advisory Unit on Solid Tumors in Children; Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, and Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy; Norwegian Cancer Registry and Department of Pediatric Medicine, Oslo University Hospital, Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Norway; Hungarian Childhood Cancer Registry, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Department of Pediatrics and Adolescent Medicine, Turku University and Turku University Hospital, Turku, Finland; Institute of Oncology, Ljubljana, Slovenia; Department of Pediatrics, University Children's Hospital of Bern, University of Bern, Bern, Switzerland
| | - Jop Teepen
- Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham, Birmingham, UK; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France; Cancer and Radiation Team, U1018 INSERM, Villejuif, France; Epidemiology and Biostatistics Section, Gaslini Children Hospital, Genova, Italy; 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Kepler Universitätsklinikum, Linz, Austria; Survivorship Unit, Danish Cancer Society Research Center, Copenhagen, Denmark; Boyne Research Institute, Drogheda, Ireland; Department of Pediatric Oncology, Emma Children's Hospital/Academic Medical Center, Amsterdam, the Netherlands; Department of Pediatrics, Skane University Hospital, Lund University, Lund, Sweden; German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Mainz, Germany; Children's Hospital, Landspitali University Hospital, Reykjavik, Iceland; Pediatric Hematology Unit, San Gerardo Hospital, Monza, Italy; Swiss Childhood Cancer Registry, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and AOU Città della Salute e della Scienza di Torino, Torino, Italy; Norwegian National Advisory Unit on Solid Tumors in Children; Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, and Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy; Norwegian Cancer Registry and Department of Pediatric Medicine, Oslo University Hospital, Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Norway; Hungarian Childhood Cancer Registry, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Department of Pediatrics and Adolescent Medicine, Turku University and Turku University Hospital, Turku, Finland; Institute of Oncology, Ljubljana, Slovenia; Department of Pediatrics, University Children's Hospital of Bern, University of Bern, Bern, Switzerland
| | - Monica Terenziani
- Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham, Birmingham, UK; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France; Cancer and Radiation Team, U1018 INSERM, Villejuif, France; Epidemiology and Biostatistics Section, Gaslini Children Hospital, Genova, Italy; 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Kepler Universitätsklinikum, Linz, Austria; Survivorship Unit, Danish Cancer Society Research Center, Copenhagen, Denmark; Boyne Research Institute, Drogheda, Ireland; Department of Pediatric Oncology, Emma Children's Hospital/Academic Medical Center, Amsterdam, the Netherlands; Department of Pediatrics, Skane University Hospital, Lund University, Lund, Sweden; German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Mainz, Germany; Children's Hospital, Landspitali University Hospital, Reykjavik, Iceland; Pediatric Hematology Unit, San Gerardo Hospital, Monza, Italy; Swiss Childhood Cancer Registry, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and AOU Città della Salute e della Scienza di Torino, Torino, Italy; Norwegian National Advisory Unit on Solid Tumors in Children; Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, and Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy; Norwegian Cancer Registry and Department of Pediatric Medicine, Oslo University Hospital, Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Norway; Hungarian Childhood Cancer Registry, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Department of Pediatrics and Adolescent Medicine, Turku University and Turku University Hospital, Turku, Finland; Institute of Oncology, Ljubljana, Slovenia; Department of Pediatrics, University Children's Hospital of Bern, University of Bern, Bern, Switzerland
| | - Giao Vu-Bezin
- Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham, Birmingham, UK; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France; Cancer and Radiation Team, U1018 INSERM, Villejuif, France; Epidemiology and Biostatistics Section, Gaslini Children Hospital, Genova, Italy; 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Kepler Universitätsklinikum, Linz, Austria; Survivorship Unit, Danish Cancer Society Research Center, Copenhagen, Denmark; Boyne Research Institute, Drogheda, Ireland; Department of Pediatric Oncology, Emma Children's Hospital/Academic Medical Center, Amsterdam, the Netherlands; Department of Pediatrics, Skane University Hospital, Lund University, Lund, Sweden; German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Mainz, Germany; Children's Hospital, Landspitali University Hospital, Reykjavik, Iceland; Pediatric Hematology Unit, San Gerardo Hospital, Monza, Italy; Swiss Childhood Cancer Registry, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and AOU Città della Salute e della Scienza di Torino, Torino, Italy; Norwegian National Advisory Unit on Solid Tumors in Children; Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, and Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy; Norwegian Cancer Registry and Department of Pediatric Medicine, Oslo University Hospital, Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Norway; Hungarian Childhood Cancer Registry, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Department of Pediatrics and Adolescent Medicine, Turku University and Turku University Hospital, Turku, Finland; Institute of Oncology, Ljubljana, Slovenia; Department of Pediatrics, University Children's Hospital of Bern, University of Bern, Bern, Switzerland
| | - Finn Wesenberg
- Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham, Birmingham, UK; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France; Cancer and Radiation Team, U1018 INSERM, Villejuif, France; Epidemiology and Biostatistics Section, Gaslini Children Hospital, Genova, Italy; 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Kepler Universitätsklinikum, Linz, Austria; Survivorship Unit, Danish Cancer Society Research Center, Copenhagen, Denmark; Boyne Research Institute, Drogheda, Ireland; Department of Pediatric Oncology, Emma Children's Hospital/Academic Medical Center, Amsterdam, the Netherlands; Department of Pediatrics, Skane University Hospital, Lund University, Lund, Sweden; German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Mainz, Germany; Children's Hospital, Landspitali University Hospital, Reykjavik, Iceland; Pediatric Hematology Unit, San Gerardo Hospital, Monza, Italy; Swiss Childhood Cancer Registry, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and AOU Città della Salute e della Scienza di Torino, Torino, Italy; Norwegian National Advisory Unit on Solid Tumors in Children; Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, and Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy; Norwegian Cancer Registry and Department of Pediatric Medicine, Oslo University Hospital, Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Norway; Hungarian Childhood Cancer Registry, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Department of Pediatrics and Adolescent Medicine, Turku University and Turku University Hospital, Turku, Finland; Institute of Oncology, Ljubljana, Slovenia; Department of Pediatrics, University Children's Hospital of Bern, University of Bern, Bern, Switzerland
| | - Thomas Wiebe
- Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham, Birmingham, UK; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France; Cancer and Radiation Team, U1018 INSERM, Villejuif, France; Epidemiology and Biostatistics Section, Gaslini Children Hospital, Genova, Italy; 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Kepler Universitätsklinikum, Linz, Austria; Survivorship Unit, Danish Cancer Society Research Center, Copenhagen, Denmark; Boyne Research Institute, Drogheda, Ireland; Department of Pediatric Oncology, Emma Children's Hospital/Academic Medical Center, Amsterdam, the Netherlands; Department of Pediatrics, Skane University Hospital, Lund University, Lund, Sweden; German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Mainz, Germany; Children's Hospital, Landspitali University Hospital, Reykjavik, Iceland; Pediatric Hematology Unit, San Gerardo Hospital, Monza, Italy; Swiss Childhood Cancer Registry, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and AOU Città della Salute e della Scienza di Torino, Torino, Italy; Norwegian National Advisory Unit on Solid Tumors in Children; Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, and Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy; Norwegian Cancer Registry and Department of Pediatric Medicine, Oslo University Hospital, Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Norway; Hungarian Childhood Cancer Registry, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Department of Pediatrics and Adolescent Medicine, Turku University and Turku University Hospital, Turku, Finland; Institute of Oncology, Ljubljana, Slovenia; Department of Pediatrics, University Children's Hospital of Bern, University of Bern, Bern, Switzerland
| | - Zsuzsanna Jakab
- Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham, Birmingham, UK; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France; Cancer and Radiation Team, U1018 INSERM, Villejuif, France; Epidemiology and Biostatistics Section, Gaslini Children Hospital, Genova, Italy; 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Kepler Universitätsklinikum, Linz, Austria; Survivorship Unit, Danish Cancer Society Research Center, Copenhagen, Denmark; Boyne Research Institute, Drogheda, Ireland; Department of Pediatric Oncology, Emma Children's Hospital/Academic Medical Center, Amsterdam, the Netherlands; Department of Pediatrics, Skane University Hospital, Lund University, Lund, Sweden; German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Mainz, Germany; Children's Hospital, Landspitali University Hospital, Reykjavik, Iceland; Pediatric Hematology Unit, San Gerardo Hospital, Monza, Italy; Swiss Childhood Cancer Registry, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and AOU Città della Salute e della Scienza di Torino, Torino, Italy; Norwegian National Advisory Unit on Solid Tumors in Children; Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, and Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy; Norwegian Cancer Registry and Department of Pediatric Medicine, Oslo University Hospital, Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Norway; Hungarian Childhood Cancer Registry, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Department of Pediatrics and Adolescent Medicine, Turku University and Turku University Hospital, Turku, Finland; Institute of Oncology, Ljubljana, Slovenia; Department of Pediatrics, University Children's Hospital of Bern, University of Bern, Bern, Switzerland
| | - Riccardo Haupt
- Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham, Birmingham, UK; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France; Cancer and Radiation Team, U1018 INSERM, Villejuif, France; Epidemiology and Biostatistics Section, Gaslini Children Hospital, Genova, Italy; 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Kepler Universitätsklinikum, Linz, Austria; Survivorship Unit, Danish Cancer Society Research Center, Copenhagen, Denmark; Boyne Research Institute, Drogheda, Ireland; Department of Pediatric Oncology, Emma Children's Hospital/Academic Medical Center, Amsterdam, the Netherlands; Department of Pediatrics, Skane University Hospital, Lund University, Lund, Sweden; German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Mainz, Germany; Children's Hospital, Landspitali University Hospital, Reykjavik, Iceland; Pediatric Hematology Unit, San Gerardo Hospital, Monza, Italy; Swiss Childhood Cancer Registry, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and AOU Città della Salute e della Scienza di Torino, Torino, Italy; Norwegian National Advisory Unit on Solid Tumors in Children; Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, and Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy; Norwegian Cancer Registry and Department of Pediatric Medicine, Oslo University Hospital, Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Norway; Hungarian Childhood Cancer Registry, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Department of Pediatrics and Adolescent Medicine, Turku University and Turku University Hospital, Turku, Finland; Institute of Oncology, Ljubljana, Slovenia; Department of Pediatrics, University Children's Hospital of Bern, University of Bern, Bern, Switzerland
| | - Päivi Lähteenmäki
- Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham, Birmingham, UK; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France; Cancer and Radiation Team, U1018 INSERM, Villejuif, France; Epidemiology and Biostatistics Section, Gaslini Children Hospital, Genova, Italy; 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Kepler Universitätsklinikum, Linz, Austria; Survivorship Unit, Danish Cancer Society Research Center, Copenhagen, Denmark; Boyne Research Institute, Drogheda, Ireland; Department of Pediatric Oncology, Emma Children's Hospital/Academic Medical Center, Amsterdam, the Netherlands; Department of Pediatrics, Skane University Hospital, Lund University, Lund, Sweden; German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Mainz, Germany; Children's Hospital, Landspitali University Hospital, Reykjavik, Iceland; Pediatric Hematology Unit, San Gerardo Hospital, Monza, Italy; Swiss Childhood Cancer Registry, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and AOU Città della Salute e della Scienza di Torino, Torino, Italy; Norwegian National Advisory Unit on Solid Tumors in Children; Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, and Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy; Norwegian Cancer Registry and Department of Pediatric Medicine, Oslo University Hospital, Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Norway; Hungarian Childhood Cancer Registry, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Department of Pediatrics and Adolescent Medicine, Turku University and Turku University Hospital, Turku, Finland; Institute of Oncology, Ljubljana, Slovenia; Department of Pediatrics, University Children's Hospital of Bern, University of Bern, Bern, Switzerland
| | - Lorna Zadravec Zaletel
- Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham, Birmingham, UK; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France; Cancer and Radiation Team, U1018 INSERM, Villejuif, France; Epidemiology and Biostatistics Section, Gaslini Children Hospital, Genova, Italy; 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Kepler Universitätsklinikum, Linz, Austria; Survivorship Unit, Danish Cancer Society Research Center, Copenhagen, Denmark; Boyne Research Institute, Drogheda, Ireland; Department of Pediatric Oncology, Emma Children's Hospital/Academic Medical Center, Amsterdam, the Netherlands; Department of Pediatrics, Skane University Hospital, Lund University, Lund, Sweden; German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Mainz, Germany; Children's Hospital, Landspitali University Hospital, Reykjavik, Iceland; Pediatric Hematology Unit, San Gerardo Hospital, Monza, Italy; Swiss Childhood Cancer Registry, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and AOU Città della Salute e della Scienza di Torino, Torino, Italy; Norwegian National Advisory Unit on Solid Tumors in Children; Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, and Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy; Norwegian Cancer Registry and Department of Pediatric Medicine, Oslo University Hospital, Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Norway; Hungarian Childhood Cancer Registry, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Department of Pediatrics and Adolescent Medicine, Turku University and Turku University Hospital, Turku, Finland; Institute of Oncology, Ljubljana, Slovenia; Department of Pediatrics, University Children's Hospital of Bern, University of Bern, Bern, Switzerland
| | - Claudia E Kuehni
- Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham, Birmingham, UK; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France; Cancer and Radiation Team, U1018 INSERM, Villejuif, France; Epidemiology and Biostatistics Section, Gaslini Children Hospital, Genova, Italy; 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Kepler Universitätsklinikum, Linz, Austria; Survivorship Unit, Danish Cancer Society Research Center, Copenhagen, Denmark; Boyne Research Institute, Drogheda, Ireland; Department of Pediatric Oncology, Emma Children's Hospital/Academic Medical Center, Amsterdam, the Netherlands; Department of Pediatrics, Skane University Hospital, Lund University, Lund, Sweden; German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Mainz, Germany; Children's Hospital, Landspitali University Hospital, Reykjavik, Iceland; Pediatric Hematology Unit, San Gerardo Hospital, Monza, Italy; Swiss Childhood Cancer Registry, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and AOU Città della Salute e della Scienza di Torino, Torino, Italy; Norwegian National Advisory Unit on Solid Tumors in Children; Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, and Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy; Norwegian Cancer Registry and Department of Pediatric Medicine, Oslo University Hospital, Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Norway; Hungarian Childhood Cancer Registry, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Department of Pediatrics and Adolescent Medicine, Turku University and Turku University Hospital, Turku, Finland; Institute of Oncology, Ljubljana, Slovenia; Department of Pediatrics, University Children's Hospital of Bern, University of Bern, Bern, Switzerland
| | - Jeanette F Winther
- Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham, Birmingham, UK; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France; Cancer and Radiation Team, U1018 INSERM, Villejuif, France; Epidemiology and Biostatistics Section, Gaslini Children Hospital, Genova, Italy; 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Kepler Universitätsklinikum, Linz, Austria; Survivorship Unit, Danish Cancer Society Research Center, Copenhagen, Denmark; Boyne Research Institute, Drogheda, Ireland; Department of Pediatric Oncology, Emma Children's Hospital/Academic Medical Center, Amsterdam, the Netherlands; Department of Pediatrics, Skane University Hospital, Lund University, Lund, Sweden; German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Mainz, Germany; Children's Hospital, Landspitali University Hospital, Reykjavik, Iceland; Pediatric Hematology Unit, San Gerardo Hospital, Monza, Italy; Swiss Childhood Cancer Registry, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and AOU Città della Salute e della Scienza di Torino, Torino, Italy; Norwegian National Advisory Unit on Solid Tumors in Children; Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, and Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy; Norwegian Cancer Registry and Department of Pediatric Medicine, Oslo University Hospital, Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Norway; Hungarian Childhood Cancer Registry, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Department of Pediatrics and Adolescent Medicine, Turku University and Turku University Hospital, Turku, Finland; Institute of Oncology, Ljubljana, Slovenia; Department of Pediatrics, University Children's Hospital of Bern, University of Bern, Bern, Switzerland
| | - Florent de Vathaire
- Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham, Birmingham, UK; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France; Cancer and Radiation Team, U1018 INSERM, Villejuif, France; Epidemiology and Biostatistics Section, Gaslini Children Hospital, Genova, Italy; 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Kepler Universitätsklinikum, Linz, Austria; Survivorship Unit, Danish Cancer Society Research Center, Copenhagen, Denmark; Boyne Research Institute, Drogheda, Ireland; Department of Pediatric Oncology, Emma Children's Hospital/Academic Medical Center, Amsterdam, the Netherlands; Department of Pediatrics, Skane University Hospital, Lund University, Lund, Sweden; German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Mainz, Germany; Children's Hospital, Landspitali University Hospital, Reykjavik, Iceland; Pediatric Hematology Unit, San Gerardo Hospital, Monza, Italy; Swiss Childhood Cancer Registry, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and AOU Città della Salute e della Scienza di Torino, Torino, Italy; Norwegian National Advisory Unit on Solid Tumors in Children; Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, and Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy; Norwegian Cancer Registry and Department of Pediatric Medicine, Oslo University Hospital, Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Norway; Hungarian Childhood Cancer Registry, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Department of Pediatrics and Adolescent Medicine, Turku University and Turku University Hospital, Turku, Finland; Institute of Oncology, Ljubljana, Slovenia; Department of Pediatrics, University Children's Hospital of Bern, University of Bern, Bern, Switzerland
| | - Leontien C Kremer
- Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham, Birmingham, UK; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France; Cancer and Radiation Team, U1018 INSERM, Villejuif, France; Epidemiology and Biostatistics Section, Gaslini Children Hospital, Genova, Italy; 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Kepler Universitätsklinikum, Linz, Austria; Survivorship Unit, Danish Cancer Society Research Center, Copenhagen, Denmark; Boyne Research Institute, Drogheda, Ireland; Department of Pediatric Oncology, Emma Children's Hospital/Academic Medical Center, Amsterdam, the Netherlands; Department of Pediatrics, Skane University Hospital, Lund University, Lund, Sweden; German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Mainz, Germany; Children's Hospital, Landspitali University Hospital, Reykjavik, Iceland; Pediatric Hematology Unit, San Gerardo Hospital, Monza, Italy; Swiss Childhood Cancer Registry, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and AOU Città della Salute e della Scienza di Torino, Torino, Italy; Norwegian National Advisory Unit on Solid Tumors in Children; Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, and Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy; Norwegian Cancer Registry and Department of Pediatric Medicine, Oslo University Hospital, Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Norway; Hungarian Childhood Cancer Registry, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Department of Pediatrics and Adolescent Medicine, Turku University and Turku University Hospital, Turku, Finland; Institute of Oncology, Ljubljana, Slovenia; Department of Pediatrics, University Children's Hospital of Bern, University of Bern, Bern, Switzerland
| | - Lars Hjorth
- Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham, Birmingham, UK; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France; Cancer and Radiation Team, U1018 INSERM, Villejuif, France; Epidemiology and Biostatistics Section, Gaslini Children Hospital, Genova, Italy; 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Kepler Universitätsklinikum, Linz, Austria; Survivorship Unit, Danish Cancer Society Research Center, Copenhagen, Denmark; Boyne Research Institute, Drogheda, Ireland; Department of Pediatric Oncology, Emma Children's Hospital/Academic Medical Center, Amsterdam, the Netherlands; Department of Pediatrics, Skane University Hospital, Lund University, Lund, Sweden; German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Mainz, Germany; Children's Hospital, Landspitali University Hospital, Reykjavik, Iceland; Pediatric Hematology Unit, San Gerardo Hospital, Monza, Italy; Swiss Childhood Cancer Registry, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and AOU Città della Salute e della Scienza di Torino, Torino, Italy; Norwegian National Advisory Unit on Solid Tumors in Children; Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, and Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy; Norwegian Cancer Registry and Department of Pediatric Medicine, Oslo University Hospital, Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Norway; Hungarian Childhood Cancer Registry, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Department of Pediatrics and Adolescent Medicine, Turku University and Turku University Hospital, Turku, Finland; Institute of Oncology, Ljubljana, Slovenia; Department of Pediatrics, University Children's Hospital of Bern, University of Bern, Bern, Switzerland
| | - Michael M Hawkins
- Centre for Childhood Cancer Survivor Studies, Institute of Applied Health Research, University of Birmingham, Birmingham, UK; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France; Cancer and Radiation Team, U1018 INSERM, Villejuif, France; Epidemiology and Biostatistics Section, Gaslini Children Hospital, Genova, Italy; 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Kepler Universitätsklinikum, Linz, Austria; Survivorship Unit, Danish Cancer Society Research Center, Copenhagen, Denmark; Boyne Research Institute, Drogheda, Ireland; Department of Pediatric Oncology, Emma Children's Hospital/Academic Medical Center, Amsterdam, the Netherlands; Department of Pediatrics, Skane University Hospital, Lund University, Lund, Sweden; German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center, Mainz, Germany; Children's Hospital, Landspitali University Hospital, Reykjavik, Iceland; Pediatric Hematology Unit, San Gerardo Hospital, Monza, Italy; Swiss Childhood Cancer Registry, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; Childhood Cancer Registry of Piedmont, Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and AOU Città della Salute e della Scienza di Torino, Torino, Italy; Norwegian National Advisory Unit on Solid Tumors in Children; Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, and Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy; Norwegian Cancer Registry and Department of Pediatric Medicine, Oslo University Hospital, Oslo, Norway; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Norway; Hungarian Childhood Cancer Registry, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary; Department of Pediatrics and Adolescent Medicine, Turku University and Turku University Hospital, Turku, Finland; Institute of Oncology, Ljubljana, Slovenia; Department of Pediatrics, University Children's Hospital of Bern, University of Bern, Bern, Switzerland
| |
Collapse
|
35
|
Langer CE, de Llobet P, Dalmau A, Wiart J, Goedhart G, Hours M, Benke GP, Bouka E, Bruchim R, Choi KH, Eng A, Ha M, Karalexi M, Kiyohara K, Kojimahara N, Krewski D, Kromhout H, Lacour B, 't Mannetje A, Maule M, Migliore E, Mohipp C, Momoli F, Petridou E, Radon K, Remen T, Sadetzki S, Sim MR, Weinmann T, Vermeulen R, Cardis E, Vrijheid M. Patterns of cellular phone use among young people in 12 countries: Implications for RF exposure. Environ Int 2017; 107:65-74. [PMID: 28668725 DOI: 10.1016/j.envint.2017.06.002] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/03/2017] [Revised: 05/29/2017] [Accepted: 06/05/2017] [Indexed: 06/07/2023]
Abstract
Characterizing exposure to radiofrequency (RF) fields from wireless telecommunications technologies during childhood and adolescence is a research priority in investigating the health effects of RF. The Mobi-Expo study aimed to describe characteristics and determinants of cellular phone use in 534 young people (10-24years) in 12 countries. The study used a specifically designed software application installed on smartphones to collect data on the use of wireless telecommunications devices within this age group. The role of gender, age, maternal education, calendar period, and country was evaluated through multivariate models mutually adjusting for all variables. Call number and duration were higher among females compared to males (geometric mean (GM) ratio 1.17 and 1.42, respectively), among 20-24year olds compared to 10-14year olds (GM ratio 2.09 and 4.40, respectively), and among lowest compared to highest social classes (GM ratio 1.52 and 1.58, respectively). The number of SMS was higher in females (GM ratio 1.46) and the middle age group (15-19year olds: GM ratio 2.21 compared to 10-14year olds) and decreased over time. Data use was highest in the oldest age group, whereas Wi-Fi use was highest in the middle age group. Both data and Wi-Fi use increased over time. Large differences in the number and duration of calls, SMS, and data/Wi-Fi use were seen by country, with country and age accounting for up to 50% of the variance. Hands-free and laterality of use did not show significant differences by sex, age, education, study period, or country. Although limited by a convenience sample, these results provide valuable insights to the design, analysis, and interpretation of future epidemiological studies concerning the health effects of exposure resulting from cellular phone use in young people. In addition, the information provided by this research may be used to design strategies to minimize RF exposure.
Collapse
Affiliation(s)
- Chelsea E Langer
- ISGlobal, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain; Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Spain; Universitat Pompeu Fabra, Barcelona, Spain.
| | - Patricia de Llobet
- ISGlobal, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain; Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Spain; Universitat Pompeu Fabra, Barcelona, Spain
| | - Albert Dalmau
- ISGlobal, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain; Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Spain; Universitat Pompeu Fabra, Barcelona, Spain
| | - Joe Wiart
- Chaire C2M, LTCI, Telecom ParisTech, Universite Paris-Saclay, 75013 Paris, France
| | - Geertje Goedhart
- Division of Environmental Epidemiology, Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands
| | - Martine Hours
- Epidemiological Research and Surveillance Unit in Transport, Occupation and Environment (UMRESTTE), Universite de Lyon/The French Institute of Science and Technology for Transport, Development and Networks (IFSTTAR), Lyon, France
| | - Geza P Benke
- Department of Epidemiology & Preventive Medicine, School of Public Health & Preventive Medicine, Monash University, Melbourne, Australia
| | - Evdoxia Bouka
- Department of Hygiene, Epidemiology and Medical Statistics, National and Kapodistrian University of Athens, Athens, Greece
| | - Revital Bruchim
- Cancer and Radiation Epidemiology Unit, Gertner Institute for Epidemiology and Health Policy Research, Chaim Sheba Medical Center, Tel Hashomer, Israel
| | - Kyung-Hwa Choi
- Department of Preventive Medicine, Dankook University College of Medicine, Cheonan, Republic of Korea
| | - Amanda Eng
- Centre for Public Health Research, Massey University, Wellington, New Zealand
| | - Mina Ha
- Department of Preventive Medicine, Dankook University College of Medicine, Cheonan, Republic of Korea
| | - Maria Karalexi
- Department of Hygiene, Epidemiology and Medical Statistics, National and Kapodistrian University of Athens, Athens, Greece
| | - Kosuke Kiyohara
- Department of Public Health, Tokyo Women's Medical University, Tokyo, Japan
| | - Noriko Kojimahara
- Department of Public Health, Tokyo Women's Medical University, Tokyo, Japan
| | - Daniel Krewski
- McLaughlin Centre for Population Health Risk Assessment, School of Epidemiology, Public Health and Preventive Medicine, University of Ottawa, Canada
| | - Hans Kromhout
- Division of Environmental Epidemiology, Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands
| | - Brigitte Lacour
- French National Registry of Childhood Solid Tumours, CHU, Nancy, Inserm UMRS-1153, CRESS-EPICEA, University of Paris-Sorbonne, Paris, France
| | - Andrea 't Mannetje
- Centre for Public Health Research, Massey University, Wellington, New Zealand
| | - Milena Maule
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and AOU Città della Salute e della Scienza di Torino, Italy
| | - Enrica Migliore
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and AOU Città della Salute e della Scienza di Torino, Italy
| | - Charmaine Mohipp
- Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Canada
| | - Franco Momoli
- Children's Hospital of Eastern Ontario Research Institute, Ottawa Hospital Research Institute, University of Ottawa, Canada
| | - Eleni Petridou
- Department of Hygiene, Epidemiology and Medical Statistics, National and Kapodistrian University of Athens, Athens, Greece
| | - Katja Radon
- Occupational and Environmental Epidemiology & NetTeaching Unit, Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine, University Hospital of Munich (LMU), Munich, Germany
| | - Thomas Remen
- French National Registry of Childhood Solid Tumours, CHU, Nancy, France
| | - Siegal Sadetzki
- Cancer and Radiation Epidemiology Unit, Gertner Institute for Epidemiology and Health Policy Research, Chaim Sheba Medical Center, Tel Hashomer, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - Malcolm R Sim
- Department of Epidemiology & Preventive Medicine, School of Public Health & Preventive Medicine, Monash University, Melbourne, Australia
| | - Tobias Weinmann
- Occupational and Environmental Epidemiology & NetTeaching Unit, Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine, University Hospital of Munich (LMU), Munich, Germany
| | - Roel Vermeulen
- Division of Environmental Epidemiology, Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands
| | - Elisabeth Cardis
- ISGlobal, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain; Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Spain; Universitat Pompeu Fabra, Barcelona, Spain
| | - Martine Vrijheid
- ISGlobal, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain; Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Spain; Universitat Pompeu Fabra, Barcelona, Spain
| |
Collapse
|
36
|
Quaglino P, Maule M, Prince HM, Porcu P, Horwitz S, Duvic M, Talpur R, Vermeer M, Bagot M, Guitart J, Papadavid E, Sanches JA, Hodak E, Sugaya M, Berti E, Ortiz-Romero P, Pimpinelli N, Servitje O, Pileri A, Zinzani PL, Estrach T, Knobler R, Stadler R, Fierro MT, Alberti Violetti S, Amitay-Laish I, Antoniou C, Astrua C, Chaganti S, Child F, Combalia A, Fabbro S, Fava P, Grandi V, Jonak C, Martinez-Escala E, Kheterpal M, Kim EJ, McCormack C, Miyagaki T, Miyashiro D, Morris S, Muniesa C, Nikolaou V, Ognibene G, Onida F, Osella-Abate S, Porkert S, Postigo-Llorente C, Ram-Wolff C, Ribero S, Rogers K, Sanlorenzo M, Stranzenbach R, Spaccarelli N, Stevens A, Zugna D, Rook AH, Geskin LJ, Willemze R, Whittaker S, Hoppe R, Scarisbrick J, Kim Y. Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium. Ann Oncol 2017; 28:2517-2525. [PMID: 28961843 DOI: 10.1093/annonc/mdx352] [Citation(s) in RCA: 84] [Impact Index Per Article: 12.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
BACKGROUND Advanced-stage mycosis fungoides (MF)/Sézary syndrome (SS) patients are weighted by an unfavorable prognosis and share an unmet clinical need of effective treatments. International guidelines are available detailing treatment options for the different stages but without recommending treatments in any particular order due to lack of comparative trials. The aims of this second CLIC study were to retrospectively analyze the pattern of care worldwide for advanced-stage MF/SS patients, the distribution of treatments according to geographical areas (USA versus non-USA), and whether the heterogeneity of approaches has potential impact on survival. PATIENTS AND METHODS This study included 853 patients from 21 specialist centers (14 European, 4 USA, 1 each Australian, Brazilian, and Japanese). RESULTS Heterogeneity of treatment approaches was found, with up to 24 different modalities or combinations used as first-line and 36% of patients receiving four or more treatments. Stage IIB disease was most frequently treated by total-skin-electron-beam radiotherapy, bexarotene and gemcitabine; erythrodermic and SS patients by extracorporeal photochemotherapy, and stage IVA2 by polychemotherapy. Significant differences were found between USA and non-USA centers, with bexarotene, photopheresis and histone deacetylase inhibitors most frequently prescribed for first-line treatment in USA while phototherapy, interferon, chlorambucil and gemcitabine in non-USA centers. These differences did not significantly impact on survival. However, when considering death and therapy change as competing risk events and the impact of first treatment line on both events, both monochemotherapy (SHR = 2.07) and polychemotherapy (SHR = 1.69) showed elevated relative risks. CONCLUSION This large multicenter retrospective study shows that there exist a large treatment heterogeneity in advanced MF/SS and differences between USA and non-USA centers but these were not related to survival, while our data reveal that chemotherapy as first treatment is associated with a higher risk of death and/or change of therapy and thus other therapeutic options should be preferable as first treatment approach.
Collapse
Affiliation(s)
- P Quaglino
- Dermatologic Clinic, Department of Medical Sciences;.
| | - M Maule
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Torino, Torino, Italy
| | - H M Prince
- Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne;; University of Melbourne, Melbourne, Australia
| | - P Porcu
- Division of Hematologic Malignancies, Ohio State University
| | - S Horwitz
- Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York
| | - M Duvic
- Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA
| | - R Talpur
- Department of Dermatology and Pathology, MD Anderson Cancer Centre, Houston, USA
| | - M Vermeer
- Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands
| | - M Bagot
- Dermatology Department, Hospital St Louis, Paris, France
| | - J Guitart
- Department of Dermatology and Pathology, Northwestern University, Chicago, USA
| | - E Papadavid
- 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece
| | - J A Sanches
- Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil
| | - E Hodak
- Beilinson Hospital, Petach Tikva;; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - M Sugaya
- Department of Dermatology, Faculty of Medicine, University of Tokyo, Tokyo, Japan
| | - E Berti
- Dermatologic Clinic, University of Milano, Milano, Italy
| | - P Ortiz-Romero
- Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain
| | - N Pimpinelli
- Dermatologic Clinic, University of Florence, Florence, Italy
| | - O Servitje
- Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain
| | - A Pileri
- Dermatologic Clinic, University of Bologna, Bologna
| | - P L Zinzani
- Seragnoli Institute of Haematology, Bologna, Italy
| | - T Estrach
- Department of Dermatology, Hospital Clinico, University of Barcelona, Barcelona, Spain
| | - R Knobler
- Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria
| | - R Stadler
- University Clinic for Dermatology, Venereology, Allergology and Phlebology, Minden, Germany
| | - M T Fierro
- Dermatologic Clinic, Department of Medical Sciences
| | | | - I Amitay-Laish
- Beilinson Hospital, Petach Tikva;; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - C Antoniou
- 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece
| | - C Astrua
- Dermatologic Clinic, Department of Medical Sciences
| | - S Chaganti
- Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham
| | - F Child
- Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK
| | - A Combalia
- Department of Dermatology, Hospital Clinico, University of Barcelona, Barcelona, Spain
| | - S Fabbro
- Division of Hematologic Malignancies, Ohio State University
| | - P Fava
- Dermatologic Clinic, Department of Medical Sciences
| | - V Grandi
- Dermatologic Clinic, University of Florence, Florence, Italy
| | - C Jonak
- Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria
| | - E Martinez-Escala
- Department of Dermatology and Pathology, Northwestern University, Chicago, USA
| | - M Kheterpal
- Department of Medicine, Memorial Sloan-Kettering Cancer Centre, New York
| | - E J Kim
- Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia
| | - C McCormack
- Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne;; University of Melbourne, Melbourne, Australia
| | - T Miyagaki
- Department of Dermatology, Faculty of Medicine, University of Tokyo, Tokyo, Japan
| | - D Miyashiro
- Department of Dermatology, University of Sao Paulo Medical School, Sao Paulo, Brazil
| | - S Morris
- Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK
| | - C Muniesa
- Department of Dermatology, Hospital Universitari de Bellvitge, Barcelona, Spain
| | - V Nikolaou
- 2nd Department of Dermatology and Venereology, Attikon General Hospital, University of Athens, Chaidari, Greece
| | - G Ognibene
- Comprehensive Skin Cancer Center, Columbia University Medical Center
| | - F Onida
- Dermatologic Clinic, University of Milano, Milano, Italy
| | | | - S Porkert
- Dermatologic Clinic, University of Vienna Medical School, Vienna, Austria
| | | | - C Ram-Wolff
- Dermatology Department, Hospital St Louis, Paris, France
| | - S Ribero
- Dermatologic Clinic, Department of Medical Sciences
| | - K Rogers
- Comprehensive Skin Cancer Center, Columbia University Medical Center
| | - M Sanlorenzo
- Dermatologic Clinic, Department of Medical Sciences
| | - R Stranzenbach
- University Clinic for Dermatology, Venereology, Allergology and Phlebology, Minden, Germany
| | - N Spaccarelli
- Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia
| | - A Stevens
- Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham
| | - D Zugna
- Cancer Epidemiology Unit, Department of Medical Sciences, University of Torino, Torino, Italy
| | - A H Rook
- Department of Dermatology and Pathology, University of Pennsylvania, Philadelphia
| | - L J Geskin
- Comprehensive Skin Cancer Center, Columbia University Medical Center
| | - R Willemze
- Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands
| | - S Whittaker
- Kings College London, Guys and St Thomas NHS Foundation Trust, London, UK
| | - R Hoppe
- Department of Dermatology, Stanford University Medical Centre, USA
| | - J Scarisbrick
- Cutaneous Lymphoma Service, University Hospital Birmingham, Birmingham
| | - Y Kim
- Department of Dermatology, Stanford University Medical Centre, USA
| |
Collapse
|
37
|
Gatta G, Peris-Bonet R, Visser O, Stiller C, Marcos-Gragera R, Sánchez MJ, Lacour B, Kaatsch P, Berrino F, Rutkowski S, Botta L, Hackl M, Zielonke N, Oberaigner W, Van Eycken E, Henau K, Valerianova Z, Dimitrova N, Sekerija M, Storm H, Engholm G, Mägi M, Aareleid T, Malila N, Seppä K, Faivre J, Bossard N, Uhry Z, Colonna M, Clavel J, Lacour B, Desandes E, Brenner H, Kaatsch P, Katalinic A, Garami M, Jakab Z, Comber H, Mazzoleni G, Bulatko A, Buzzoni C, Giacomin A, Sutera Sardo A, Mancuso P, Ferretti S, Barchielli A, Caldarella A, Gatta G, Sant M, Amash H, Amati C, Baili P, Berrino F, Bonfarnuzzo S, Botta L, Capocaccia R, Di Salvo F, Foschi R, Margutti C, Meneghini E, Minicozzi P, Trama A, Serraino D, Zucchetto A, De Angelis R, Caldora M, Carrani E, Francisci S, Mallone S, Pierannunzio D, Roazzi P, Rossi S, Santaquilani M, Tavilla A, Pannozzo F, Busco S, Filiberti R, Marani E, Ricci P, Pascucci C, Autelitano M, Spagnoli G, Cirilli C, Fusco M, Vitale M, Usala M, Vitale F, Ravazzolo B, Michiara M, Merletti F, Maule M, Tumino R, Mangone L, Di Felice E, Falcini F, Iannelli A, Sechi O, Cesaraccio R, Piffer S, Madeddu A, Tisano F, Maspero S, Fanetti A, Candela P, Scuderi T, Stracci F, Bianconi F, Tagliabue G, Contiero P, Rugge M, Guzzinati S, Pildava S, Smailyte G, Calleja N, Agius D, Johannesen T, Rachtan J, Góźdź S, Mężyk R, Błaszczyk J, Bębenek M, Bielska-Lasota M, Forjaz de Lacerda G, Bento M, Castro C, Miranda A, Mayer-da-Silva A, Safaei Diba C, Primic-Zakelj M, Errezola M, Bidaurrazaga J, Vicente Raneda M, Díaz García J, Marcos-Navarro A, Marcos-Gragera R, Izquierdo Font A, Sanchez M, Chang D, Navarro C, Chirlaque M, Moreno-Iribas C, Ardanaz E, Peris-Bonet R, Pardo Romaguera E, Galceran J, Carulla M, Lambe M, Mousavi M, Bouchardy C, Usel M, Ess S, Frick H, Lorez M, Herrmann C, Bordoni A, Spitale A, Konzelmann I, Visser O, Aarts M, Otter R, Coleman M, Allemani C, Rachet B, Verne J, Stiller C, Gavin A, Donnelly C, Brewster D. Geographical variability in survival of European children with central nervous system tumours. Eur J Cancer 2017; 82:137-148. [DOI: 10.1016/j.ejca.2017.05.028] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2017] [Revised: 05/11/2017] [Accepted: 05/16/2017] [Indexed: 11/28/2022]
|
38
|
Revelli A, Canosa S, Bergandi L, Skorokhod OA, Biasoni V, Carosso A, Bertagna A, Maule M, Aldieri E, D’Eufemia MD, Evangelista F, Colacurci N, Benedetto C. Oocyte polarized light microscopy, assay of specific follicular fluid metabolites, and gene expression in cumulus cells as different approaches to predict fertilization efficiency after ICSI. Reprod Biol Endocrinol 2017; 15:47. [PMID: 28645283 PMCID: PMC5481970 DOI: 10.1186/s12958-017-0265-2] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/07/2023] Open
Abstract
BACKGROUND The complex relationship between oocyte morphology, specific follicular fluid metabolites, gene expression in cumulus granulosa cells, and oocyte competence toward fertilization and embryo development still needs further clarification. METHODS Forty-six oocytes retrieved from the largest pre-ovulatory follicle of patients undergoing intra-cytoplasmic sperm injection (ICSI) were considered assessing: (a) oocyte morphological characteristics at polarized light microscopy (PLM), (b) specific follicular fluid (FF) metabolites previously suggested to influence oocyte competence (AMH, markers of redox status and of cytotoxicity), (c) transcription of AMH and AMH type II receptor genes in cumulus cells. Data were analyzed using mono-parametric tests and multivariable logistic analysis in order to correlate morphological and biochemical data with fertilization. RESULTS Comparing normally fertilized oocytes (n = 29, F group) with unfertilized (n = 17, nF group) we observed that: (a) the meiotic spindle area and major axis were significantly higher in nF group and in fertilized oocytes undergoing an early embryo development arrest; (b) AMH level in FF was comparable in F and nF groups; (c) the FF of nF group contained significantly higher levels of cytotoxicity (lactate dehydrogenase) and oxidative stress (Cu,Zn-superoxide dismutase, catalase, 4-hydroxynonenal-protein conjugates) markers; (d) cumulus cells of nF group showed significantly higher AMH receptor type II gene expression. CONCLUSIONS Taken together, these observations suggest that an excessive cytotoxicity level can alter AMH signal transduction within cumulus cells, in turn leading to partial inhibition of aromatase activity, altered cytoplasmic maturation and increased oxidative stress, factors able to impair oocyte fertilization competence and embryo growth.
Collapse
Affiliation(s)
- Alberto Revelli
- 0000 0001 2336 6580grid.7605.4Chair of Gynecology and Obstetrics 1, Physiopathology of Reproduction and IVF Unit, Department of Surgical Sciences, S. Anna Hospital, University of Torino, Torino, Italy
| | - Stefano Canosa
- 0000 0001 2336 6580grid.7605.4Chair of Gynecology and Obstetrics 1, Physiopathology of Reproduction and IVF Unit, Department of Surgical Sciences, S. Anna Hospital, University of Torino, Torino, Italy
| | - Loredana Bergandi
- 0000 0001 2336 6580grid.7605.4Department of Oncology, University of Torino, Torino, Italy
| | - Oleksii A. Skorokhod
- 0000 0001 2336 6580grid.7605.4Department of Oncology, University of Torino, Torino, Italy
| | - Valentina Biasoni
- 0000 0001 2336 6580grid.7605.4Chair of Gynecology and Obstetrics 1, Physiopathology of Reproduction and IVF Unit, Department of Surgical Sciences, S. Anna Hospital, University of Torino, Torino, Italy
| | - Andrea Carosso
- 0000 0001 2336 6580grid.7605.4Chair of Gynecology and Obstetrics 1, Physiopathology of Reproduction and IVF Unit, Department of Surgical Sciences, S. Anna Hospital, University of Torino, Torino, Italy
| | - Angela Bertagna
- 0000 0001 2336 6580grid.7605.4Endocrinology Laboratory, Department of Internal Medicine, University of Torino, Torino, Italy
| | - Milena Maule
- 0000 0001 2336 6580grid.7605.4Department of Medical Sciences, Cancer Epidemiology Unit, University of Torino, Torino, Italy
| | - Elisabetta Aldieri
- 0000 0001 2336 6580grid.7605.4Department of Oncology, University of Torino, Torino, Italy
| | - Maria Diletta D’Eufemia
- 0000 0001 2200 8888grid.9841.4Department of Woman, Child, General and Special Surgery, Second University of Napoli, Naples, Italy
| | - Francesca Evangelista
- 0000 0001 2336 6580grid.7605.4Chair of Gynecology and Obstetrics 1, Physiopathology of Reproduction and IVF Unit, Department of Surgical Sciences, S. Anna Hospital, University of Torino, Torino, Italy
| | - Nicola Colacurci
- 0000 0001 2200 8888grid.9841.4Department of Woman, Child, General and Special Surgery, Second University of Napoli, Naples, Italy
| | - Chiara Benedetto
- 0000 0001 2336 6580grid.7605.4Chair of Gynecology and Obstetrics 1, Physiopathology of Reproduction and IVF Unit, Department of Surgical Sciences, S. Anna Hospital, University of Torino, Torino, Italy
| |
Collapse
|
39
|
Corbin M, Haslett S, Pearce N, Maule M, Greenland S. A comparison of sensitivity-specificity imputation, direct imputation and fully Bayesian analysis to adjust for exposure misclassification when validation data are unavailable. Int J Epidemiol 2017; 46:1063-1072. [DOI: 10.1093/ije/dyx027] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/19/2017] [Indexed: 11/14/2022] Open
|
40
|
Grasso C, Zugna D, Fiano V, Robles Rodriguez N, Maule M, Gillio-Tos A, Ciuffreda L, Lista P, Segnan N, Merletti F, Richiardi L. Subfertility and Risk of Testicular Cancer in the EPSAM Case-Control Study. PLoS One 2016; 11:e0169174. [PMID: 28036409 PMCID: PMC5201268 DOI: 10.1371/journal.pone.0169174] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/22/2016] [Accepted: 12/13/2016] [Indexed: 11/19/2022] Open
Abstract
Background/objectives It has been suggested that subfertility and testicular cancer share genetic and environmental risk factors. We studied both subfertility and the strongest known testicular cancer susceptibility gene, the c-KIT ligand (KITLG), whose pathway is involved in spermatogenesis. Methods The EPSAM case-control study is comprised of testicular cancer patients from the Province of Turin, Italy, diagnosed between 1997 and 2008. The present analysis included 245 cases and 436 controls from EPSAM, who were aged 20 years or older at diagnosis/recruitment. The EPSAM questionnaire collected information on factors such as number of children, age at first attempt to conceive, duration of attempt to conceive, use of assisted reproduction techniques, physician-assigned diagnosis of infertility, number of siblings, and self-reported cryptorchidism. Genotyping of the KITLG single nucleotide polymorphism (SNP) rs995030 was performed on the saliva samples of 202 cases and 329 controls. Results Testicular cancer was associated with the number of children fathered 5 years before diagnosis (odds ratio (OR) per additional child: 0.78, 95% confidence interval (CI): 0.58–1.04) and sibship size (OR per additional sibling: 0.76, 95% CI: 0.66–0.88). When considering the reproductive history until 1 year before diagnosis, attempting to conceive for at least 12 months or fathering a child using assisted reproduction techniques was not associated with the risk of testicular cancer, nor was age at first attempt to conceive or physician-assigned diagnosis of infertility. The SNP rs995030 was strongly associated with risk of testicular cancer (per allele OR: 1.83; 95%CI: 1.26–2.64), but it did not modify the association between number of children and the risk of testicular cancer. Conclusion This study supports the repeatedly reported inverse association between number of children and risk of testicular cancer, but it does not find evidence of an association for other indicators of subfertility.
Collapse
Affiliation(s)
- Chiara Grasso
- Cancer Epidemiology Unit-CeRMS, Department of Medical Sciences, University of Turin and CPO Piedmont, Turin, Italy
- * E-mail:
| | - Daniela Zugna
- Cancer Epidemiology Unit-CeRMS, Department of Medical Sciences, University of Turin and CPO Piedmont, Turin, Italy
| | - Valentina Fiano
- Cancer Epidemiology Unit-CeRMS, Department of Medical Sciences, University of Turin and CPO Piedmont, Turin, Italy
| | - Nena Robles Rodriguez
- Cancer Epidemiology Unit-CeRMS, Department of Medical Sciences, University of Turin and CPO Piedmont, Turin, Italy
| | - Milena Maule
- Cancer Epidemiology Unit-CeRMS, Department of Medical Sciences, University of Turin and CPO Piedmont, Turin, Italy
| | - Anna Gillio-Tos
- Cancer Epidemiology Unit-CeRMS, Department of Medical Sciences, University of Turin and CPO Piedmont, Turin, Italy
| | - Libero Ciuffreda
- Medical Oncology Division 1, University Hospital “Città della Salute e della Scienza”, Turin, Italy
| | - Patrizia Lista
- Medical Oncology Division 1, University Hospital “Città della Salute e della Scienza”, Turin, Italy
| | - Nereo Segnan
- Department of Cancer Screening and Unit of Cancer Epidemiology, WHO Collaborative Center for Cancer Early Diagnosis and Screening, CPO Piedmont and University Hospital “Città della Salute e della Scienza”, Turin, Italy
| | - Franco Merletti
- Cancer Epidemiology Unit-CeRMS, Department of Medical Sciences, University of Turin and CPO Piedmont, Turin, Italy
| | - Lorenzo Richiardi
- Cancer Epidemiology Unit-CeRMS, Department of Medical Sciences, University of Turin and CPO Piedmont, Turin, Italy
| |
Collapse
|
41
|
Maule M, Terracini B. [Childhood cancer epidemiology and available evidence on case clustering]. Epidemiol Prev 2016; 40:5-8. [PMID: 27807953] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
This paper introduces a Monograph on childhood cancer clusters addressed to Italian public health workers, paediatricians and paediatric oncologists, and the general public. Two issues have been underlined in most definitions of cancer clusters reported in the literature over the last 30 years. The first is the need for an unbiased methodological approach for the detection and the interpretation of clustering and of individual clusters. The other is the responsibility for scientists and public health workers to unravel suspicious events and to interact with the population in circumstances which may turn out to be false alarms. The relative weight given to epidemiological methods and to risk perception has varied between definitions of clusters given in different periods. In the field of childhood cancer clusters, epidemiological research has produced very little fresh knowledge. However, it is recognized that this is not a sufficient reason for refusing to pay attention to reports of perceived clusters. Models of spatio-temporal interactions according to Birch et al. (2000) are taken in consideration: the literature offers a very limited number of circumstances fitting such models. In Italy, over the years, only two childhood cancer clusters have been reported in the indexed literature, both of them regarded cases of acute lymphatic leukaemia and occurred in Sardinia in the Eighties and in the area of Roma in the Nineties. A possible reason for the paucity of reports (compared, for instance, to the UK scenario) is the limited availability of health statistics.
Collapse
Affiliation(s)
- Milena Maule
- Unità di epidemiologia dei tumori, Dipartimento di scienze mediche, Università di Torino e Centro per la prevenzione oncologica della Regione Piemonte, Torino.
| | - Benedetto Terracini
- Unità di epidemiologia dei tumori, Dipartimento di scienze mediche, Università di Torino e Centro per la prevenzione oncologica della Regione Piemonte, Torino.
| |
Collapse
|
42
|
Ferrari A, Rondelli R, Pession A, Mascarin M, Buzzoni C, Mosso ML, Maule M, Barisone E, Bertolotti M, Clerici CA, Jankovic M, Fagioli F, Biondi A. Adolescents with Cancer in Italy: Improving Access to National Cooperative Pediatric Oncology Group (AIEOP) Centers. Pediatr Blood Cancer 2016; 63:1116-9. [PMID: 26914476 DOI: 10.1002/pbc.25954] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/11/2015] [Accepted: 01/28/2016] [Indexed: 10/22/2022]
Abstract
This analysis compared the numbers of patients treated at Italian pediatric oncology group (Associazione Italiana Ematologia Oncologia Pediatrica [AIEOP]) centers with the numbers of cases predicted according to the population-based registry. It considered 32,431 patients registered in the AIEOP database (1989-2012). The ratio of observed (O) to expected (E) cases was 0.79 for children (0-14 years old) and 0.15 for adolescents (15-19 years old). The proportion of adolescents increased significantly over the years, however, from 0.05 in the earliest period to 0.10, 0.18, and then 0.28 in the latest period of observation, suggesting a greater efficacy of local/national programs dedicated to adolescents.
Collapse
Affiliation(s)
- Andrea Ferrari
- Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy
| | - Roberto Rondelli
- Pediatric Oncology and Hematology Unit "Lalla Seràgnoli,", University of Bologna, Bologna, Italy
| | - Andrea Pession
- Pediatric Oncology and Hematology Unit "Lalla Seràgnoli,", University of Bologna, Bologna, Italy
| | - Maurizio Mascarin
- Pediatric Radiotherapy Unit, Centro di Riferimento Oncologico, Aviano, Italy
| | - Carlotta Buzzoni
- Clinical and Descriptive Epidemiology and Registries Unit, ISPO-Cancer Research and Prevention Institute, Florence, Italy
| | - Maria Luisa Mosso
- Childhood Cancer Registry of Piedmont, Department of Medical Sciences, University of Turin, Italy
| | - Milena Maule
- Childhood Cancer Registry of Piedmont, Department of Medical Sciences, University of Turin, Italy
| | - Elena Barisone
- Pediatric Onco-Hematology, Stem Cell Transplantation and Cellular Therapy Division, Regina Margherita Children's Hospital, Torino, Italy
| | - Marina Bertolotti
- Pediatric Onco-Hematology, Stem Cell Transplantation and Cellular Therapy Division, Regina Margherita Children's Hospital, Torino, Italy
| | - Carlo Alfredo Clerici
- Department of Biomolecular Sciences and Biotechnology, Psychology Section, Faculty of Medicine, University of Milan, Milano, Italy
| | - Momcilo Jankovic
- Pediatric Hematology-Oncology Department and "Tettamanti" Research Centre, Milano-Bicocca University, "Fondazione MBBM," San Gerardo Hospital, Monza, Italy
| | - Franca Fagioli
- Pediatric Onco-Hematology, Stem Cell Transplantation and Cellular Therapy Division, Regina Margherita Children's Hospital, Torino, Italy
| | - Andrea Biondi
- Pediatric Hematology-Oncology Department and "Tettamanti" Research Centre, Milano-Bicocca University, "Fondazione MBBM," San Gerardo Hospital, Monza, Italy
| |
Collapse
|
43
|
Scarisbrick JJ, Prince HM, Vermeer MH, Quaglino P, Horwitz S, Porcu P, Stadler R, Wood GS, Beylot-Barry M, Pham-Ledard A, Foss F, Girardi M, Bagot M, Michel L, Battistella M, Guitart J, Kuzel TM, Martinez-Escala ME, Estrach T, Papadavid E, Antoniou C, Rigopoulos D, Nikolaou V, Sugaya M, Miyagaki T, Gniadecki R, Sanches JA, Cury-Martins J, Miyashiro D, Servitje O, Muniesa C, Berti E, Onida F, Corti L, Hodak E, Amitay-Laish I, Ortiz-Romero PL, Rodríguez-Peralto JL, Knobler R, Porkert S, Bauer W, Pimpinelli N, Grandi V, Cowan R, Rook A, Kim E, Pileri A, Patrizi A, Pujol RM, Wong H, Tyler K, Stranzenbach R, Querfeld C, Fava P, Maule M, Willemze R, Evison F, Morris S, Twigger R, Talpur R, Kim J, Ognibene G, Li S, Tavallaee M, Hoppe RT, Duvic M, Whittaker SJ, Kim YH. Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model. J Clin Oncol 2015; 33:3766-73. [PMID: 26438120 PMCID: PMC4979132 DOI: 10.1200/jco.2015.61.7142] [Citation(s) in RCA: 271] [Impact Index Per Article: 30.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022] Open
Abstract
PURPOSE Advanced-stage mycosis fungoides (MF; stage IIB to IV) and Sézary syndrome (SS) are aggressive lymphomas with a median survival of 1 to 5 years. Clinical management is stage based; however, there is wide range of outcome within stages. Published prognostic studies in MF/SS have been single-center trials. Because of the rarity of MF/SS, only a large collaboration would power a study to identify independent prognostic markers. PATIENTS AND METHODS Literature review identified the following 10 candidate markers: stage, age, sex, cutaneous histologic features of folliculotropism, CD30 positivity, proliferation index, large-cell transformation, WBC/lymphocyte count, serum lactate dehydrogenase, and identical T-cell clone in blood and skin. Data were collected at specialist centers on patients diagnosed with advanced-stage MF/SS from 2007. Each parameter recorded at diagnosis was tested against overall survival (OS). RESULTS Staging data on 1,275 patients with advanced MF/SS from 29 international sites were included for survival analysis. The median OS was 63 months, with 2- and 5-year survival rates of 77% and 52%, respectively. The median OS for patients with stage IIB disease was 68 months, but patients diagnosed with stage III disease had slightly improved survival compared with patients with stage IIB, although patients diagnosed with stage IV disease had significantly worse survival (48 months for stage IVA and 33 months for stage IVB). Of the 10 variables tested, four (stage IV, age > 60 years, large-cell transformation, and increased lactate dehydrogenase) were independent prognostic markers for a worse survival. Combining these four factors in a prognostic index model identified the following three risk groups across stages with significantly different 5-year survival rates: low risk (68%), intermediate risk (44%), and high risk (28%). CONCLUSION To our knowledge, this study includes the largest cohort of patients with advanced-stage MF/SS and identifies markers with independent prognostic value, which, used together in a prognostic index, may be useful to stratify advanced-stage patients.
Collapse
Affiliation(s)
- Julia J. Scarisbrick
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - H. Miles Prince
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Maarten H. Vermeer
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Pietro Quaglino
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Steven Horwitz
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Pierluigi Porcu
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Rudolf Stadler
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Gary S. Wood
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Marie Beylot-Barry
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Anne Pham-Ledard
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Francine Foss
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Michael Girardi
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Martine Bagot
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Laurence Michel
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Maxime Battistella
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Joan Guitart
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Timothy M. Kuzel
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Maria Estela Martinez-Escala
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Teresa Estrach
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Evangelia Papadavid
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Christina Antoniou
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Dimitis Rigopoulos
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Vassilki Nikolaou
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Makoto Sugaya
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Tomomitsu Miyagaki
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Robert Gniadecki
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - José Antonio Sanches
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Jade Cury-Martins
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Denis Miyashiro
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Octavio Servitje
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Cristina Muniesa
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Emilio Berti
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Francesco Onida
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Laura Corti
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Emilia Hodak
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Iris Amitay-Laish
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Pablo L. Ortiz-Romero
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Jose L. Rodríguez-Peralto
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Robert Knobler
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Stefanie Porkert
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Wolfgang Bauer
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Nicola Pimpinelli
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Vieri Grandi
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Richard Cowan
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Alain Rook
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Ellen Kim
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Alessandro Pileri
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Annalisa Patrizi
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Ramon M. Pujol
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Henry Wong
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Kelly Tyler
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Rene Stranzenbach
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Christiane Querfeld
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Paolo Fava
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Milena Maule
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Rein Willemze
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Felicity Evison
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Stephen Morris
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Robert Twigger
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Rakhshandra Talpur
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Jinah Kim
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Grant Ognibene
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Shufeng Li
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Mahkam Tavallaee
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Richard T. Hoppe
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Madeleine Duvic
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Sean J. Whittaker
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| | - Youn H. Kim
- Julia J. Scarisbrick and Felicity Evison, University Hospital Birmingham, Birmingham; Richard Cowan, The Christie Hospital, Manchester; Stephen Morris and Sean J. Whittaker, St Thomas' Hospital, London, United Kingdom; H. Miles Prince and Robert Twigger, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Maarten H. Vermeer and Rein Willemze, Leiden University Medical Centre, Leiden, the Netherlands; Pietro Quaglino, Paolo Fava, and Milena Maule, University of Turin (Torino), Turin; Emilio Berti, Francesco Onida, and Laura Corti, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda Ospedale Maggiore Policlinico, University of Milano-Bicocca, Milan; Nicola Pimpinelli and Vieri Grandi, University of Florence, Florence; Alessandro Pileri and Annalisa Patrizi, University of Bologna, Bologna, Italy; Steven Horwitz and Christiane Querfeld, Memorial Sloan-Kettering Cancer Center, New York, NY; Pierluigi Porcu, Henry Wong, and Kelly Tyler, Ohio State University, Columbus, OH; Gary S. Wood, University of Wisconsin, Madison, WI; Francine Foss and Michael Girardi, Yale University, New Haven, CT; Joan Guitart, Timothy M. Kuzel, and Maria Estela Martinez-Escala, Northwestern University, Chicago, IL; Alain Rook and Ellen Kim, University of Pennsylvania, Philadelphia; PA; Christiane Querfeld, City of Hope Hospital, Duarte; Jinah Kim, Grant Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, and Youn H. Kim, Stanford University Medical Center, Stanford, CA; Rakhshandra Talpur and Madeleine Duvic, The University of Texas MD Anderson Cancer Center, Houston, TX; Rudolf Stadler and Rene Stranzenbach, Unit University Munster, Minden, Germany; Marie Beylot-Barry and Anne Pham-Ledard, Centre Hospitalier Universitaire Hospital de Bordeaux, Bordeaux; Martine Bagot, Laurence Michel, and Maxime Battistella, Hospital St Louis, Paris, France; Teresa Estrach, Hospital Clínico, University of Barcelona, Villarroel; Octavio Servitje and Cristina Muniesa, Hospital Universatari de Bellvitge, Idibell; Ramon M. Pujol, Hospital del Mar, Universitat Autònoma Barcelona, Barcelona; Pablo L. Ortiz-Romero and Jose L. Rodríguez-Peralto, Hospital 12 de Octubre, Research Institute, Medical School, Universidad Complutense, Madrid, Spain; Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, and Vassilki Nikolaou, Athens University Medical School, Athens, Greece; Makoto Sugaya and Tomomitsu Miyagaki, University of Tokyo, Tokyo, Japan; Robert Gniadecki, Bispebjerg Hospital, Copenhagen University, Copenhagen, Denmark; José Antonio Sanches, Jade Cury-Martins, and Denis Miyashiro, University of Sao Paulo Medical School, Sao Paulo, Brazil; Emilia Hodak and Iris Amitay-Laish, Rabin Medical, Beilinson Hospital, Tel Aviv University, Tel Aviv, Israel; and Robert Knobler, Stefanie Porkert, and Wolfgang Bauer, Medical University of Vienna, Vienna, Austria
| |
Collapse
|
44
|
Magnani C, Bianchi C, Chellini E, Consonni D, Fubini B, Gennaro V, Marinaccio A, Menegozzo M, Mirabelli D, Merler E, Merletti F, Musti M, Oddone E, Romanelli A, Terracini B, Zona A, Zocchetti C, Alessi M, Baldassarre A, Dianzani I, Maule M, Mensi C, Silvestri S. III Italian Consensus Conference on Malignant Mesothelioma of the Pleura. Epidemiology, Public Health and Occupational Medicine related issues. Med Lav 2015; 106:325-332. [PMID: 26384258] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Received: 06/22/2015] [Accepted: 06/24/2015] [Indexed: 06/05/2023]
Abstract
The III Italian Consensus Conference on Pleural Mesothelioma (MM) convened on January 29th 2015. This report presents the conclusions of the 'Epidemiology, Public Health and Occupational Medicine' section. MM incidence in 2011 in Italy was 3.64 per 100,000 person/years in men and 1.32 in women. Incidence trends are starting to level off. Ten percent of cases are due to non-occupational exposure. Incidence among women is very high in Italy, because of both non-occupational and occupational exposure. The removal of asbestos in place is proceeding slowly, with remaining exposure. Recent literature confirms the causal role of chrysotile. Fibrous fluoro-edenite was classified as carcinogenic by IARC (Group 1) on the basis of MM data. A specific type (MWCNT-7) of Carbon Nanotubes was classified 2B. For pleural MM, after about 45 years since first exposure, the incidence trend slowed down; with more studies needed. Cumulative exposure is a proxy of the relevant exposure, but does not allow to distinguish if duration or intensity may possibly play a prominent role, neither to evaluate the temporal sequence of exposures. Studies showed that duration and intensity are independent determinants of MM. Blood related MM are less than 2.5%. The role of BAP1 germline mutations is limited to the BAP1 cancer syndrome, but negligible for sporadic cases. Correct MM diagnosis is baseline; guidelines agree on the importance of the tumor gross appearance and of the hematoxylin-eosin-based histology. Immunohistochemical markers contribute to diagnostic confirmation: the selection depends on morphology, location, and differential diagnosis. The WG suggested that 1) General Cancer Registries and ReNaM Regional Operational Centres (COR) interact and systematically compare MM cases; 2) ReNaM should report results presenting the diagnostic certainty codes and the diagnostic basis, separately; 3) General Cancer Registries and COR should interact with pathologists to assure the up-to-date methodology; 4) Necroscopy should be practiced for validation. Expert referral centres could contribute to the definition of uncertain cases. Health surveillance should aim to all asbestos effects. No diagnostic test is recommended for MM screening. Health surveillance should provide information on risks, medical perspective, and smoking cessation. The economic burden associated to MM was estimated in 250,000 Euro per case.
Collapse
Affiliation(s)
- C Magnani
- Dipartimento di Medicina Traslazionale - Università del Piemonte Orientale.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
45
|
Cadoni G, Boccia S, Leoncini E, Petrelli L, Vukovic V, Pastorino R, Arzani D, Bosetti C, Canova C, Garavello W, La Vecchia C, Maule M, Pira E, Polesel J, Richiardi L, Serraino D, Simonato L, Ricciardi W, Pandolfi ni M, Batti sta M, Paludetti G, Almadori G. P17 Clinical features and prognostic factors in patients with head and neck cancer – Results from a multicentric study. Oral Oncol 2015. [DOI: 10.1016/j.oraloncology.2015.02.065] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
46
|
Richiardi L, Maule M. [Stem cell division is necessary for oncogenesis, primary prevention is necessary to fight cancer]. Epidemiol Prev 2015; 39:86-87. [PMID: 26036736] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Affiliation(s)
- Lorenzo Richiardi
- SCDU epidemiologia dei tumori, Dipartimento di scienze mediche, Università di Torino e CPO-Piemonte, Torino.
| | - Milena Maule
- SCDU epidemiologia dei tumori, Dipartimento di scienze mediche, Università di Torino e CPO-Piemonte, Torino
| |
Collapse
|
47
|
Sadetzki S, Langer CE, Bruchim R, Kundi M, Merletti F, Vermeulen R, Kromhout H, Lee AK, Maslanyj M, Sim MR, Taki M, Wiart J, Armstrong B, Milne E, Benke G, Schattner R, Hutter HP, Woehrer A, Krewski D, Mohipp C, Momoli F, Ritvo P, Spinelli J, Lacour B, Delmas D, Remen T, Radon K, Weinmann T, Klostermann S, Heinrich S, Petridou E, Bouka E, Panagopoulou P, Dikshit R, Nagrani R, Even-Nir H, Chetrit A, Maule M, Migliore E, Filippini G, Miligi L, Mattioli S, Yamaguchi N, Kojimahara N, Ha M, Choi KH, Mannetje A', Eng A, Woodward A, Carretero G, Alguacil J, Aragones N, Suare-Varela MM, Goedhart G, Schouten-van Meeteren AAYN, Reedijk AAMJ, Cardis E. The MOBI-Kids Study Protocol: Challenges in Assessing Childhood and Adolescent Exposure to Electromagnetic Fields from Wireless Telecommunication Technologies and Possible Association with Brain Tumor Risk. Front Public Health 2014; 2:124. [PMID: 25295243 PMCID: PMC4172002 DOI: 10.3389/fpubh.2014.00124] [Citation(s) in RCA: 47] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2014] [Accepted: 08/05/2014] [Indexed: 12/18/2022] Open
Abstract
The rapid increase in mobile phone use in young people has generated concern about possible health effects of exposure to radiofrequency (RF) and extremely low frequency (ELF) electromagnetic fields (EMF). MOBI-Kids, a multinational case-control study, investigates the potential effects of childhood and adolescent exposure to EMF from mobile communications technologies on brain tumor risk in 14 countries. The study, which aims to include approximately 1,000 brain tumor cases aged 10-24 years and two individually matched controls for each case, follows a common protocol and builds upon the methodological experience of the INTERPHONE study. The design and conduct of a study on EMF exposure and brain tumor risk in young people in a large number of countries is complex and poses methodological challenges. This manuscript discusses the design of MOBI-Kids and describes the challenges and approaches chosen to address them, including: (1) the choice of controls operated for suspected appendicitis, to reduce potential selection bias related to low response rates among population controls; (2) investigating a young study population spanning a relatively wide age range; (3) conducting a large, multinational epidemiological study, while adhering to increasingly stricter ethics requirements; (4) investigating a rare and potentially fatal disease; and (5) assessing exposure to EMF from communication technologies. Our experience in thus far developing and implementing the study protocol indicates that MOBI-Kids is feasible and will generate results that will contribute to the understanding of potential brain tumor risks associated with use of mobile phones and other wireless communications technologies among young people.
Collapse
Affiliation(s)
- Siegal Sadetzki
- Cancer and Radiation Epidemiology Unit, Gertner Institute, Chaim Sheba Medical Center , Ramat Gan , Israel
| | - Chelsea Eastman Langer
- Centre for Research in Environmental Epidemiology (CREAL) , Barcelona , Spain ; Universitat Pompeu Fabra (UPF) , Barcelona , Spain ; Ciber Epidemiología y Salud Pública (CIBERESP) , Barcelona , Spain
| | - Revital Bruchim
- Cancer and Radiation Epidemiology Unit, Gertner Institute, Chaim Sheba Medical Center , Ramat Gan , Israel
| | - Michael Kundi
- Center for Public Health, Institute of Environmental Health, Medical University Vienna , Vienna , Austria
| | - Franco Merletti
- Unit of Cancer Epidemiology, Department of Medical Sciences, University of Turin , Turin , Italy
| | - Roel Vermeulen
- Division Environmental Epidemiology, Institute for Risk Assessment Sciences, Utrecht University , Utrecht , Netherlands
| | - Hans Kromhout
- Division Environmental Epidemiology, Institute for Risk Assessment Sciences, Utrecht University , Utrecht , Netherlands
| | - Ae-Kyoung Lee
- Radio Technology Research Department, Electronics and Telecommunication Research Institute (ETRI) , Daejeon , South Korea
| | - Myron Maslanyj
- Centre for Radiation, Chemical and Environmental Hazards, Public Health England , Chilton , UK
| | - Malcolm R Sim
- Department of Epidemiology and Preventive Medicine, Monash University, Melbourne , VIC , Australia
| | - Masao Taki
- Department of Electrical Engineering, Tokyo Metropolitan University , Tokyo , Japan
| | | | | | - Elizabeth Milne
- Telecom Institute for Child Health Research Western Australia , Perth, WA , Australia
| | - Geza Benke
- Department of Epidemiology and Preventive Medicine, Monash University, Melbourne , VIC , Australia
| | - Rosa Schattner
- Department of Epidemiology and Preventive Medicine, Monash University, Melbourne , VIC , Australia
| | - Hans-Peter Hutter
- Center for Public Health, Institute of Environmental Health, Medical University Vienna , Vienna , Austria
| | - Adelheid Woehrer
- Clinical Institute of Neurology, Medical University Vienna , Vienna , Austria
| | - Daniel Krewski
- McLaughlin Centre for Population Health Risk Assessment, Institute of Population Health , Ottawa, ON , Canada ; Department of Epidemiology and Community Medicine, Faculty of Medicine, University of Ottawa , Ottawa, ON , Canada
| | - Charmaine Mohipp
- Children's Hospital of Eastern Ontario , Ottawa, ON , Canada ; University of Ottawa , Ottawa, ON , Canada
| | - Franco Momoli
- Ottawa Hospital Research Institute , Ottawa, ON , Canada ; Children's Hospital of Eastern Ontario Research Institute , Ottawa, ON , Canada
| | - Paul Ritvo
- Research, Prevention and Cancer Control, Cancer Care Ontario , Ontario, ON , Canada
| | - John Spinelli
- Cancer Control Research, British Columbia Cancer Agency , Vancouver, BC , Canada
| | - Brigitte Lacour
- French National Registry of Childhood Solid Tumors, CHU , Nancy , France ; UMRS 1018, CESP, INSERM , Villejuif , France
| | - Dominique Delmas
- French National Registry of Childhood Solid Tumors, CHU , Nancy , France
| | - Thomas Remen
- French National Registry of Childhood Solid Tumors, CHU , Nancy , France
| | - Katja Radon
- Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine, University Hospital of Munich (LMU) , Munich , Germany
| | - Tobias Weinmann
- Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine, University Hospital of Munich (LMU) , Munich , Germany
| | - Swaantje Klostermann
- Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine, University Hospital of Munich (LMU) , Munich , Germany
| | - Sabine Heinrich
- Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine, University Hospital of Munich (LMU) , Munich , Germany
| | - Eleni Petridou
- Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens , Athens , Greece
| | - Evdoxia Bouka
- Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens , Athens , Greece
| | - Paraskevi Panagopoulou
- Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens , Athens , Greece
| | - Rajesh Dikshit
- Centre for Cancer Epidemiology, Tata Memorial Centre , Mumbai , India
| | - Rajini Nagrani
- Centre for Cancer Epidemiology, Tata Memorial Centre , Mumbai , India
| | - Hadas Even-Nir
- Cancer and Radiation Epidemiology Unit, Gertner Institute, Chaim Sheba Medical Center , Ramat Gan , Israel
| | - Angela Chetrit
- Cancer and Radiation Epidemiology Unit, Gertner Institute, Chaim Sheba Medical Center , Ramat Gan , Israel
| | - Milena Maule
- Unit of Cancer Epidemiology, Department of Medical Sciences, University of Turin , Turin , Italy
| | - Enrica Migliore
- Unit of Cancer Epidemiology, Citta' della Salute e della Scienza, University of Turin , Turin , Italy
| | - Graziella Filippini
- Neuroepidemiology Research Unit, Instituto Nazionale Neurologico C. Besta , Milan , Italy
| | - Lucia Miligi
- Unit of Occupational and Environmental Epidemiology, Institute for the Study and Prevention of Cancer , Florence , Italy
| | - Stefano Mattioli
- Department of Medical and Surgical Sciences, University of Bologna , Bologna , Italy
| | - Naohito Yamaguchi
- Department of Public Health, Tokyo Women's Medical University , Tokyo , Japan
| | - Noriko Kojimahara
- Department of Public Health, Tokyo Women's Medical University , Tokyo , Japan
| | - Mina Ha
- Department of Preventive Medicine, Dankook University College of Medicine , Cheonan , South Korea
| | - Kyung-Hwa Choi
- Department of Public Health, Graduate School of Dankook University , Cheonan , South Korea
| | - Andrea 't Mannetje
- Centre for Public Health Research, Massey University , Wellington , New Zealand
| | - Amanda Eng
- Centre for Public Health Research, Massey University , Wellington , New Zealand
| | - Alistair Woodward
- School of Population Health, University of Auckland , Auckland , New Zealand
| | - Gema Carretero
- Centre for Research in Environmental Epidemiology (CREAL) , Barcelona , Spain ; Universitat Pompeu Fabra (UPF) , Barcelona , Spain ; Ciber Epidemiología y Salud Pública (CIBERESP) , Barcelona , Spain
| | - Juan Alguacil
- Centro de Investigación en Salud y Medio Ambiente (CYSMA), Universidad de Huelva , Huelva , Spain ; Ciber Epidemiología y Salud Pública (CIBERESP) , Huelva , Spain
| | - Nuria Aragones
- Cancer and Environmental Epidemiology Area, National Center for Epidemiology, Carlos III Institute of Health , Madrid , Spain ; Ciber Epidemiología y Salud Pública (CIBERESP) , Madrid , Spain
| | - Maria Morales Suare-Varela
- Ciber Epidemiología y Salud Pública (CIBERESP) , Madrid , Spain ; Área de Medicina Preventiva y Salud Pública, Universitat de Valencia , Valencia , Spain
| | - Geertje Goedhart
- Division Environmental Epidemiology, Institute for Risk Assessment Sciences, Utrecht University , Utrecht , Netherlands
| | - A Antoinette Y N Schouten-van Meeteren
- Department of Paediatric Oncology, Academic Medical Center, Emma Children's Hospital, University of Amsterdam , Amsterdam , Netherlands ; Dutch Childhood Oncology Group (DCOG) , Den Haag , Netherlands
| | | | - Elisabeth Cardis
- Centre for Research in Environmental Epidemiology (CREAL) , Barcelona , Spain ; Universitat Pompeu Fabra (UPF) , Barcelona , Spain ; Ciber Epidemiología y Salud Pública (CIBERESP) , Barcelona , Spain
| |
Collapse
|
48
|
Iavarone I, Biggeri A, Cadum E, Carere M, Conti S, Crocetti E, Martuzzi M, Maule M, Michelozzi P, Pirastu R, Rondelli R, Scondotto S. [SENTIERI KIDS: monitoring children's health in Italian polluted sites]. Epidemiol Prev 2014; 38:153-157. [PMID: 24986504] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
Protecting children's health from the effects of environmental contamination is a public health priority. In recent years, particular care has been devoted in Italy to the study of the relationship between environmental pollutants and health during infancy. The SENTIERI Project has called attention to increases in infant mortality in National Priority Contaminated Sites (NPCSs). SENTIERI KIDS provides a blueprint for the establishment of a task force charged with establishing multi and inter-disciplinary cooperation between central and regional institutions on the subject of children's health in contaminated sites. SENTIERI KIDS introduces a multiple outcome analytical model based on updated health outcomes (mortality, cancer incidence, hospital discharges) in order to establish a permanent observation system to monitor the state of health of infants residing in contaminated areas. This will pave the way for more in-depth epidemiological enquiries on an individual basis, and support the establishment and continued monitoring of primary prevention projects. Particular attention is devoted to issues of information and communication.
Collapse
Affiliation(s)
- Ivano Iavarone
- WHO Collaborating Centre for Environmental Health in Contaminated Sites, Roma.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
49
|
Manzoni P, Meyer M, Stolfi I, Rinaldi M, Cattani S, Pugni L, Romeo MG, Messner H, Decembrino L, Laforgia N, Vagnarelli F, Memo L, Bordignon L, Maule M, Gallo E, Mostert M, Quercia M, Bollani L, Pedicino R, Renzullo L, Betta P, Ferrari F, Alexander T, Magaldi R, Farina D, Mosca F, Stronati M. Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in very-low-birth-weight neonates: a randomized clinical trial. Early Hum Dev 2014; 90 Suppl 1:S60-5. [PMID: 24709463 DOI: 10.1016/s0378-3782(14)70020-9] [Citation(s) in RCA: 137] [Impact Index Per Article: 13.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
IMPORTANCE NEC is a common and severe complication in premature neonates, particularly those with very-low-birth-weight (VLBW, <1500 g at birth). Probiotics including lactobacillus rhamnosus GG (LGG) proved effective in preventing NEC in preterm infants in several RCTs. OBJECTIVE Lactoferrin, a mammalian milk glycoprotein involved in innate immune host defences, can reduce the incidence of NEC in animal models, and its action is enhanced by LGG. We tried to assess whether bovine lactoferrin (BLF), alone or with the probiotic LGG, has a similar effect in human infants, something that has not yet been studied. DESIGN An international, multicenter, randomized, double-blind, placebo-controlled trial conducted from October 1st, 2007 through July 31st, 2010. SETTING Thirteen Italian and New Zealand tertiary neonatal intensive care units. PARTICIPANTS 743 VLBW neonates were assessed until discharge for development of NEC. INTERVENTION Infants were randomly assigned to receive orally either BLF (100 mg/day) alone (group LF; n = 247) or with LGG (at 6×10(9) CFU/day; group BLF + LGG; n = 238), or placebo (Control group; n = 258) from birth until day 30 of life (45 for neonates <1000 g at birth). MAIN OUTCOME MEASURES ≥ stage 2 NEC; death-and/or-≥ stage 2 NEC prior to discharge. RESULTS Demographics, clinical and management characteristics of the 3 groups were similar, including type of feeding and maternal milk intakes. NEC incidence was significantly lower in groups BLF and BLF + LGG [5/247 (2.0%)] and 0/238 (0%), respectively] than in controls [14/258 (5.4%)] (RR = 0.37; 95% CI: 0.136-1.005; p = 0.055 for BLF vs. control; RR = 0.00; p < 0.001 for BLF + LGG vs. control). The incidence of death-and/or-NEC was significantly lower in both treatment groups (4.0% and 3.8% in BLF and BLF + LGG vs. 10.1% in control; RR = 0.39; 95% CI: 0.19-0.80; p = 0.008. RR = 0.37; 95% CI: 0.18-0.77; p = 0.006, respectively). No adverse effects or intolerances to treatment occurred. CONCLUSIONS AND RELEVANCE Compared with placebo, BLF supplementation alone or in combination with LGG reduced the incidence of ≥ stage 2 NEC and of death-and/or ≥ stage 2 NEC in VLBW neonates. BLF might be a promising strategy to prevent NEC in NICU settings. Further data on larger sample sizes are warranted before BLF can be widespreadly used in clinical settings. TRIAL REGISTRATION ISRCTN53107700-http://www.controlled-_trials.com/ISRCTN53107700.
Collapse
Affiliation(s)
- Paolo Manzoni
- Neonatology and NICU, S. Anna Hospital; Torino, Italy.
| | - Michael Meyer
- Neonatology and NICU, Middlemore Hospital; Auckland, New Zealand
| | - Ilaria Stolfi
- Neonatology and NICU, Policlinico Umberto, Roma, Italy
| | | | - Silvia Cattani
- Neonatology and NICU, University of Modena, Modena, Italy
| | - Lorenza Pugni
- NICU, Department of Clinical Sciences and Community Health, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano; Milano, Italy
| | - Mario Giovanni Romeo
- Neonatology and NICU, Azienda Ospedaliera Universitaria Policlinico, Catania, Italy
| | - Hubert Messner
- Neonatology and NICU, Ospedale Regionale, Bolzano, Italy
| | - Lidia Decembrino
- Neonatology and NICU, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
| | - Nicola Laforgia
- Neonatology and NICU, Policlinico University Hospital, Bari, Italy
| | | | - Luigi Memo
- Neonatology and NICU, Cà Foncello Hospital, Treviso, Italy
| | | | - Milena Maule
- Department of Biomedical Sciences and Human Oncology, Cancer Epidemiology Unit, University of Torino, Torino, Italy
| | - Elena Gallo
- Neonatology and NICU, S. Anna Hospital; Torino, Italy
| | - Michael Mostert
- Department of Pediatrics, University of Torino, Torino, Italy
| | - Michele Quercia
- Neonatology and NICU, Policlinico University Hospital, Bari, Italy
| | - Lina Bollani
- Neonatology and NICU, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
| | | | - Livia Renzullo
- Neonatology and NICU, Ospedale Regionale, Bolzano, Italy
| | - Pasqua Betta
- Neonatology and NICU, Azienda Ospedaliera Universitaria Policlinico, Catania, Italy
| | | | - Tanith Alexander
- Neonatology and NICU, Middlemore Hospital; Auckland, New Zealand
| | | | | | - Fabio Mosca
- NICU, Department of Clinical Sciences and Community Health, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano; Milano, Italy
| | | |
Collapse
|
50
|
Bruno G, Maule M, Biggeri A, Ledda A, Mannu C, Merletti F, Songini M. More than 20 years of registration of type 1 diabetes in Sardinian children: temporal variations of incidence with age, period of diagnosis, and year of birth. Diabetes 2013; 62:3542-6. [PMID: 23835336 PMCID: PMC3781461 DOI: 10.2337/db12-1771] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
We analyzed Sardinian registry data to assess time trends in incidence rates (IRs) of type 1 diabetes during the period 1989-2009 (2,371 case subjects 0-14 years of age). Poisson regression models were used to estimate the effects of sex, age, period of diagnosis, and birth cohorts. IR was 44.8 cases/100,000 person-years (95% CI 43.1-46.7). The annual increase was 2.12% (1.45-2.80; test for linear trend, P < 0.001). For boys, the increasing trend was evident up to 5 years of age and for girls up to 8 years of age. Compared with the 1989-1994 birth cohort, the relative risk increased from 0.78 (0.61-1.10) in 1974-1979 to 1.62 (1.18-2.23) in 2004-2009. The increase over period was less striking, with a tendency to regress in more recent years. The best-fitting model for boys included age and a linear time trend, and for girls age and nonlinear effects of calendar period and birth cohort. In conclusion, incidence increased over time, and the increase tended to level off in more recent years by calendar period but not by birth cohort, with some evidence of a stronger increase among girls than boys. Should the increase be attributable to the effects of some perinatal environmental factor, this would mean that such a factor has started affecting females before males.
Collapse
Affiliation(s)
- Graziella Bruno
- Department of Medical Sciences, University of Turin, Turin, Italy
- Corresponding author: Graziella Bruno,
| | - Milena Maule
- Department of Medical Sciences, University of Turin, Turin, Italy
- Cancer Epidemiology Unit, Center for Experimental Research and Medical Studies, and CPO-Piemonte, Hospital Città della Salute e della Scienza, Turin, Italy
| | - Annibale Biggeri
- Department of Statistics G. Parenti, University of Florence, Florence, Italy
| | | | - Carla Mannu
- Diabetes Unit, Brotzu Hospital, Cagliari, Italy
| | - Franco Merletti
- Department of Medical Sciences, University of Turin, Turin, Italy
- Cancer Epidemiology Unit, Center for Experimental Research and Medical Studies, and CPO-Piemonte, Hospital Città della Salute e della Scienza, Turin, Italy
| | | | | |
Collapse
|